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S1D-1-1  Genetically engineered mice 
used as tools in the pathophysiological 
clarifi cation of the role of histamine in 
allergic reactions
Hiroshi Ohtsu1, Noriyasu Hirasawa2
1Grad. Sch. Engineering., Tohoku Univ., 2Grad. Sch. Pharmaceu. Sci., Tohoku 
Univ.
Allergic reactions to metals are characterized by itching 
sensation, redness, swelling, and blistering in the affected 
skin region. The metal is ionized by the body fluids, 
penetrates the skin, or is absorbed from the digestive 
tract. Once incorporated into the system, it sensitizes 
the body. Ionized metals act as haptens by binding to 
Langerhans or dendritic cells, which enter the lymph nodes. 
Histamine is an important mediator of allergy to metals. 
However, its precise source and role in allergic response 
is yet to be determined. Using histidine-decarboxylase 
gene knockout mice, we demonstrated histamine-induced 
skin thickening during metal-induced inflammation. We 
have also generated reporter mice for this gene, in which 
the histamine-producing cells were expected to produce 
fluorescence. The green fluorescent protein gene was 
inserted at the transcription start site of the HDC gene in a 
bacterial artiÀ cial chromosome vector. The gene expression 
was confirmed in the tuberomammillary nucleus and in 
enterochromaffin-like cells, both of which are well-known 
histamine producers. Through nickel-induced inÁ ammation 
in these mice, we aim to further elucidate the roles of 
histamine and histamine producing cells, which is important 
for skin pathology.
S1D-1-3  Protective effect of histamine 
H3 receptor antagonist on cerebral 
ischemic injury
Wei-wei Hu1,2, Xiang-nan Zhang1, Hai-jing Yan1, 
Hiroshi Ohtsu2, Feng Han1, Zhong Chen1
1Dept. Pharmacol., Key Lab. of Med. Neurobiol. of the Ministry of Health of 
China, Coll. Pharmaceu. Sci., Zhejiang Univ., 2Dept. Engineering, Sch. Med., 
Tohoku Univ.
In the present study, we found that H3 receptor expression 
was upregulated after ischemia/reperfusion (I/R) both in 
transient middle cerebral artery occlusion and oxygen-
glucose-deprivation/reperfusion models. Moreover, 
overexpression of H3R in HEK293 cells led to more cell 
death after serum deprivation. Either H3R antagonists 
(thioperamide, clobenpropit and A331440) or H3R knockout 
attenuated I/R-induced neuronal injury and apoptosis, which 
was reversed by its agonist immepip. Interestingly, H1 and 
H2 receptor-antagonists, alpha-FMH, a selective histidine 
decarboxylase (HDC) inhibitor, and HDC knockout all failed 
to compromise the protection by thioperamide. In addition, 
neuroprotection by thiopermide against I/R was reversed 
by 3-methyladenine and siRNA for Atg7. In Atg5-/- mouse 
embryonic fibroblasts, the protection was also diminished. 
Furthermore, either the peptide Tat-H3RCT414-436, which 
blocks chloride intracellular channel 4 (CLIC4) binding with 
the H3R, or siRNA for CLIC4 further increased I/R-induced 
autophagy and consequently protected against I/R injury. 
Therefore, we here provided direct evidence that H3R 
promotes I/R injury, its inhibition is protective, and this is 
independent of histamine, but attributable to suppressed 
H3R/CLIC4 binding-induced autophagy. Our results strongly 
suggest that H3R inhibition may be attractive as a potential 
clinical therapeutic target for cerebral ischemia.
Acknowledgement: This work was funded by the National 
Basic Research of China 973 Program (2011CB504403) 
the National Natural Science Foundation of China 
(81030061,81273506).S31S1D-1-2  The histamine H4 receptor: 
Translation of preclinical pharmacology 
to clinical effi cacy
Robin L. Thurmond
Janssen Pharmaceutical Research & Development, LLC
The histamine H4 receptor (H4R) is a high afÀ nity receptor 
for histamine and ligands that target the receptor have been 
reported to have effects in a variety of inflammatory and 
pruritic models. These data have generated interest in the 
therapeutic potential of these ligands for the treatment of 
asthma, atopic dermatitis, rheumatoid arthritis and many 
other diseases. The H4R responses in eosinophils have been 
well characterized. In these cells the receptor mediates 
calcium responses and chemotaxis. The chemotactic effect of 
histamine (and other chemoattractants) can be detected by 
changes in cell shape related to actin reorganization. This 
has now been used in a clinical setting to test the target 
engagement of the H4R antagonist JNJ-39758979 and the 
data show good correlation to the preclinical pharmacology 
data. JNJ-39758979 has also shown efficacy in preclinical 
pruritus and atopic dermatitis models. Preclinically it 
reduces histamine-induced scratching in mice and it 
reduces inÁ ammation in a FITC-induced dermatitis model. 
These À ndings have been validated in the clinic with JNJ-
39758979 being shown to reduce histamine-induce itch in 
humans and have effects in patients with atopic dermatitis. 
These recent clinical data support the translation of the 
preclinical findings with the H4R in the areas of pruritus 
and atopic dermatitis.
S1E-2-1  Introduction: New frontier in 
vascular biology
Hideyuki Yamawaki
Lab. Vet. Pharmacol., Sch. Vet. Med., Kitasato Univ.
Ischemic cardiovascular disease that is related to metabolic 
disorders including obesity, type II diabetes, atherosclerosis 
and hypertension is one of the leading causes for mortality 
in Japan. While a number of good drugs including inhibitors 
of renin-angiotensin system, Ca2+ antagonists, and statins 
have contributed to the treatment of those diseases, novel 
pharmaco-therapeutic targets are needed. Adipocytokine 
is an adipose-tissue derived cytokine and related to the 
pathogenesis of obesity-related cardiovascular disorders. 
Imbalanced secretion (good vs. bad adipocytokine) due 
to abnormal adipose hypertrophy may be related to 
the initiation and progression of the obesity-related 
cardiovascular diseases by directly acting on cardiovascular 
systems. Similarly, EDCF (endothelium-derived contracting 
factor) counteracts the vascular protective effects of EDRF 
(endothelium-derived relaxing factor) such as NO. Thus 
the imbalance of EDRF and EDCF may also underlie the 
pathogenesis of cardiovascular diseases related to metabolic 
disorders. In this symposium, we focus on adipocytokine 
and EDCF as well as their receptors including protease-
activated receptor (PAR), discuss on the recently discovered 
mechanisms of their actions, and explore the novel 
pharmaco-therapeutic targets.
S1E-2-2  A fat-derived factor omentin 
and cardiovascular disease
Rei Shibata1, Noriyuki Ouchi2, Toyoaki Murohara1
1Dept. Cardiol., Nagoya Univ. Grad. Sch. Med., 2Molecular Cardiovascular 
Med., Nagoya Univ. Grad. Sch. Med.
Adipose tissue functions as an endocrine organ by producing 
bioactive secretory proteins, also known as adipokines, 
that can directly act on nearby or remote organs. Most 
of adipokines are upregulated by obese conditions, and 
typically promote obese complications. In contrast, some 
adipokines are downregulated in obese states. These factors 
exert salutary actions on obesity-linked cardiovascular 
disorders. Omentin is originally identified as a soluble 
galactofuranose-binding lectin. Human omentin is 
abundantly expressed in omental/visceral fat depots. Plasma 
omentin concentration is down-regulated in subjects with 
obesity-related disorders. Low levels of circulating omentin 
appear to associate with the increased prevalence of obesity-
linked diseases including atherosclerosis and ischemic heart 
disease. A number of experimental studies have shown 
that omentin exerts beneÀ cial effects on the cardiovascular 
system by directly acting on the component cells in the 
heart and blood vessels. Thus, omentin could represent a 
therapeutic target molecule for prevention or treatment of 
cardiovascular diseases.
S1E-2-4  Protease-activated receptor 
2 in metabolic syndrome
Satomi Kagota1, Kana Maruyama1, John J. McGuire2
1Dept. Pharmacol. II, Sch. Pharmaceu. Sci., Mukogawa Women’s Univ., 
2Cardiovasc. Res. Group, Div. BioMedic. Sci., Memorial Univ.
Protease-activated receptor-2 (PAR2), one of four protease-
activated receptors, is expressed in the endothelium of 
arteries. PAR2 is activated by selective proteolysis by 
trypsin-like serine proteases, i.e. mast cellǃ-tryptase, 
neutrophil protease 3, membrane-tethered serine protease-1, 
tissue factor/VIIa complex, and factor Xa. These proteases 
have been proposed, via PAR2, to affect homeostasis of 
multiple physiological systems, including the cardiovascular, 
respiratory, and gastrointestinal systems, as well as 
inflammation and cancer. Metabolic syndrome (MetS) is 
characterized by the accumulation of atherosclerotic risk, 
which includes increased adiposity, insulin resistance, 
hypertension, and dyslipidemia. Adipocytes release many 
inflammatory factors that contribute to development of 
cardiovascular complications in MetS. We have found that 
vasodilation via PAR2 activation is preserved in SHRSP.
Z-Leprfa/IzmDmcr rat even under conditions involving the 
deterioration of nitric oxide (NO)-dependent pathway, and 
balance between NO and other relaxing factor(s) is altered 
for preserving vasodilation. In this symposium, we will 
introduce our findings about PAR2 modulation of vascular 
function and discuss deriving potential therapeutic beneÀ ts 
in MetS.S3S1E-2-3  Endothelium-derived 
contracting factor (EDCF) and vascular 
diseases: Focused on a novel EDCF 
uridine adenosine tetraphosphate
Takayuki Matsumoto, Kumiko Taguchi, 
Tsuneo Kobayashi
Dept. Physiol. and Morphol., Inst. Med. Chem., Hoshi Univ.
Endothelial dysfunction is hallmark in vascular associated 
diseases such as hypertension and diabetes. Endothelial 
cells release various vasoactive substances, namely, 
endothelium-derived relaxing factors (EDRFs) and 
contracting factors (EDCFs). In disease states, the balance 
between EDRFs and EDCFs is lost in various arteries. 
The alterations of signaling/response by these factors such 
as decreased EDRFs and increased EDCFs are seen in 
vessels from hypertension and diabetes. The regulation of 
these factors is one of the most important targets against 
the diseases. Uridine adenosine tetraphosphate (Up4A) is 
newly identified as an EDCF. Although some reports are 
investigated the responses of Up4A in various arteries, 
there are few studies focused on pathophysiological states. 
We recently found that the alterations of Up4A-induced 
contraction in various arteries were seen in hypertensive 
and diabetic animal models. In the present symposium, we 
will focus on the responses and signaling of Up4A in arteries 
from disease states and on the putative role of Up4A in the 
pathophysiological states.
S1F-3-1  Age- and pathophysiological-
dependent responses to Hojinzai
Hiroyasu Satoh1, Seiichiro Nishida2, 
Katsuharu Tsuchida3
1Health Life Sci., Shitennoji Univ., 2Seiran Hosp., 3Dept. of Rational Med. Sci. 
Pharmaceut. Sci., Doshisha Women’s College
These Kampo formulations increase the number of 
contained ingredients in increment of two herbs, and 
are applied for kidney-related disorders with ageing. 
Rokumigan (Rok) has six herbs as a base, Hachimijiogan 
(Hac) eight herbs (Rok plus two herbs), and Goshajinkigan 
(Gos) ten herbs (two herbs are added to Hac). These drugs 
produced a concentration-dependent vasodilatation (VD). In 
10-15w rats, prior administrations of 100ǍM L-NAME and 
100ǍM indomethacin did not affect the VD induced by three 
formulations. Nicardipine (2ǍM) attenuated Rok-induced 
VD, but failed to affect both Hac- and Gos-induced VDs. 
These drugs reduced high KCl induced, and attenuated a 
PK-C activator-induced vasoconstrictions. These results 
indicate that the VD is not due to endothelium dependent 
mechanisms, but due to PK-C inhibition. Rok inhibited 
Ca2+ channel. As compared with young rats, the responses 
were stronger in elder rats. The larger the number of the 
contained ingredients of herbs became, the more potent 
VD was exhibited. On the other hands, the responses to 
these drugs in aorta with diabetes mellitus were inversed, 
and were age-independent. The effects would be due to the 
differences among the poor functions of endothelium, Ca2+ 
channel and PK-C inhibition under the diseases.2
S1F-3-2  Molecular mechanism of 
active substances from anti-allergic 
natural medicines
Hiroyuki Fukui1, Hiroyuki Mizuguchi2, 
Yoshiki Kashiwada3, Hisao Nemoto4, Noriaki Takeda5 
1Dept. Mol. Stud. Incurable Dis., Inst. Health Biosci., Tokushima Univ. Grad. 
Sch., 2Dept. Mol. Pharmacol., Inst. Health Biosci., Tokushima Univ. Grad. 
Sch., 3Dept. Pharmacog., Inst. Health Biosci., Tokushima Univ. Grad. Sch., 
4Dept. Bioorg. Syn. Chem., Inst. Health Biosci., Tokushima Univ. Grad. Sch., 
5Dept. Otolaryngol. Commun. Neurosci., Inst. Health Biosci., Tokushima 
Univ. Grad. Sch.
Allergic rhinitis is a representative incurable disease with 
nasal hypersensitivity symptoms of sneezing, rhinorrhea 
and nasal obstruction. Allergic rhinitis model rats showed 
elevation of histamine H1 receptor (H1R) mRNA in nasal 
mucosa after provocation of hypersensitivity. Previously, 
we elucidated that H1R gene expression was up-regulated 
by the stimulation of H1R through protein kinase C (PKC)-
delta signaling. Kujin , as an anti-allergic Kampo  medicine, 
improve symptoms of sneezing and rhinorrhea, and also 
suppress elevated H1R mRNA in allergic rhinitis model 
rats. Further purification of Kujin  extract elucidated (-)
maackiain as the major compound responsible for anti-
allergic activity. Target molecule of (-)maackiain was also 
attempted to identify for the elucidation of molecular 
mechanism, and heat shock protein 90 (hsp90) revealed as 
the target protein. Improvement of sneezing and rhinorrhea 
was attained by the treatment of (-)maackiain, and similar 
result was also achieved with celastrol, an inhibitor of 
hsp90. Accumulating evidences suggest that PKC-delta 
signaling play an important role in allergic symptoms, and 
both antihistamines and Kujin  improve allergic symptoms 
by the common mechanism.
S1F-3-4  Improving effects of 
chotosan on the brain malfunction in 
rodent’s disease models
Jun-Ichiro Oka1, Kinzo Matsumoto2, 
Sachie Sasaki-Hamada1
1Lab. Pharmacol., Fac. Pharm. Sci., Tokyo Univ. Sci., 2Div. Med. Pharmacol., 
Inst. Natural Med., Univ. Toyama
Chotosan  (CTS) is a Kampo formula that consists of 10 
different medical herbs and gypsum fibrosum , which has 
long been used for the treatment of chronic headaches 
and hypertension.  In a clinical study, CTS was shown 
to have ameliorative effects on cognitive dysfunction 
in stroke patients.  CTS also had preventive effects on 
cognitive deficits in a mouse model of transient cerebral 
ischemia and improved learning and memory impairments 
in a mouse model of chronic cerebral hypoperfusion.  In 
addition, we have investigated the effect of CTS on juvenile-
onset diabetes mellitus (JDM) rats.  Our previous study 
showed that working memory and hippocampal long-term 
depression (LTD) were impaired in JDM rats.  The repeated 
treatment with CTS (1 g/kg per day) for 3-7 days restored 
spatial working memory and hippocampal LTD in JDM rats. 
The expression level of NR2B glutamate receptor subunits, 
but not other glutamate receptor subunits was enhanced in 
the hippocampus of JDM rats, and the repeated treatment 
with CTS reversed these changes.  These results suggest 
that CTS improves diabetes-induced cognitive deficits 
by modulating NMDA-receptor subunit expression.  Our 
findings provide further evidence for the anti-dementia 
effects of CTS.S3S1F-3-3  Phytosterol saponin of 
ginseng (ginsenoside) provides 
cardiovascular protection as a specifi c 
non-genomic ligand of sex hormone 
receptors
Tetsushi Furukawa, Junko Kurokawa, Chang-Xi Bai 
Dept. Bio-Inform. Pharmacol., MRI, TMDU
Herbal medicine has been successfully used for over 5000 
years in the Eastern World. With growing evidence for their 
beneficial effects on human health, herbs are medicinal 
seeds awaiting mechanism of actions to be unveiled. Ginseng 
root is one of the most popular herbs throughout the world. 
Here, we show that phytosterol saponin (ginsenoside), a 
main constituent of ginseng, is a speciÀ c ligand for the non-
genomic pathway of sex steroid hormones that provides 
protective effects against cardiac ischemia and heart failure, 
a major cause of death in the West. Ginsenoside binds to 
sex hormone receptors (androgen, estrogen, progesterone 
receptors), and releases nitric oxide via a sequential 
activation of c-Src, PI3-kinase, Akt, and nitric oxide synthase 
3. Released nitric oxide directly nitrosylates and activates 
potassium channels, thereby preventing Ca2+ overload 
during cardiac ischemia/reperfusion. Ginsenoside does 
not activate a genomic pathway of sex hormones, because 
it binds to sex hormone receptors, but fails to recruit co-
activators. We anticipate that, in addition to cardiovascular 
protection, ginsenoside can be a medicinal seed for common 
diseases in elderly populations.
S1D-4-1  Creating the kidney in vitro
Ryuichi Nishinakamura
Inst. Mol. Embryol. Genet., Kumamoto Univ.
The kidney derives from the embryonic metanephros, 
which develops by the reciprocal interaction between the 
metanephric mesenchyme and the ureteric bud. Here, 
we define the developmental origins of the nephron 
progenitors, which reside in the metanephric mesenchyme 
and generate most nephron components such as glomeruli 
and renal tubules. While nephron progenitors are believed 
to originate from the intermediate mesoderm that expresses 
a transcription factor Osr1, we unexpectedly find that 
nephron progenitors are derived from posteriorly located 
T-positive population at the post-gastrulation stage, which 
is developmentally distinct from Osr1-positive ureteric 
bud precursors. We also identify phasic Wnt stimulation 
and stage-speciÀ c growth factor addition as molecular cues 
that promote the development of T-positive precursors into 
the nephron progenitors. We then use this information to 
derive nephron progenitors from mouse embryonic stem 
cells and human induced pluripotent stem cells. Upon 
Wnt4 stimulation, the induced nephron progenitors readily 
reconstitute the three-dimensional structures of the kidney 
in vitro. Thus, by redefining the developmental origin of 
nephron progenitors, we have succeeded in generating the 
three-dimensional nephrons in vitro from pluripotent stem 
cells.3
S1D-4-2  Proteomics of kidney 
physiology and pathology
Tadashi Yamamoto1,2
Dept. Struct. Patholo., Inst. Nephrol., Grad. Sch. Med. Dent. Sci., Niigata 
Univ, 2BB-C, SBCCL, Niigata Univ
Proteomics approaches are now applicable to basic and 
clinical nephrology for understanding kidney physiology 
and pathology. Normal human kidney parts (cortex, 
medulla, glomerulus and other nephron segments) and 
disease glomerulus were laser-microdissected and the 
peptides were prepared to analyze their proteomes by 
label-free quantitative (normalized spectral index) liquid 
chromatography-mass spectrometry (LC-MS). The proteins 
were veriÀ ed by  immunohistochemistry (IHC) and analyzed 
by bioinformatics using pathway analysis tools. Thousands 
of proteins were identified and verified in each kidney 
part by LC-MS and  IHC. Bioinformatics tools depicted 
interesting networks and pathways in the kidney parts. For 
example, networks of oxidative stress, immune response, 
fibrosis, and hypertension and pathways in membranous 
nephropathy glomerulus. Proteins identified in normal 
kidney nephron segments demonstrated systems and 
features of their functions. Proteomics and bioinformatics 
analysis of kidney parts could provide new insights into 
molecular systems of these parts, such as functions of the 
kidney parts and pathological mechanisms of glomerular 
diseases, which may promote efÀ cient personalized medicine 
in the near future after proteomics analysis of kidney biopsy 
specimens.
S1D-4-4  Alteration of the intestinal 
environment is associated with 
amelioration of CKD
Takaaki Abe
Div. Med. Sci., Tohoku Univ. Grad. Sch. Biomed. Engineering
The accumulation of uremic toxins is involved in the 
progression of CKD.  It is well known that various uremic 
toxins are derived from gut microbiota and that an 
imbalance of gut microbiota, or dysbiosis is related to CKD. 
Using an adenine-induced CKD model, we evaluated the 
beneficial effects of the ClC-2 chloride channel activator 
lubiprostone on CKD.  Oral administration of lubiprostone 
changed the fecal and intestinal properties in the mice with 
renal failure.  In addition, lubiprostone treatment reduced 
the elevated BUN and protected against tubulointerstitial 
damage, renal À brosis and inÁ ammation.  Gut microbiome 
analysis of 16S rRNA genes in the CKD mice showed 
lubiprostone altered their microbial composition, especially 
the recovery of Lactobacillaceae family and Prevotella 
genus, which were significantly reduced in the CKD mice. 
Metabolome analysis showed that lubiprostone treatment 
decreased the plasma level of uremic toxins, such as 
indoxyl sulfate and hippurate, which are derived from gut 
microbiota as well as a new uremic toxin, trans-aconitate. 
This suggests that lubiprostone ameliorates the progression 
of chronic kidney disease and the accumulation of uremic 
toxins by improving the gut microbiota and intestinal 
environment.S34S1D-4-3  A new therapeutic target for 
a genetic chronic kidney disease
Mary Ann Suico, Ryosuke Fukuda, Tsuyoshi Shuto, 
Hirofumi Kai
Dept. Mol. Med., Kumamoto Univ.
Alport syndrome (AS) is one of the most common types 
of inherited nephritis caused by mutation in one of the 
glomerular basement membrane components. AS is 
characterized by proteinuria at early stage, and glomerular 
hyperplastic phenotype and renal fibrosis at late stage 
of the disease. Although the etiology of AS is known, the 
genes responsible for regulating AS progression are largely 
undetermined. Here, we found that whole-body deficiency 
of tumor suppressor p53 significantly accelerated AS 
progression in X-linked AS mouse. Moreover, the expression 
of p53 protein was decreased in the glomeruli of AS mouse 
at late stage of the disease. In vitro experiments revealed 
that p53 modulates podocyte proliferation and migration 
and positively regulates the expression of podocyte-speciÀ c 
genes. We established podocyte-specific p53 (pod-p53)-
deficient AS mice, and determined that pod-p53 deficiency 
enhanced the AS-induced renal dysfunction and proliferative 
glomerular gene expression pattern. The present study 
revealed the mechanism that underlies the progression of 
AS and the novel role of p53 in maintaining glomerular 
homeostasis by modulating the hyperplastic phenotype of 
podocyte in AS.
S1E-5-1  Opposite functions of 
exosomes on cardiovascular diseases
Yasukatsu Izumi1, Takehiro Yamaguchi2, 
Mayuko Oka3, Masayuki Shiota1, Masako Tanaka4, 
Katsuyuki Miura4, Hiroshi Iwao5
1Dept. Pharmacol., Osaka City Univ. Med. Sch., 2Dept. Cadiovasc. Med., 
Osaka City Univ. Med. Sch., 3Grad. Sch. Life Enviro. Sci., Kyoto Pref. Univ., 
4Appl. Pharmacol. Th er., Osaka City Univ. Med. Sch., 5Dept. Edu., Shitennoji 
Univ.
Chronic heart failure, a clinical syndrome representing the 
end-stage of a number of different cardiac diseases, cannot 
be still prevented in spite of existing pharmacological and 
non-pharmacological therapies. Exosomes are nanovesicles, 
shed into the extracellular space from a variety of cells that 
play diverse intracellular communication roles. The role of 
exosomes has been elucidated in malignant diseases, but 
their role on cardiovascular diseases is less well understood. 
In our recent studies, an amount of proteins in serum 
exosomes was increased in angiotensin II-infused and a 
nitric oxide synthase inhibitor-administrated hypertensive 
model rats. Addition of serum exosomes from hypertensive 
rats induced endothelial cell damage. On the other hand, 
remote ischemic conditioning (RIC) by repeated treatment of 
transient limb ischemia increased an amount of proteins in 
serum exosomes and improved left ventricular dysfunction 
of rats with heart failure. This beneficial effect by RIC 
was partially due to exosome-mediated intercellular 
communication such as microRNAs and proteins. Thus, 
exosomes have not only a deleterious effect but also a 
beneficial effect for cardiovascular diseases. More detailed 
elucidation of exosomes may be applicable for preventing 
heart failure.
S1E-5-2  Roles of Nuclear 
Transcriptional Pathway on Heart 
Failure
Tatsuya Morimoto1,2
1Div. of Mol. Med., Sch. Pharm. Sci., Univ. Shizuoka, 2Shizuoka General Hosp. 
Clin. Resarc. Centr.
Neurohormonal signals activated during heart failure (HF) 
finally reach nuclei of cardiomyocytes, change patterns of 
gene expression and cause their maladaptive hypertrophy. 
We have performed extensive research to establish 
pharmacological HF therapy targeting signal transduction 
pathways that lead to maladaptive cardiomyocyte 
hypertrophy. We found that acetylation of hypertrophy-
responsive transcription factors by an intrinsic histone 
acetyltransferase (HAT), p300, is a critical event during 
this process. A natural compound, curcumin, possesses 
HAT inhibitory activity with specificity for p300. We have 
demonstrated that curcumin treatment prevents the 
deterioration of systolic function in two different rat models 
of HF, hypertension and myocardial infarction (MI). By 
using a novel drug-delivery system, we have developed 
highly absorptive curcumin. Treatment of hypertensive 
patients by 60mg/day of highly absorptive curcumin for 24 
weeks signiÀ cantly improved the ratio of E/E`, a parameter 
of diastolic function by Doppler echocardiography. However, 
systolic and diastolic blood pressures were unchanged. 
These findings suggest that highly absorptive curcumin 
improves left ventricular diastolic function independent of 
blood pressure in hypertensive patients.
S1E-5-4  Role of a novel secreted 
factor omentin in cardiovascular 
disease
Noriyuki Ouchi1, Koji Ohashi1, Rei Shibata2, 
Toyoaki Murohara2
1Mol. Cardiovas. Med., Nagoya Univ. Grad. Sch. Med., 2Dept. Cardiol., Nagoya 
Univ. Grad. Sch. Med.
Obesity, in particular, excessive visceral fat accumulation, 
is causally linked with the progression of cardiovascular 
disease. It is well recognized that adipose tissue functions 
as an endocrine organ that secretes a variety of bioactive 
molecules, also referred to as adipocytokines or adipokines. 
Most adipocytokines are upregulated under conditions of 
obesity, and these molecules typically promote obesity-
related disorders. In contrast, there are a few adipocytokines 
that are downregulated by obesity, and these factors 
appear to exert beneficial actions on obese complications. 
Omentin is a newly discovered adipocytokine that is 
expressed abundantly in human visceral adipose tissue. 
Plasma levels of omentin are reduced in association with 
obese complications including coronary artery disease. 
Omentin promotes ischemia-induced revascularization and 
reduces pathological vascular remodeling in response to 
injury in mice. Moreover, omentin ameliorates myocardial 
injury following ischemia-reperfusion and prevents cardiac 
hypertrophy after pressure overload. I will talk about our 
recent À ndings on the role of this adipocytokine in regulation 
of cardiovascular disorders.S3S1E-5-3  Non-apoptotic cell death in 
cardiac pathogenesis
Hiroyuki Nakayama, Yasushi Fujio
Lab. Clin. Sci. Biomed., Grad. Sch. Pharma. Sci. Osaka. Univ.
Heart failure (HF) is one of the leading etiologies of 
demise and cardiomyocyte (CM) death is the major cause 
of HF. While molecular mechanisms of apoptosis are well 
investigated, those of necrosis remain to be elucidated. Ca2+ 
and radical oxygen species (ROS) are two well-known cell 
death inducers. We previously reported that augmented 
Ca2+ inÁ uxes via L-type Ca2+ channel mediated necrotic cell 
death, however the roles of ROS in cardiac necrosis are not 
fully investigated. Herein, we show underlying mechanism 
of ROS-induced CM death (RICD). RICD was not prevented 
by pan-caspase inhibitors accompanied by absence of other 
apoptotic features, suggesting non-apoptotic cell death. In 
contrast, RICD was partially attenuated by BAPTA-AM, an 
intracellular Ca2+ chelator indicatingCa2+ dependent. Among 
various Ca2+ channel inhibitors, solely 2-APB strongly 
suppressed RICD, suggesting speciÀ c channels are involved 
in the mechanisms. Finally, treatment of 2-APB in mice 
repressed fibrotic area after pressure overload, suggesting 
prevention of CM death by 2-APB in vivo. Taken together, 
we revealed that ROS induces CM death in a non-apoptotic, 
Ca2+-dependent and 2-APB-sensitive manner. Thus, 
prevention of cell death by 2-APB could be a promising 
therapeutic strategy for HF.
S1F-6-1  Next generation zebrafi sh-
based drug discovery
Toshio Tanaka1,2,3,4,5, Yuhei Nishimura1,2,3,4,5, 
Yasuhito Shimada1,2,3,4,5
1Dept. Pharmacogenomics, Mie Univ. Grad. Sch. Med., 2Dept. Systems 
Pharmacol. Mie Univ. Grad. Sch. Med., 3Mie Univ., Medical Zebrafi sh 
Research C., 4Dept., Bioinfo., Mie Univ. Life Science Research C., 5Dept., 
Omics Med. Mie Univ. Ind. Tech. Innov. Inst.
Here, we propose the strategy of zebraÀ sh-based quantitative 
and systems pharmacology, which synergistically combine 
the desirable features of systems pharmacology and 
emerging technology of zebraÀ sh-based phenotype screening 
system for functional omics and chemical biology. The unique 
attributes of zebrafish are being increasingly leveraged to 
create functional disease models, facilitate drug discovery, 
and provide critical scientific bases for the development 
of new clinical tools for the diagnosis and treatment of 
human disease. Zebrafish-based systems pharmacology 
that analyze in vivo regulatory networks involved in drug 
action can account for a drug’s multiple targets and for 
the effects of genomic, epigenomic, and posttranslational 
changes on the drug efÀ cacy. The next generation discipline 
of systems pharmacology aims to combine experimental 
analysis and computational modeling of in vivo networks 
with quantitative pharmacology approaches to drive the 
drug discovery processes, predict rare adverse events, and 
catalyze the practice of personalized medicine. This new 
systems pharmacology can drive zebrafish-based drug 
discovery and shape personalized medicine.5
S1F-6-2  Effi cient genome 
modifi cation using CRISPR
Atsuo Kawahara
Yamanashi Univ.
The clustered regularly interspaced short palindromic 
repeats (CRISPR)/CRISPR-associated (Cas) system becomes 
a powerful genetic tool in various model organisms including 
zebrafish. The targeted gene knockout zebrafish is easily 
established by using CRISPR-mediated genome modiÀ cation. 
Recently, it was reported that an exogenous DNA was 
efÀ ciently integrated into zebraÀ sh genome using homology-
independent DNA repair system, but this integration 
contained various insertion and deletion mutations at the 
junction. Therefore, we tried to develop a novel method that 
enables us to perform the precise genome modiÀ cation into 
the target locus. We introduce about the efÀ cient CRISPR-
mediated precise integration using a donor vector containing 
short homologous sequences near the target locus. We 
succeeded in integrating an exogenous Á uorescent gene into 
the target locus at high efÀ ciency. Further, we ascertained 
that this precise genome modification was heritable in 
zebraÀ sh. I will discuss a possible application of the precise 
targeted gene knockin method that is a very useful genome 
technology acceptable for any model organism.
S1F-6-4  Zebrafi sh: As a model animal 
for toxicity evaluation in drug discovery
Akihito Yamashita
Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd.
During the drug discovery and development research, 
to prioritize a compound with less toxicity is important 
especially in the early drug discovery stage. Since only a 
limited amount of samples can be available in this stage, 
mammalian in vivo  test systems are not adequate for that 
purpose. A variety of cell-based assay systems for toxicity 
screening has been established, but these assays do not 
necessarily reflect the actual phenotype of mammalian 
toxicity, which makes it difÀ cult to predict the precise safety 
proÀ le of compounds. Nowadays, zebraÀ sh are considered to 
be a valuable “ in vivo  “ animal model for safety evaluation, 
owing to their small size, rapid morphogenesis, transparent 
body and developmental similarities to mammals. In this 
presentation, we will introduce three safety evaluation 
methods using the zebraÀ sh which we have established in 
our facilities: teratogenicity, convulsion liability and cardiac 
toxicity evaluation.S3S1F-6-3  Whole-organism drug 
screening in zebrafi sh: Progress and 
future challenges
Naoki Tsuji
Frontier Research Lab., Daiichi-Sankyo Co., Ltd.
For first-in-class drug discovery, phenotypic screens with 
new methodologies and approaches might present promising 
strategies to increase success rates. Since many diseases 
today are still difÀ cult to faithfully mirror in test plates and 
model organisms, the establishment of more physiological 
assay systems that better reflect the actual disease are 
required. Whole organism screening with zebrafish, one 
of the novel phenotypic screens, allows for an unbiased 
screening for relevant drug targets or compounds that 
reverse the disease within the physiological context of the 
organism. Moreover, recent progress in genetic tools and 
imaging technologies enable us to monitor a large variety 
of physiological and/or pathophysiologic phenotypes. In this 
talk, I will introduce updated zebrafish drug screens and 
discuss potential advantages in drug discovery.
S1B-7-1  Screening of the diabetic 
factors affecting stem cell functions in
vivo
Takeshi Imamura
Dept. Med., Shiga Univ. Med. Sci.
In the patients with diabetes, it is frequently observed that 
intra-abdominal fat tissues are enlarged with adipocyte 
hypertrophy, caused by the excess amount of energy intake. 
Many studies have shown that hypertrophic changes in 
adipocytes induce insulin resistance via the mechanisms 
of chronic inflammation. There is a possibility to protect 
adipocyte hypertrophy if enough cell number of adipocytes 
were provided by the stem cells. Therefore, we have tested 
our hypothesis that the stem cell functions are disturbed 
under the diabetic conditions in vivo .
Using the immunoisolation capsules, we performed the 
pluripotent stem cell transplantation in diabetic or healthy 
monkeys. Ten or 20 days after the transplantation, the cells 
recovered from the capsules were analyzed, and we found 
the abnormality of gene expressions in both pluripotent and 
differentiation markers in the cells from diabetic subjects. 
In order to investigate the in vivo  factors affecting the stem 
cell functions, we examined the interstitial fluids inside 
capsules, and found the suggested factors which can affect 
cultured iPS cells. In this presentation, we will show the 
possible mechanism that stem cell functions are modified 
under the diabetic conditions in vivo .6
S1B-7-2  Translational research 
of iPS cell sheet-based myocardial 
regeneration therapy
Shigeru Miyagawa1, Yoshiki Sawa2
1Dept. Cardiovascular Surgery, Osaka Univ., 2Dept. Cardiovascular Surgery, 
Osaka Univ.
Although LVAD implantation and Heart transplantation 
have been well accepted as the ultimate lifesaving means 
of supporting end-staged heart failure patients, there are 
some limitations. So we developed cell sheet technology 
experimentally and introduced this to the treatment of 
severely damaged myocardium as translational research.
In a series of pre-clinical experiments using animal heart 
failure model, we proved that myoblast sheets could heal 
the impaired heart mainly by cytokine paracrine effect. We 
applied myoblast sheets to 23 heart failure patients and 
some patients showed LV reverse remodeling, functional 
recovery was limited in severe heart failure patients. 
Recently we have developed human iPS cell derived 
cardiomyocyte sheet and obtained Proof of Concept by 
using porcine myocardial infarction model as preclinical 
study. And recently we have proved synchronous movement 
with recipient myocardium in vivo study and its functional 
superiority compared with myoblast sheet. And also we have 
established large culture system and checked safety of iPS 
cell derived cardiomyocyte sheets for the purpose of clinical 
trial.iPS cell derived cardiomyocyte sheet may open new era 
in the treatment of severely damaged myocardium.
S1B-7-4  Modeling muscular diseases 
using patient-derived iPS cells
Hidetoshi Sakurai
Dept. Clin. Application., CiRA, Kyoto Univ.
The establishment of human induced pluripotent stem cells 
(hiPSCs) has enabled the production of in vitro , patient-
specific cell models of human disease. In vitro  recreation 
of disease pathology from patient-derived hiPSCs depends 
on efficient differentiation protocols producing relevant 
adult cell types. However, for studying muscular diseases, 
myogenic differentiation of hiPSCs has faced obstacles, 
namely, low efÀ ciency and/or poor reproducibility.Here, we 
show the rapid, efficient, and reproducible differentiation 
of hiPSCs into mature myocytes. We demonstrated that 
inducible expression of myogenic differentiation1 (MYOD1 ) 
in immature hiPSCs for at least 5 days drives cells along 
the myogenic lineage, with efficiencies reaching 70-
90%. Myocytes induced in this manner reach maturity 
within 2 weeks of differentiation as assessed by marker 
gene expression and functional properties, including in 
vitro  and in vivo  cell fusion and twitching in response to 
electrical stimulation. Now we have been investigating for 
pathological phenotype of several muscular diseases. In this 
presentation, we would like to share our resent progress 
with you and to show the potentials of the iPSC-mediated 
drug development.SS1B-7-3  Cell therapy for Parkinson’s 
disease with induced pluripotent stem 
cells
Asuka Morizane, Jun Takahashi
Dept. Clinic App., CiRA, Kyoto Univ.
Although pharmacological treatments for Parkinson’s 
disease, such as L-dopa, show good response in the 
early phase, patient outcomes over the long term are 
unsatisfactory. As an additional treatment, cell therapy 
with aborted fetal tissues has been performed. Despite 
positive results, the limited supply of donor source and 
the unstable quality of the cells prevent this therapy from 
becoming standard. Induced pluripotent stem cells (iPSCs) 
have attracted much attention, as they may circumvent 
these problems. We are preparing a clinical study that 
involves the transplantation of dopaminergic neurons 
differentiated from iPSCs. We have successfully established 
a protocol to induce dopamine neurons from iPSCs and 
have transplanted these neurons into Parkinson models of 
mice, rats, and cynomolgus monkeys for preclinical study. 
One advantage of iPSC technology is the possibility of 
autologous transplantation, which minimizes immunological 
rejection. We previously demonstrated in cynomolgus 
monkeys that autologous transplantation has better efÀ cacy 
than allogeneic transplantation. Based on this result, 
we will start the first clinical study as the autologous 
transplantation of iPSC-derived dopaminergic neurons.
S1D-8-1  Optogenetic control of glial 
activity can suppress ischemic brain 
damage
Ko Matsui
Div. Interdisciplinary Med. Sci., Ctr. for Neurosci., Tohoku Univ. Grad. Sch. 
Med.
The brain demands high-energy supply and obstruction of 
blood flow causes rapid deterioration of the healthiness of 
brain cells. Two major events occur upon ischemia; acidosis 
and glutamate exictotoxicity. Oxygen and glucose deprivation 
leads to the shutting down of the aerobic metabolism; 
however, lactate production continues from glycogen stored 
predominantly in glial cells, which is likely the cause of the 
severe acidosis. Liberation of excess glutamate and neuronal 
cell death follow; however, cellular source of glutamate and 
its release mechanism upon ischemia remained unknown. 
Here we show a causal relationship between glial acidosis 
and neuronal excitotoxicity. As the major cation that Á ows 
through channelrhodopsin-2 (ChR2) is proton, this could 
be regarded as an optogenetic tool for instant intracellular 
acidification. Optical activation of ChR2 expressed in glial 
cells led to glial acidiÀ cation and to release of glutamate. On 
the other hand, glial alkalization via optogenetic activation 
of a proton pump, archaerhodopsin (ArchT), led to cessation 
of glutamate release and to the relief of ischemic brain 
damage in vivo. Our results suggest that controlling glial 
pH may be an effective therapeutic strategy for intervention 
of ischemic brain damage.37
S1D-8-2  A new transgenic mouse 
model revealed a role of astrocytic 
calcium in vivo
Mika Tanaka1, Pei-Yu Shih1, Hiroshi Gomi2, 
Takamasa Yoshida1, Junichi Nakai3, Reiko Ando1, 
Teiichi Furuichi4, Katsuhiko Mikoshiba1, 
Alexey Semyanov1, Shigeyoshi Itohara1
1RIKEN BSI, 2College of Biores. Sci. Nihon Univ., 3Saitama Univ. BSI, 4Faculty 
of Science and Technology, Tokyo University of Science
Neuronal activity alters calcium ion dynamics in 
astrocytes, but the physiologic relevance of these changes is 
controversial. To examine this issue further, we generated 
an inducible transgenic mouse model in which the 
expression of an inositol 1,4,5-trisphosphate (IP3) absorbent, 
“IP3 sponge”, attenuates astrocytic Ca2+ signaling. We 
found that attenuated Ca2+ activity correlated with 
reduced astrocytic coverage of asymmetric synapses in the 
hippocampal CA1 region in these animals. In hippocampal 
slices, glutamate transporter currents were prolonged in 
stratum radiatum astrocytes and N-methyl-D-aspartate 
receptor (NMDAR) currents in CA1 pyramidal neurons 
were enhanced in response to burst stimulation. These mice 
also exhibited behavioral impairments in spatial reference 
memory and remote contextual fear memory, in which 
hippocampal circuits are involved. Our findings suggest 
that IP3-mediated astrocytic Ca2+ signaling correlates 
with the formation of functional tripartite synapses in the 
hippocampus.
S1D-8-4  Accumulation of neurogenic 
microglia in the early postnatal SVZ 




Microglia have long been considered as resident immune 
cells, which are activated in response to pathological 
events.  We recently clarified that a certain population of 
neurogenic microglia accumulated in the subventricular 
zone (SVZ) by a simple stereological imaging technique. 
Anterior, middle, posterior stereotaxic coordinates of rat pup 
brain were marked and coronal sections were cut at each 
marked point at P1, 3, 10, 30.  Immunostaining revealed 
the accumulation of a large numbers of activated microglia 
in the SVZ from P1 to P10.  Pharmacological suppression 
of the activation, which produces a decrease in levels of 
a number of proinflammatory cytokines, i.e., IL-1ǃ, IL-6, 
TNF-ǂ, and IFN-Ǆ, significantly inhibited neurogenesis in 
the SVZ.  In vitro neurosphere-assays reproduced the in 
vivo results and further clariÀ ed that the cytokines revealed 
the effects complementarily.  These results suggest that 
activated microglia accumulate in the early postnatal SVZ 
and that they enhance neurogenesis via released cytokines. 
Currently we are investigating the comprehensive profile 
of the cytokine networks in the SVZ from embryonic to 
postnatal ages.SS1D-8-3  Visualization and 
manipulation of Ca2+ excitability of 
astrocytes at interface of synapses
Eiji Shigetomi1, Shuichi Koizumi1,2
1Dept. Neuropharmacol., Interdiscipl. Grad. Sch. Med., Univ. Yamanashi, 
2CREST, JST
Emerging evidence suggest that astrocytes not only support 
but also regulate neurons, especially synaptic functions. It 
has been proposed that intracellular Ca2+ in astrocytes has a 
central role in its regulation of synapses. However, the role 
of Ca2+ in astrocytes is still controversial probably because 
the lack of methods to visualize and manipulate Ca2+ in 
astrocytes at interface of synapses. To resolve the problem, 
we took two novel approaches. First, we used transgenic 
mice which allow to enhance Ca2+ signals by manipulating 
gene expression of P2Y1 receptors speciÀ cally into astrocytes. 
In situ  Ca2+ imaging data suggest that overexpression of 
P2Y1 receptors in astrocyte showed three-fold increase in 
somatic Ca2+ responses by its agonist. Second, we used 
membrane-targeted genetically encoded Ca2+ indicator, 
Lck-GCaMP3, to visualize Ca2+ signals at fine astrocytic 
processes. Lck-GCaMP3 reported numerous Ca2+ signals in 
entire astrocyte territories in situ  and most of them occurred 
at peripheral processes where astrocytes interact with 
synapses. Combination of these novel approaches will be 
important tools to ask whether, when, and how Ca2+ signals 
in astrocytes regulate synapses.
S1E-9-1  Manipulation of specifi c type 
of neurons to reveal its physiological 
role
Akihiro Yamanaka, Ayumu Inutsuka1, 
Akira Yamashita
Dept. Neurosci. II, Res. Inst. Env. Med., Nagoya Univ.
Neurons form complex network which work as functional 
circuit to regulate behavior in the brain. Little is known 
about how these circuit functions to regulate behavior since 
it had been impossible to control the activity of speciÀ c type 
of neurons among them. Recently developed techniques, 
optogenetics and pharmacogenetics (chemicogenetics) 
enables control the activity of specific type of neurons in 
the brain using light or chemical substances. These new 
techniques allow us to study the function of these network 
and behavior using the whole animal. Especially, instinctive 
behaviors such as feeding, drinking and sleep/wakefulness 
behaviors are exhibited only in the whole animal. To 
reveal its regulatory mechanism, in vivo study using whole 
animal is essential. I developed a series of transgenic 
mice line which allow us to easily apply optogenetics. 
These instinctive behaviors are regulated by neuropeptide 
containing neurons in the hypothalamus. The activity of 
these peptidergic neurons was acutely manipulated using 
optogenetics or pharmacogenetics to control instinctive 
behaviors. In this symposium, I will discuss about neural 
regulatory mechanism of these instinctive behaviors using 
our recent results.38
S1E-9-2  Multi-Omics analysis 
associated with characterization 
of a “pain-induced network” for 
identifi cation of the mechanism of 
refractory pain: Application of chemical 
genetics and a genome-wide study
Minoru Narita1,2
1Dept. Pharmacol., Hoshi Univ. Sch. Pharm. Pharmaceut. Sci, 2Life Science 
Tokyo Advanced Recerch Center (L-StaR)
Chronic pain, including neuropathic pain, often has a 
negative effect on the patient’s quality of life, can act 
as a stressor and increases the incidence of anxiety and 
depression. However, the molecular mechanism of such 
refractory pain is not yet fully understood. Multi-Omics 
analysis aims at the characterization and quantification 
of pools of biological molecules that underlie the structure, 
function, and dynamics of an organism.  Therefore, Multi-
Omics proÀ ling using a next-generation sequencer is likely 
to be very useful for identifying the molecular mechanism of 
refractory pain. Furthermore, a designer receptor exclusively 
activated by designer drug (DREADD) system has recently 
emerged as powerful tools for studying the “ brain multi-
network “.  In this symposium, we will discuss our recent 
genome-wide Omics study associated with characterization 
of a “ pain-induced network “ by a DREADD system to 
identify the molecular mechanism of refractory pain.
S1E-9-4  Analysis and synthesis 
of insect brain: From genes, neural 
networks, and behavior to robots
Ryohei Kanzaki
RCAST, Th e Univ. of Tokyo
To elucidate the dynamic information processing in a brain 
underlying adaptive behavior, it is necessary to understand 
the behavior and corresponding neural activities. This 
requires animals which have clear relationships between 
behavior and corresponding neural activities. Insects are 
precisely such animals and one of the adaptive behaviors 
of insects is high-accuracy odor source orientation. In order 
to understand the neural basis of odor source orientation 
in silkmoth, we have worked at multiple levels, from genes, 
single cells of the neural system to the actual behavior. 
Relatively small size of the moth brain and a large body of 
identiÀ ed neuron data are being used to attempt rebuilding 
behaviorally relevant circuits of the moth brain by means of 
realistic biophysical simulations. Moreover, in order to know 
the relationships between neural activity and behavior, 
a novel ‘insect-robot hybrid system’ was developed. This 
experimental system has a mobile robot as its body. The 
robot is controlled by the insect through its behavior or the 
neural activities recorded from the brain. This system will 
contribute to evaluation of the adaptability of behavior, 
and to a better understanding of the dynamics of neural 
networks.S3S1E-9-3  Visualization of learning-
related memory trace and its erasure by 
“Synaptic optogenetics”
Akiko Hayashi-Takagi, Haruo Kasai
Lab. for Structural Physiol., Univ. of Tokyo
The regulation of dendritic spines, protrusions of neural 
connectivity, is thought to be important for memory storage, 
but the links between spines and memory have been 
largely correlational because of lacks of a technique for 
manipulating individual spine. To overcome this problem, 
we here developed a novel synaptic optoprobe, AS-PaRac1 
(Activated Synapse targeting PhotoActivatable Rac1), 
which is unique not only because it can specifically label 
the recently potentiated spine in a translation-dependent 
manner, but can also selectively induce shrinkage in 
just those spines containing AS-PaRac1. This indicates 
AS-PaRac1 visualizes the recently “written” spine, and 
“written trace” can be erased by blue light.  Together with 
motor learning paradigm, AS-PaRac1 imaging revealed 
that memory in the cerebral cortex for motor learning was 
“written” on substantial number of spines in a relatively 
small number of neurons to form a new neural assembly. 
This novel light-dependent tool of “Synaptic optogenetics” 
would open up new avenue of the neural networks research, 
and by extension, shed light on the pathophysiology of 
psychiatric disorders as the disruption of the proper function 
of neural networks.
S1F-10-1  Anti-HMGB1 therapy 
for intracerebral hemorrhage and 
vasospasm after subarachnoid 
hemorrhage
Dengli Wang1, Katsuyaku Ryu, Masahiro Nishibori
Dept. Pharmacol., Okayama Univ. Sch. Med.
High mobility group box-1 (HMGB1) is an ubiquitous and 
abundant nonhistone DNA-binding protein, and is also an 
important proinflammatory cytokine once released into 
extracellular space from the nuclei. In the present study, we 
examined the effects of anti-HMGB1 mAb on intracerebral 
hemorrhage(ICH)-induced secondary brain injury and 
vasospasm after subarachnoid hemorrhage. Here, we show 
that treatment with neutralizing anti-HMGB1 mAb (1mg/
kg, twice) remarkably ameliorated ICH injury induced by 
local injection of collagenaseIV in the striatum of the rats. 
Administration of anti-HMGB1 mAb inhibited the release 
of HMGB1 into the extracellular space and reduced serum 
HMGB1 levels, thereby decreased activated microglia and 
the expression of inflammation-related factors including 
TNF-ǂ, iNOS, IL-1ǃ, IL-6, IL-8R, COX-2, MMP2, MMP9 
and VEGF A121 at 24h after ICH. Also, the administration 
of anti-HMGB1 mAb inhibited the vasospasm after SAH. 
These results strongly indicate that HMGB1 plays a critical 
role in the development of ICH-induced secondary injury 
and vasospasm after SAH through the amplification of 
plural inflammatory responses. Intravenous injection of 
anti-HMGB1 mAb provides a novel therapeutic strategy for 
different types of stroke.9
S1F-10-2  Treatment of spinal 
cord injury by neural stem cell 
transplantation
Kinichi Nakashima
Dept. Stem Cell Biol. Med., Grad. Sch. Med. Sci., Kyushu Univ.
Neural stem cells (NSCs) possess the ability to self-renew 
and to differentiate into the three major cell types found 
in the central nervous system (CNS): neurons, astrocyte 
and oligodendrocytes. We have previously shown that the 
histone deacetylase (HDAC) inhibitor and well-known 
antiepileptic drug, valproic acid (VPA) enhances neuronal 
differentiation of NSCs. Here, using a mouse model of 
spinal cord injury (SCI), we show that administering VPA 
and transplanting mouse NSCs (Hdac Inhibitor and Neural 
stem cell Transplantation; HINT) enhances the functional 
recovery of their hindlimbs. Neuronal differentiation of 
transplanted NSCs was promoted in VPA-treated mice. 
Anterograde corticospinal tract tracing revealed that 
transplant-derived neurons partially reconstructed the 
broken neuronal circuits, most likely in a ‘relay’ manner. 
Ablation of the transplanted cells abolished the recovery of 
hindlimb motor function, indicating that transplanted cells 
contributed directly to the improvement of motor function. 
These data raise the possibility that epigenetic regulation in 
transplanted neural stem cells can be exploited to provide 
treatment for SCI. We will also discuss the effect of human 
iPS derived-NSC transplantation into the mouse model of 
spinal cord injury.
S1F-10-4  Anti-HMGB1 therapy for 
visceral pain
Maho Tsubota, Atsufumi Kawabata
Div. Pharmacol. Pathophysiol. Kinki Univ. Sch. Pharm.
High mobility group box 1 (HMGB1), a nuclear protein, is 
actively secreted by certain cells including macrophages 
and passively released from necrotic cells, contributing to 
not only the development of inflammation but also pain 
signaling mainly through RAGE or TLR4. Here we show 
evidence that HMGB1 is involved in visceral pain signals, 
especially in the bladder. We created two distinct cystitis/
bladder pain models caused by cyclophosphamide (CP) or 
lipopolysaccharide (LPS). Systemic administration of CP 
induced cystitis characterized by bladder edema and related 
bladder pain. The CP-induced bladder pain, but not edema, 
was prevented by anti-HMGB1 neutralizing antibody 
(antiHMGB1Ab) or human soluble thrombomodulin (rhsTM) 
that sequesters HMGB1 and promotes its degradation, and 
also suppressed by low molecular weight heparin, known 
to block RAGE, but not by LPS-RS, a TLR4 antagonist. 
Intravesical administration of LPS also induced cystitis 
accompanied by bladder pain. rhsTM at relatively high 
doses prevented both LPS-induced bladder edema and pain, 
whereas it at low doses inhibited only the edema. Moreover, 
antiHMGB1Ab blocked LPS-induced bladder pain but not 
edema. Thus, anti-HMGB1 therapy using the neutralizing 
antibody or rhsTM is considered useful for the treatment of 
bladder pain.S40S1F-10-3  Role of HMGB1 in 
neuropathic pain and anti-HMGB1 
therapy for neuropathic pain
Norimitsu Morioka, Yoki Nakamura, 
Yoshihiro Nakata
Dept. Pharmacol., Hiroshima Univ. Grad. Sch. Biomed. Health Sci.
Accumulating evidence indicates that high mobility group 
box 1 (HMGB1) contributes to either the induction or 
maintenance of abnormal nociceptive disorders such as 
neuropathic and inflammatory pain. The current study 
found that increased HMGB1 in spinal dorsal horn is closely 
associated with the maintenance of hind paw mechanical 
hypersensitivity of rats with a partial sciatic nerve 
ligation (PSNL)--intravenous treatment with anti-HMGB1 
monoclonal antibody significantly reduced PSNL-induced 
mechanical hypersensitivity. The source of HMGB1 is mainly 
neuronal as PSNL-induced the translocation of HMGB1 
from the nucleus to the cytosol in dorsal horn neurons, but 
not in astrocytes and microglia. Furthermore, anti-HMGB1 
monoclonal antibody blocked the expression of microglial 
marker ionized calcium binding adaptor molecule 1 and 
spinal neuron (c-fos) activity, but not astrocytic activity (glial 
À brillary acidic protein), indicating involvement of HMGB1 
in microglial and neural activity. These results demonstrate 
that HMGB1 is involved in the interaction between neurons 
and glia in spinal dorsal horn, and anti-HMGB1 therapy 
could be a novel therapeutic for neuropathic pain.
S1B-11-1  Reprogramming of human 
intermediately reprogrammed stem 
cells into ips cells
Takashi Tada
Dept. Stem Cell Engineering, IFMS, Kyoto Univ.
Human iPS cells are generated from somatic cells by forced 
expression of exogenous Oct4, Sox2, Klf4, and c-Myc genes, 
which is known as reprogramming. Molecular mechanism 
involved in reprogramming is not fully understood, 
because reprogramming is multi-step event occurring at 
extremely low efficiency. Furthermore, the progress of 
medical applications of iPS cell technology is impeded 
by the difficulty of single-cell cloning. To address these 
difficulties, we established new progenitors of iPS cells, 
named intermediately reprogrammed stem (iRS) cells. iRS 
cells were maintained stably  with characters resemble to 
mesenchymal stem cells. Once exposed to certain external 
stimuli, iRS cells efficiently and simultaneously restarted 
reprogramming into iPS cells. iRS-derived iPS cells 
exhibited stem cell identity similar to conventional iPS 
cells. An advantage of iRS cells is the feasibility of single-
cell cloning, indicating that widely used genome editing 
technologies are applicable. Consequently, genome-edited 
iPS cells can be handled easily. We introduced the reporter 
gene, GFP into the endogenous OCT4 gene by CRISPR-
mediated homologous recombination. Visualization of 
the endogenous OCT4 demonstrated a new insight of 
reprogramming into iPS cells in human.
S1B-11-2  Multiple analysis of 
intracellular responses in intractable 
diseases related to dopaminergic 
neuron vulnerability with the use 
of human disease-specifi c iPS cell 
technique
Naoko Kuzumaki1, Hideyuki Okano2,4, 
Nobutaka Hattori3, Minoru Narita1,4
1Dept. Pharmacol., Hoshi Univ. Sch. Pharm. Pharmaceut. Sci., 2Dept. Physiol., 
Keio Univ. Sch. Med., 3Dept. Neurol., Juntendo Univ. Grad. Sch. Med., 4Life 
Science Tokyo Advanced Recerch Center (L-StaR)
Dopamine neurons are key regulators of emotional 
behavior and motor coordination. Great efforts are in place 
to understand the molecular mechanisms that trigger 
Parkinson’s disease (PD), taking advantage of human 
genetics and animal modeling. On the other hand, the 
pathological investigation of disease progression, including 
disease onset and the time course of disease advance, 
requires human materials. These materials are difficult 
to obtain in practice and until recently, researchers had to 
utilize the tissues of PD patients. However, thanks to the 
present revolution in iPSCs technology, cells differentiated 
in vitro from iPSCs can be used instead of human tissues 
for these purposes. In the present study we found the 
dopaminergic cell vulnerability associated with abnormality 
of both energy balance and dopamine metabolism in 
differentiated dopaminergic neurons derived from Parkinson 
disease-speciÀ c iPSCs. In this symposium, we will address 
the importance of transomics study to detect the mechanism 
of dopaminergic cell vulnerability under PD.
S1B-11-4  Pluripotent stem cell 
research for cardiovacular cell 
differentiation and regeneration
Jun Yamashita
Inst. for iPS Cell Res. & Appl., Kyoto Univ.
We have  been  inves t igat ing  card iovascu lar  ce l l 
differentiation and regeneration with the use of pluripotent 
stem cells, ES and iPS cells. Previously, we established a 
systematic cardiovascular cell differentiation system using 
Flk1+ cells as common progenitors. We are examining cell 
therapy strategies combining a cell sheet technology and 
our stem cell system. We observed that transplantation 
of  cardiac tissue sheet re-assembled with defined 
cardiovascular populations entirely from mouse ES cells 
or human iPS cells to rat myocardial infarction model 
significantly improved systolic function mainly through 
paracrine effects including neovascularization but not with 
direct cellular contribution. To improve cellular contribution 
after transplantation, we recently developed a novel 3D 
tissue engineering method in which large viable cardiac 
cell mass (more than 1mm thickness) can be formed by 
stacking up the cardiac cell sheets (up to 15 sheets). The 
stacked cardiac sheets efficiently survived 3 months after 
transplantation to rat MI models and generated a thick 
vascularized cardiac tissue-like structure in vivo. We are, 
thus, trying to explore next-generation cardiac regenerative 
strategies with stem cells.S4S1B-11-3  Direct induction of neural 
stem cells from somatic cells
Wado Akamatsu
Center for Genomics and Regenerative Medicine, Juntendo Univ. Sch. Med.
Neural stem cells are a promising source for cell therapy in 
neural diseases. However, the preparation of human neural 
stem cells from induced pluripotent stem cells is time-
consuming, and the preparation of a patient’s own neural 
stem cells within the sub-acute phase after spinal cord 
injury is impossible. We succeeded in inducing self-renewing 
and tri-potent neural stem cells directly from mouse 
and human fibroblasts using Oct4, Sox2, Klf4, and cMyc 
without clonal isolation of the induced pluripotent stem 
cells. These directly induced cells, which bypassed complete 
reprogramming into induced pluripotent stem cells, rapidly 
differentiated into their progenies, compared with similar 
cells that differentiated from induced pluripotent stem 
cells. For future cell-based therapy, induced neural stem 
cells, which are reprogrammed by neural stem cell-speciÀ c 
transcriptional factors and are identical to those in vivo, 
should be established.
S1C-12-1  The transporter domain of 
glutamate transporters is a process tip 
localizer and stabilizer
Mariko Hayashi, Masato Yasui 
Dept. Pharmacol., Keio. Univ. Sch. Med.
Glutamate transporters remove glutamate released from 
neurons to terminate the signal. These transporters 
localize to astrocyte process tips approaching neuronal 
synapses. The mechanisms underlying the localization of 
glutamate transporters to these processes, however, are 
not known. In this study, we demonstrate that the trimeric 
transmembrane transporter domains of these transporters 
have two additional functions. First, the transporter domain 
of these transporters is sufÀ cient for process tip localization 
and serves as a sorting signal. Cytoplasmic tails at the both 
terminus are not necessary. This is a common property of 
trimeric transporters. An extracellular loop at the center of 
the 4th transmembrane helices, unique for metazoans, is 
required for the localization. Moreover, a C186S mutation at 
the 4th transmembrane region of EAAT1, found in episodic 
ataxia patients, significantly decreased its process tip 
localization. Second, the transporter domain at À lopodia tips 
stabilizes the attachment to external substrates, playing 
a structural role. These additional functions optimize the 
efÀ ciency of amino acid uptake, the primary function of the 
transporter, by placing the transporter at sites where it is 
most needed.1
S1C-12-2  CDC42EP4/septin-based 
perisynaptic glial scaffold that 
facilitates glutamate clearance
Makoto Kinoshita1, Maya Yamazaki2, 
Kohtarou Konno3, Hisako Nakayama4, Manabu Abe2, 
Kenji Hashimoto5, Tomoki Nishioka6, Kozo Kaibuchi6, 
Tsuyoshi Miyakawa7, Kouichi Hashimoto4, 
Masahiko Watanabe3, Kenji Sakimura2, 
Natsumi Ageta-Ishihara1
1Dept. Mol. Biol., Nagoya Univ. Grad. Sch. Sci., 2Dept. Cell. Neurobiol, Niigata 
Univ. Grad. Sch. Med., 3Dept. Anat., Hokkaido Univ. Grad. Sch. Med., 4Dept. 
Neurophysiol., Hiroshima Univ. Grad. Sch. Med., 5Dept. Clin. Neurosci, Chiba 
Univ. Grad. Sch. Med., 6Dept. Cell Pharmacol., Nagoya Univ. Grad. Sch. Med., 
7Dept. Syst. Med. Sci., Fujita Health Univ.
C D C 4 2 E P 1 - 5 / B O R G 1 - 5  i n t e r a c t  w i t h  C D C 4 2  o r 
heterooligomers of septin GTPases in a mutually exclusive 
manner, but the physiological signiÀ cance is unknown. We À nd that CDC42EP4 is expressed exclusively in Bergmann 
glia(BG), where CDC42EP4 localizes to speciÀ c membrane 
domains enwrapping dendritic spines of Purkinje cell(PC)
s. Proteomic analyses show that CDC42EP4 is in complex 
with septin heterooligomers (SEPT2/3/4/5/6/7/8/10/11), 
and the glutamate transporter GLAST. In Cdc42ep4 -/- 
mice, GLAST is dissociated from the septins, and GLAST 
signals on perisynaptic BG membranes are delocalized 
away from parallel fiber(PF)-PC synapses. Slice patch-
clamp analysis reveals that the inward current to PCs 
following PF stimulation is mildly protracted after blocking 
AMPA receptor desensitization, and surges severely upon 
additional inhibition of glutamate transporters. These data 
indicate that glutamate clearance capacity in Cdc42ep4 -/- 
BG is compromised, which is partially compensated by two 
adaptive mechanisms. The glutamate intolerance manifests 
in vivo  as motor learning defects. These data indicates that 
CDC42EP4-dependent interaction with septins facilitates 
perisynaptic localization of GLAST and its glutamate-
buffering/clearance.
S1C-12-4  Molecular mechanism of 
endocytosis/localization of vesicular 
neurotransmitter transporters
Takashi Okuda
Dept. Pharmacol., Fac. Pharm., Keio Univ.
Vesicular neurotransmitter transporters are responsible for 
the packaging of neurotransmitters into synaptic vesicles in 
the presynaptic terminals. Endocytosis is a critical step for 
synaptic vesicular localization of the transporters. I devised 
a novel assay designed to probe an endocytic signal sequence 
of transmembrane proteins using the M2 muscarinic 
acetylcholine receptor as a reporter of endocytosis. Each 
cytoplasmic region of transmembrane proteins is fused to 
the M2 receptor, and dynamin-dependent endocytosis of 
these chimeric receptors is examined in mammalian cell 
lines. We searched an endocytic signal of the vesicular GABA 
transporter VGAT, and identified a novel phenylalanine-
based signal within the N-terminal cytoplasmic region, 
which can direct dynamin-dependent endocytosis of the 
M2 receptor. The N-terminal region of VGAT directly binds 
to the alpha/sigma subunit of clathrin adaptor AP2 in an 
endocytic signal-dependent manner. An endocytic signal-
less VGAT mutant shows synaptic localization but resides 
in the plasma membrane when expressed in primary 
hippocampal neurons. I also demonstrate that this endocytic 
signal is functionally conserved in the vesicular glutamate 
transporter VGLUT1.S4S1C-12-3  Role of vesicular nucleotide 
transporter (VNUT) in the purinergic 
chemical transmission
Miki Hiasa
Dept. Memb. Biochem., Okayama Univ. Grad. School of Med. Dent. Pharm. 
Sci.
Vesicular neurotransmitter transporters are responsible for 
vesicular storage of neurotransmitters in synaptic vesicles 
and secretory granules through active transport, which is 
energized by vacuolar proton ATPases.  So far, six types 
of transporters have been identified, which are vesicular 
inhibitory amino acid transporter (VIAAT), vesicular 
glutamate transporters (VGLUTs) and so on. Vesicular 
nucleotide transporter (VNUT), we found in 2008, is the 
last member of SLC17 anion transporter family. VNUT 
can transport various nucleotides such as ATP and ADP, 
which are stored in secretory granules of purinergic cells. To 
obtain the final conclusion that VNUT is fully responsible 
for ATP secretion in the purinergic cells, we generated gene 
knockout mice of Vnut . In the present study, we show that 
neuronal synaptic vesicles, adrenal chromafÀ n granules and 
pancreatic insulin granules of VNUT knockout mice were 
devoid of internal nucleotide, thereby, lost the ability of ATP 
secretion. Furthermore, it was found that typical phenotype 
of VNUT knockout mice is the increased insulin resistance. 
These results concluded that VNUT is fully responsible for 
ATP storage in the purinergic cells, and involved in blood 
glucose homeostasis through ATP secretion.
S1D-13-1  Deep sequencing and 
association analysis of schizophrenia 
candidate genes: Focus on glial 
assembly
Branko Aleksic, Hiroki Kimura, Jingrui Xing, 
Chenyao Wang, Yuto Takasaki, Kanako Ishizuka, 
Daisuke Mori, Itaru Kushima, Tomoko Oya, 
Yukako Nakamura, Akira Yoshimi, Norio Ozaki
Dept. Psychiatry, Nagoya Univ. Grad. Sch. Med.
We selected number genes for which there was reasonable 
evidence for involvement in the etiology of schizophrenia. We 
prioritized glia related genes based on previous biological 
studies and preformed deep sequencing and association 
analysis. Although schizophrenia candidate genes have not 
always received support from far larger and comprehensive 
subsequent studies, and may not contain common etiological 
variations, it is possible that they contain uncommon 
variations of etiological importance. To test this hypothesis, 
we conducted a multistage sequencing study.
We conducted mutation screening of coding exons using 
schizophrenia and pervasive developmental disorders 
samples in order to identify rare single nucleotide variants 
with a minor allele frequency 5%. We then performed 
genetic association analysis using a large number of 
unrelated individuals.
As the conclusion, our results showed that in case of 
schizophrenia, the “rare high-risk variant” vs the “common 
variant with low effect” hypotheses should not be viewed 
as 2 mutually exclusive hypotheses. Therefore, direct 
sequencing of candidate genes and copy number variants on 
the one side and GWAS analyses on the other side could be 
viewed as complementary approaches to analyze the genetic 
susceptibilities to schizophrenia.
2
S1D-13-2  Involvement of microglial 
subtypes in the pathogenesis of 
neuropsychiatric diseases
Makoto Sawada
Dept. Brain Function, RIEM, Nagoya Univ.
The presence of inflammatory activity and glial activation 
is one of the significant pathological features of several 
neuropsychiatric  diseases.   Since microglia are a 
principal source of inflammatory activity in CNS, the 
data support microglial involvement in the pathogenesis 
of neuropsychiatric diseases.  However, roles of activated 
microglia are still controversial.  Microglial cells show 
heterogeneity in their characteristics, so it gave rise to the 
hypothesis that these cells are differentially conditioned and, 
therefore, play differential roles in the CNS.  It was reported 
that deletion of a certain gene induced both neuropsychiatric 
behavior deÀ cit and lack of a part of microglial populations. 
Furthermore, transplantation of wild-type cells into the 
mutant mice rescued their pathological phenotype.  Recently 
we identified two distinct sub- populations of microglia in 
the normal mouse brain suggesting that there are distinct 
populations of microglia which are probably of different 
origins and have different functions in the brain.
S1D-13-4  The role of innate immune 
molecules in behavioral changes 
induced by repeated social defeat 
stress in mice
Shiho Kitaoka1, Xiang Nie2, Kohei Tanaka2, 
Atsubumi Ogawa2, Yuki Imoto3, Eri Segi-Nishida4, 
Shuh Narumiya2, Tomoyuki Furuyashiki1
1Div. Pharmacol., Kobe Univ. Grad. Sch. Med., 2Medical Innovation Center, 
Kyoto Univ. Grad. Sch. Med., 3Dept. Physiological Chemistry, Kyoto Univ. 
Grad. Sch. Pharmaceut. Sci., 4Dept. Systems Biosci. for Drug Discovery, Kyoto 
Univ. Grad. Sch. Pharmaceut. Sci.
Repeated stress alters emotional and cognitive functions 
across species, and is a risk factor for psychiatric disorders. 
Although repeated stress induces microglial activation in 
multiple brain areas, a role of stress-induced microglial 
activation and its mechanism remain elusive. Innate 
immune molecules including Toll-like receptors (TLRs) 
are known to regulate microglia. We have found that mice 
deÀ cient in TLRs fail to show social avoidance and elevated 
anxiety induced by repeated stress. Since the medial 
prefrontal cortex (mPFC) is critical for regulating stress-
induced behavioral changes, we examined stress-induced 
responses of mPFC neurons, and found that TLR is involved 
in attenuation of c-Fos expression in mPFC neurons with 
repetition of stress. Consistent with a role for microglia, 
mRNA expression of pertinent TLR isoforms was detected 
in microglia isolated from adult mice, and TLR deficiency 
abolished repeated stress-induced microglial activation in 
the mPFC. These data demonstrate a critical role for innate 
immune signaling in behavioral, neuronal and microglial 
changes induced by repeated stress, and pave the way for 
elucidating a role for neuron-microglia interaction in stress-
induced behavioral changes.S4S1D-13-3  Involvement of glial 
dysregulation of glutamatergic 
neurotransmission in development of 
behavioral abnormalities
Akihiro Mouri, Hirotake Hida1, Yukihiro Noda
Div. Clin. Sci. and Neuropsychopharm., Grad. Sch. Pharm., Meijo Univ.
Glutamate  t ranspor ters  (GLTs) ,  which  regu late 
glutamatergic transmission are mainly localized on glia. 
Abnormalities of GLTs cause neurodevelopmental disorders, 
such as ADHD and schizophrenia. In this symposium, 
we will present the functional roles of glial glutamate 
and aspartate transporter (GLAST) in neurodevelopment 
under the physiological and pathological conditions using 
mice with varying expression of GLAST. The gene deletion 
of GLAST produces phenotypic abnormalities related to 
the cognitive functions and brain morphology in adult. 
Similar phenomenon was observed in adult, which had 
been pharmacologically inhibited GLAST during neonatal. 
Subchronic phencyclidine (non-competitive N-methyl-D-
aspartate receptor antagonist) administered mice, which has 
been established as one of schizophrenia-like animal models, 
exhibited the behavioral phenotypes and glutamatergic 
dysfunction, associated with over expression of GLAST. 
These findings suggest that neurodevelopmental GLAST 
malfunction is implicated in the behavioral phenotypes 
and that glial dysregulation via malfunction as well as 
over expression of GLAST results in dysregulation of 
neurodevelopment and glutamatergic function in an animal 
model of schizophrenia.
S1E-14-1  Prenatal stress induces 
vulnerability to stress together with the 
disruption of central serotonin neurons 
in mice
Kazuya Miyagawa, Minoru Tsuji, Hiroshi Takeda
Dept. Pharmacol., Sch. Pharm., Int. Univ. Health and Welfare
Previously, we have examined the relationship between 
exposure to prenatal stress and the ability to adapt to stress 
in mice. Naive and prenatally stressed mice were exposed to 
repeated restraint stress for 7 days. After the À nal exposure 
to restraint stress, the emotionality of mice was evaluated 
in terms of exploratory activity using an automatic hole-
board apparatus. Acute emotional stress response, i.e. a 
decrease in head-dipping behavior, disappeared in naive 
mice that had been exposed to repeated restraint stress for 7 
days, which conÀ rmed the development of stress adaptation. 
In contrast, prenatally stressed mice did not develop this 
stress adaptation. Biochemical studies showed that the rate-
limiting enzyme in 5-HT synthesis, tryptophan hydroxylase, 
was increased in raphe obtained from stress-adapted mice. 
In contrast, a decrease in tryptophan hydroxylase was 
observed in stress-maladaptive mice. These À ndings suggest 
that exposure to excessive prenatal stress may induce a 
vulnerability to stress and disrupt the development of 5-HT 
neurons. In this symposium, we will introduce the effects of 
Yokukansan, a traditional Japanese herbal medicine, on the 
emotional abnormality induced by prenatal stress in mice.3
S1E-14-2  Epigenetic regulation of the 
GABAB receptor in the dorsal raphe 
nucleus associates with post-weaning 
social isolation-induced abnormal 
behaviors
Ryota Araki, Takeshi Yabe
Lab. of Funct. Biomol. Chem. Pharmacol., Fac. of Pharmaceut. Sci., Setsunan 
Univ.
Besides genetic factors, environmental factors also play 
an important role in the etiology of psychiatric disorders. 
Environmental factors can influence the genome to cause 
epigenetic changes in gene expression involved in the 
etiology of these disorders. Post-weaning social isolation 
in rodents induces behavioral abnormalities such as 
aggression. Isolation-reared mice also show social encounter-
induced hyperactivity, a novel phenotype of the abnormal 
behaviors, and the hyperactivity is triggered by activation of 
the serotonergic system from the dorsal raphe to the frontal 
cortex. We have found that mRNA and protein expression of 
GABAB1a, subunit were increased in the dorsal raphe nucleus 
of isolation-reared mice. In addition, DNA hypomethylation 
and histone hyperacetylation were observed at the promoter 
of GABAB1a gene in the raphe. Microinjection of GABAB 
receptor antagonist into the raphe attenuated encounter-
induced hyperactivity. These À ndings suggest that isolation 
rearing upregulates the GABAB receptor via epigenetic 
mechanisms and imply that disinhibition of serotonergic 
neurons by GABAB receptor activation is involved in 
abnormal behaviors in isolation-reared mice.
S1E-14-4  Female preference test: 
A novel behavioral assessment of 
motivation in mice
Yukio Ago1, Shigeru Hasebe1, Saki Nishiyama1, 
Satoshi Oka1, Yusuke Onaka1, Kazuhiro Takuma1,2, 
Toshio Matsuda1,3
1Lab. Med. Pharmacol., Grad. Sch. Pharm. Sci., Osaka Univ., 2Dept. 
Pharmacol., Grad. Sch. Dent., Osaka Univ., 3United Grad. Sch. Child Dev., 
Osaka Univ. Kanazawa Univ. Hamamatsu Univ. Sch. Med. Chiba Univ. & 
Univ. Fukui
Anhedonia is a cardinal symptom of psychiatric disorders 
such as depression. Preference for sucrose has been used as 
an index of motivation in rodent models, however, several 
mouse strains show neither preference nor reduction in 
preference after stress exposure. We have developed a novel 
method for assessing motivation using preference of a male 
mouse for a female mouse. Three-chambered free-choice 
model was used to evaluate sexual partner preference. Male 
mice showed a significant female preference regardless of 
estrus cycle. The preference was observed repeatedly from 
4 weeks old to 45 weeks old. The female preference was 
not observed in depression models such as glucocorticoid-
treated, lipopolysaccharide-treated, or isolation-reared mice. 
The impaired preference was improved by antidepressants. 
The encounter to a female, but not male, mouse causes 
an increase in c-Fos expression in the nucleus accumbens 
shell of male mice. Furthermore, the female preference 
and increased c-Fos expression were blocked by dopamine 
receptor antagonists. These findings suggest that female 
preference quantitates simply the motivation of male mice 
and provide a new methodology to assess the depressive-like 
state of mice and antidepressant activity of the drugs.SS1E-14-3  Epigenetic abnormal 
response caused by chronic pain stress
Daigo Ikegami1, Minoru Narita1,2
1Dept. of Pharmacol., Hoshi Univ. Sch. of Pharm., 2Life Science Tokyo 
Advanced Research Center (L-StaR)
Genetic factors are involved in determinants for the risk to 
psychiatric disorders, neurological and neurodegenerative 
diseases. On the other hand, there is increasing evidence 
that the investigation of epigenetics may provide new and 
unprecedented insights into the mechanisms of neural 
development, neurological and neurodegenerative diseases. 
It has also been considered that epigenetic mechanisms may 
shape short-term and long-term responses to pain stress. 
The epigenetic modification defines the three-dimensional 
structure of the genetic material in the cell nucleus and 
provides the molecular bridge between genes and the 
environment.  The epigenetic mechanisms, which are key 
cellular and molecular processes that integrate diverse 
environmental stimuli to exert potent and often long-
lasting changes in gene expression through the regulation 
of chromatin structure, contribute to transcriptional and 
behavioral changes.  In this symposium, we will discuss how 
the field of epigenetics is reshaping the current thinking 
about pain stress.
S1F-15-1  New drug discovery for 
surviving sepsis from multiple organ 
failure
Naoyuki Matsuda
Dept. Emergency & Crit. Care., Nagoya Univ. Sch. Med.
<Septic Syndrome> Sepsis is based on the infection 
with systemic inflammatory response syndrome (SIRS). 
Inflammatory molecules are rapidly produced through the 
inÁ ammatory receptors such as Toll-like receptor in sepsis. 
Sepsis is a medical emergency with high mortality more 
than cancer and stroke in the world. Global Sepsis Alliance 
organizes the world sepsis day on 9/13 every year from 2012 
(http://www.world-sepsis-day.org).  In Japan, sepsis would 
follow after cancer, surgery, heart failure and diabetes 
mellitus to bring death. <Drug Design for Sepsis>Cell lines 
of the major organs produce inflammatory molecule and 
chemokine through the intracellular signal transduction of 
DAMPs (damage associated molecular patterns) receptors. 
DAMPs receptor can activate the transcription factor such 
as nuclear factor-ƬB and activator protein-1 to increase 
signal transduction protein expression in the cell line of 
major organs. A proposal target of new drug discovery and 
design is the molecule increased in the cells of major organ 
in septic animals and in cultured human cell line. Our data 
would demonstrate the molecular targets such as ILAL-1, 
TAK-1 and FADD using human vascular endothelial cell and 
cecal ligation and puncture mouse.44
S1F-15-2  Plasma ATP and adenosine 
balance regulates immune response in 
sepsis
Yuka Sumi, Koichirou Sueyoshi, Yoshiaki Inoue, 
Ken Okamoto, Hiroshi Tanaka
Dept. Emergency and Critical Care Med., Juntendo Univ. Urayasu Hosp.
ATP has been recognized as a danger signal in various 
clinical conditions. We have previously shown that ATP 
release and feedback via P2Y2 receptors are involved in 
neutrophil activation. While, adenosine (ADO) is known to 
attenuate inÁ ammation. However, little is known about the 
role of plasma levels of ATP and ADO in sepsis patients. 
Here we investigated in 20 sepsis patients (APACHE: 24 
± 6), whether plasma ATP and ADO levels correlate with 
neutrophil activation. Plasma ATP and ADO concentrations 
and neutrophil activation were determined by HPLC and 
assessing CD11b expression, respectively. IL-1ǃlevels 
were assessed using a multiplex Elisa-based method. On 
admission, ATP levels in patients were signiÀ cantly higher 
than in healthy controls (102 ± 10 vs 42 ± 3 nM, p <0.01), 
whereas ADO levels were signiÀ cantly lower in patients (48 
± 7 vs 297 ± 57 nM, p <0.01). CD11b expression correlated 
with ATP levels and diminished over time corresponding 
to plasma ATP levels. IL-1ǃlevels correlate negatively 
with ADO levels (p < 0.01). We conclude that the ATP/
ADO balance may regulate inflammation and neutrophil 
activation in sepsis. Therapeutic interventions targeting 
ATP and adenosine levels may reduce neutrophil-induced 
host tissue damage in sepsis.
S1F-15-4  Potential effects of human 
antimicrobial peptide LL-37 on 
macrophage pyroptosis and sepsis
Isao Nagaoka1, Zhongshuang Hu1, Kaori Suzuki1, 
Hiroshi Tamura2
1Host Defense  & Biochem. Res., Juntendo Univ. Sch. Med., 2LPS Consulting 
Offi  ce
Pyroptosis is a caspase-1 dependent cell death, associated 
with proinflammatory cytokine production, and plays a 
crucial role in sepsis. Pyroptosis is induced by two distinct 
stimuli, microbial PAMPs (such as LPS) and endogenous 
DAMPs (such as ATP). Importantly, antimicrobial (host 
defense) peptides have a role in innate immune defense. 
Notably, antimicrobial peptide LL-37 protects septic animal 
models. Thus, to elucidate the mechanism for the protective 
action of LL-37 on sepsis, we examined the effect of LL-37 
on the LPS/ATP-induced macrophage pyroptosis and sepsis 
using a cecal ligation and puncture model.
LL-37 suppressed the LPS/ATP-induced IL-1ǃrelease, 
caspase-1 activation and cell death (pyroptosis). Moreover, 
LL-37 inhibited the LPS binding to the cells and ATP-
induced/P2X7-mediated caspase-1 activation, suggesting 
that LL-37 inhibits the LPS/ATP-induced pyroptosis by 
neutralizing LPS action and inhibiting P2X7 response to 
ATP. Furthermore, LL-37 improved the survival of septic 
mice, accompanied with the inhibition of macrophage 
pyroptosis and suppression of IL-1ǃin peritoneal Á uids and 
sera. Thus, the present À nding provides a novel insight into 
the modulation of sepsis utilizing LL-37 with an inhibitory 
action on pyroptosis.SS1F-15-3  The molecular mechanisms 
by which LMIR3/CD300 fi nhibits 
bacterial sepsis
Jiro Kitaura1,2, Toshio Kitamura2, Ko Okumura1, 
Kumi Izawa1,2
1Atopy Research Center, Juntendo Univ. Sch. Med., 2Dept. Cellular Th erapy, 
Inst. Med. Sci., Tokyo Univ.
An inhibitory receptor LMIR3/CD300f is mainly expressed 
in myeloid cells, including mast cells and neutrophils. We 
have recently demonstrated that ceramide-LMIR3 binding 
inhibits IgE-mediated mast cell activation and allergic 
responses. Sepsis remains a major clinical problem. Negative 
regulation of innate immunity is associated with sepsis 
progression. Here we identify the pivotal role of ceramide-
LMIR3 binding in suppressing innate host responses. 
LMIR3-/- mice were protected against lethality after cecal 
ligation and puncture (CLP), a murine model of septic 
peritonitis. In the peritoneal cavity of CLP-operated LMIR3-
/- mice, mast cells and recruited neutrophils released high 
levels of neutrophil chemoattractants, leading to enhanced 
recruitment of neutrophils that efficiently eliminated 
Escherichia coli. Ceramide-LMIR3 interaction suppressed 
such release from Escherichia coli-stimulated mast cells and 
neutrophils. Importantly, treatment with ceramide antibody 
or LMIR3-Fc, which disrupted the ceramide-LMIR3 
interaction, prevented CLP-induced sepsis by profoundly 
stimulating neutrophil recruitment. Thus, LMIR3 is an 
attractive target for the treatment of sepsis.
S2A-16-1  Structural insights into the 
dynamic process of G protein coupled 
receptor signaling
Brian K. Kobilka
Dept. Mole. & Cell. Physiol, Stanford Univ.
G protein coupled receptors (GPCRs) conduct the 
majority of transmembrane responses to hormones and 
neurotransmitters, and mediate the senses of sight, smell 
and taste. The ǃ2 adrenergic receptor (ǃ2AR) and the M2 
muscarinic receptors are prototypical Family A GPCRs 
that mediates physiologic responses to autonomic nervous 
system activity. We have obtained three-dimensional 
structures of the ǃ2AR and the M2 muscarinic receptor in 
inactive and active conformations, as well as a structure of 
the ǃ2AR in complex with the G protein Gs. We have also 
used fluorescence, EPR and NMR spectroscopy to study 
the dynamic properties of the ǃ2AR, and to map ligand-
speciÀ c conformational changes. I will discuss what we these 
studies have taught us about allosteric regulation of GPCR 
structure by G proteins and ligands.45
S2A-16-2  Towards a mechanistic 
understanding of opioid receptors 




Opioid receptors (OR), members of the G protein-coupled 
receptor (GPCR) superfamily, constitute the major and 
the most effective target for the treatment of pain. Both 
beneÀ cial and adverse effects of illicit opioid drugs (opium, 
heroin) as well as approved therapeutics (morphine and 
codeine) are mediated by the activation of the mu-opioid 
receptor (ǍOR). We recently described the structure of an 
inactive conformation of the ǍOR. It provided important 
information regarding the binding site of small morphinan 
antagonists and revealed key molecular determinants for 
antagonist binding preferences for OR.
However, much remains to be learned about the mechanisms 
by which different agonists can induce distinct levels of 
Gi protein activation and/or arrestin recruitment upon 
activation of ǍOR.
In this study, we propose to analyze the conformational 
landscape of the ǍOR in distinct pharmacological conditions 
using liquid-state NMR spectroscopy. In particular, we have 
developed a double labeling scheme to monitor signals from 
distinct methyl probes in speciÀ cally labeled ǍOR domains. 
Our goal is to provide a mechanistic understanding of opioid 
receptor activation upon binding of ligands presenting 
distinct efÀ cacy and/or biased signaling properties. A better 
knowledge of the structural basis for opioid drug efficacy 
may lead to new therapeutic approaches with limited side 
effects.
S2A-16-4 ȕ-arrestin-mediated biased 
signaling
Hitoshi Kurose
Dept. Pharmacol. and Toxicol., Grad. Sch. Pharm. Sci., Kyushu Univ.
It has been recognized that agonist-bound G protein-
coupled receptors (GPCRs) couple not only with G proteins, 
but also with ǃ-arrestins. ǃ-arrestins are scaffold proteins 
that bind GPCRs phosphorylated by G protein-coupled 
receptor kinases. They induce cellular responses different 
from those of G proteins. Agonists that selectively activate 
ǃ-arrestin-mediated signaling are called as biased agonists. 
ǃ-adrenergic receptors are members of GPCR family, and 
ǃ-adrenergic receptor blockers (ǃ-blockers) are frequently 
used for the treatment of cardiovascular diseases such 
hypertension and heart failure. The effects of ǃ-blockers are 
believed to block excess ǃ-adrenergic receptor stimulation. 
However, some ǃ-blockers can evoke cellular responses 
through ǃ-arrestins. The ǃ-arrestin-mediated signaling 
of carvedilol, a ǃ-blocker, has been extensively studied. 
However, there are other ǃ-blockers that are currently used 
for the treatment, and there may be differences between 
ǃ-blockers. I would like to show that each ǃ-blocker has 
unique property and induce different responses through 
ǃ-arrestins by comparing the effects of carvedilol to another 
ǃ-blocker, metoprolol.SS2A-16-3  Biased signaling and 
physiological role of free fatty acid 
receptor GPR120/FFAR4
Akira Hirasawa1,2, Takafumi Hara1, Keiko Iida1
1Dept. Genomic Drug Discovery Science, Grad. Sch. Pharmaceu. Sci, Kyoto 
Univ., 2Insti. for Integrated Med. Sci., Tokyo Women’s Medical Univ.
In the last decade, a strategy to deorphanize G-protein-
coupled receptors (GPCRs) identified a series of receptors 
for FFAs that play signiÀ cant roles in nutrition regulation. 
In this free fatty acid receptor family, GPR120/FFAR4 are 
activated by long-chain FFAs. GPR120/FFAR4 promotes the 
secretion of glucagon-like peptide-1 (GLP-1) in the intestine 
and also acts as the lipid sensor in the adipose tissue to 
sense dietary fat and control energy balance. Analysis for 
agonist-directed signaling of GPR120/FFAR4 coupled to 
G-protein and/or ǃ-arrestin dependent pathway suggests 
that some of the compounds showed biased signaling. 
Site-directed mutagenesis analysis based on the docking 
simulation suggests binding mode of the compounds well 
correlate with the biased signaling. These findings are 
important for further insight of ligand identification of 
GPR120/FFAR4 that could be control the physiological 
function of GPR120/FFAR4 by the compounds. In this 
symposium, summarizing recent findings on GPR120/
FFAR4 selective compounds, we will show the possibility for 
the treatment of metabolic diseases, including obesity and 
diabetes.
S2B-17-1  Towards organisms-level 
systems and synthetic biology
Hiroki R. Ueda1,2 
Dept. Systems Pharmacol., Grad. Sch. Med., Th e Univ. of Tokyo, 2RIKEN QBiC
The logic of biological networks is difficult to elucidate 
without (1) comprehensive identification of network 
structure,  (2)  prediction and validation based on 
quantitative measurement and perturbation of network 
behavior, and (3) design and implementation of artificial 
networks of identified structure and observed dynamics.
Mammalian circadian clock system is such a complex and 
dynamic system consisting of complicatedly integrated 
regulatory loops and displaying the various dynamic 
behaviors including i) endogenous oscillation with about 24-
hour period, ii) entrainment to the external environmental 
changes (temperature and light cycle), and iii) temperature 
compensation over the wide range of temperature. I will 
discuss the current and past studies on a mammalian 
circadian clock as an example of molecule-to-cell-level 
systems biology, and also discuss the challenges and 
opportunities towards the organism-level systems biology.
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S2B-17-2  Chronopharmacology of 
antitumor drugs focused on biological 
clock
Shigehiro Ohdo
Dept. Pharmaceutics, Grad. of Pharm. Sci., Kyushu Univ.
Mammalians circadian pacemaker resides in the paired 
suprachiasmatic nuclei and influences a multitude of 
biological processes. Clock genes are the genes that 
control the circadian rhythms in physiology and behavior. 
The effectiveness and toxicity of antitumor drugs vary 
depending on dosing time associated with 24-hr rhythms of 
biochemical, physiological and behavioral processes under 
the control of circadian clock. Such chronopharmacological 
phenomena are inÁ uenced by not only the pharmacokinetics 
but also pharmacodynamics of antitumor drugs. We clariÀ ed 
the regulatory mechanisms underlying the rhythmicity 
of molecular target, receptor, CYP and transporter 
transcription. For example, the transferrin receptor 1 (TfR1) 
in colon cancer-bearing mice exhibits a 24-hr rhythm in 
mRNA and protein levels. The clock-controlled gene c-MYC 
rhythmically activates transcription of the TfR1 gene. 
Platinum incorporation into tumor DNA and the antitumor 
efficacy of transferrin-conjugated liposome-delivered 
oxaliplatin can be enhanced by drug administration at times 
when TfR1 expression increased. Our À ndings suggest that 
the 24-hr rhythm of TfR1 expression may form an important 
aspect of strategies for TfR1-targeted cancer therapy.
S2D-18-1  RNA granules: A signaling 
hub and a possible therapeutic target
Reiko Sugiura
Lab. Mol. Pharmacogenom. Sc. Pharmaceutical Sci.
RNA granules are widely conserved non-membranous 
structures and the role of RNA granules has now been 
expanded to include not only a determinant of RNA-fate but 
also a signaling hub. Moreover, RNA granules are linked to 
several neurodegenerative diseases. We have been studying 
the signaling pathways with a special focus on MAPK and 
calcineurin (CN)-mediated signaling in À ssion yeast. Here, 
we showed that spatial control of CN is mediated by RNA 
granules and that CN and MAPK antagonistically regulate 
RNA granule formation. CN is a Ca2+/calmodulin-dependent 
protein phosphatase that plays a key role in various cellular 
functions. Although the CN-mediated spatial control of 
the downstream transcription factors has been intensively 
studied, little is known about the intracellular localization 
of CN in response to stresses. We showed that heat shock 
(HS) stimulates CN-dependent transcriptional activation, 
and that CN undergoes a dramatic change in subcellular 
localization in response to HS, translocating from diffuse 
cytoplasmic to RNA granules. Notably, phosphatase activity 
is important for the recruitment of CN into RNA granules 
and that CN negatively regulates RNA granule formation. 
We also discuss the possible role of RNA granule as a 
therapeutic target.SS2B-17-3  Chrono-pharmacology 
and chrono-nutrition on metabolic 
syndrome
Shigenobu Shibata
Lab. Physiol. Pharmacol. Sch. Sci. Eng. Waseda Univ.
Circadian rhythm controls many physiological functions 
including feeding and energy metabolism. There are some 
drugs and functional foods for treatment of metabolic 
syndrome. Effect of insulin shows circadian change in 
its sensitivity, and also insulin affects circadian rhythm 
resetting effects. ǚ-3 fatty acids DHA and EPA also 
possess phase-resetting effects through insulin secretion. 
In addition, nuclear receptor agonist and related drugs 
such as Pparǂ , PparǄ  agonists which are widely used for 
metabolic syndrome, affects clock gene expression levels. 
Many functional food compounds possess agonistic activity 
for Pparǂ   and/or  PparǄ . Therefore, these drugs and 
compounds may influence circadian clock system as well 
as anti-metabolic syndrome effects. In this symposium, 
interactions of chrono-nutrition and chrono-exercise are also 
discussed for promotion of health science.
S2D-18-2  Neural specifi c RNA-binding 
protein HuD grasps the translation 
regulatory networks
Toshinobu Fujiwara
Grad. Sch. Pharmaceut. Sci., Nagoya City Univ.
Hu proteins are RNA-binding proteins that stabilize 
adenine/uridine-rich element (ARE)-containing transcripts. 
We have recently shown that HuD, a member of the 
neuronal Hu family of proteins, stimulates translation of 
capped and polyadenylated mRNA1. This stimulatory effect 
of HuD on translation depends on the interaction of HuD 
with eIF4A and a poly(A) tail. Thus, HuD is a powerful tool 
to positively modulate translation initiation via eIF4A.Here, 
we applied biochemical approaches to directly examine the 
presence of key initiation factors on target mRNAs under 
repression. Using HEK293F cell extracts, we show that 
both eIF4AI and eIF4AII, but not other eIF4F components, 
dissociate from the mRNA in a miRISC-dependent manner 
at early time points. Conversely, HuD prevents the miRISC-
induced dissociation of eIF4AI and eIF4AII via a direct 
interaction with the eIF4As, thereby relieving translational 
repression by miRISC. Furthermore, pharmacological 
treatment that prevents dissociation of eIF4As from mRNA 
conferred resistance to miRNA-mediated translation 
repression in vitro and in cultured cells. Our results provide 
a mechanistic explanation of how miRNAs repress the 
initiation step of translation.47
S2D-18-3  mRNA degradation in the 
control of immunity
Osamu Takeuchi1,2 
1Inst. Virus Res., Kyoto Univ., 2CREST, JST
Proinflammatory cytokine levels are tightly controlled in 
immune responses. In addition to transcriptional regulation, 
the control of cytokine mRNA stability is important for 
maintaining appropriate cytokine levels. Tristetraprolin 
and Roquin proteins are reported to bind with TNF mRNA 
through AU rich elements and a stem-loop region in its 3’ 
untranslated region (UTR). Subsequently, they recruit a 
CCR4-NOT deadenylase complex for mRNA degradation 
at the P body. In addition, we identified Regnase-1 as an 
endonuclease directly degrading a set of immune-related 
mRNA such as IL-6 and IL-12p40 via stem-loop structures 
in their 3’ UTR. Regnase-1 is essential for inhibiting the 
development of autoimmune inÁ ammatory diseases in mice. 
We found that Toll-like receptor (TLR) stimulation rapidly 
induces Regnase-1 degradation via phosphorylation by 
the IkB kinases to stabilize Il6 mRNA. This regulation is 
important for facilitating rapid and robust production of IL-6 
in response to pathogen infection. Further, we found that 
the Regnase-1-mediated mRNA degradation is depending 
on protein translation at the endoplasmic reticulum. These 
results demonstrate that different mRNA degradation 
machineries regulate their target mRNAs at distinct status, 
to enable the À ne tuning of the immune responses.
S2E-19-1  Open innovation network for 
drug development and drug discovery 
in academia
Hidenori Ichijo
Lab. Cell Signaling, Grad. Sch. Pharm. Sci., Univ. of Tokyo
The phrase “pen Innovation for Drug Development” has 
become a trending topic. In this symposium, I would like 
to introduce the current status of the Open Innovation 
Network for Drug Development and an example of our trials 
for the Drug Discovery in Academia. ALS is a devastating 
neurodegenerative disease characterized by the selective 
motoneuron death. We have previously reported that more 
than 100 different  SOD1 mutants speciÀ cally interact with 
Derlin-1, a component of ER-associated degradation (ERAD) 
machinery. This interaction triggers ER stress through the 
disruption of ERAD and causes motoneuron death. These 
À ndings suggest that the dissociation of SOD1 mutant from 
Derlin-1 protects motoneuron from SOD1 mutant-induced 
cell death. Thus, the small molecular weight compounds that 
inhibit this interaction can be used as the novel therapeutic 
approach for ALS. We have screened about 160,000 chemical 
compounds, and the inhibitory activity of hit compounds 
has been validated by IP-WB. These compounds can be 
pharmaceutical drug candidates for ALS and also can be 
useful experimental tools to show the importance of the 
SOD1-Derlin-1 interaction in the pathogenesis of ALS.S48S2D-18-4  Targeting epigenetic 
plasticity as novel strategy for cancer 
treatment
Yutaka Kondo
Dept. Epigenomics, Nagoya City Univ.
Tumorigenic process involves developmental program, 
which is analogous to cellular reprogramming. During this 
process, epigenetic mechanisms play roles as effectors and 
modulators of reprogramming and establish functions in 
tumorigenesis. Cancer stem cells have plasticity in response 
to extracellular signals, being capable to functionally adapt 
to their microenvironment. We investigated the epigenetic 
mechanisms that regulate the differentiation of glioma 
stem cells (GSCs). We found that differentiation of GSCs is 
functionally plastic and accompanied by dynamic changes 
of polycomb repressive complex 2 (PRC2)-mediated histone 
H3 lysine 27 trimethylation on pluripotency or development 
associated genes. Further, the recruitment of PRC2 to 
certain loci is closely associated with long noncoding 
RNA (lncRNA) function, of which expression is regulated 
by the Notch signaling pathway. Our data indicate that 
epigenetic regulation by PRC2 is a key mediator of tumor 
cell plasticity and the speciÀ c roles of lncRNA in modulation 
of stemness properties in GSC in response to environmental 
signals. Targeting the tumor cell plasticity through the 
underlying molecular mechanisms may be a novel strategy 
in glioblastoma treatment.
S2E-19-2  4’-Ethynyl-2-fl uoro-2’-
deoxyadenosine (EFdA), a translocation 
defective nucleoside reverse 
transcriptase inhibitor, has high genetic 
barrier, persistently exerting potent 
activity against HIV-1 isolates including 
EFdA-selected HIV-1 variants
Hiroaki Mitsuya1,2
Depts. Hematol., Rheumatol. Clin. Immunol., & Infect. Dis., 2Natl. Center for 
Global Health & Med., Center for Clin. Sci.
EFdA, a translocation defective nucleoside reverse 
transcriptase inhibitor (NRTI), retains a 3’-hydroxyl moiety 
(3’-OH) and exerts potent activity  against diverse wild-type 
and drug-resistant HIV-1 strains in vitro with IC50 values 
of 70 pM~21 nM. The exceptional antiviral activity of EFdA 
stems in part from a mechanism of action that differs from 
that of approved NRTIs that lack 3’-OH. Intracellular T1/2 
of EFdATP was ~17 hr or longer, suggesting the possibility 
of once daily dosing schedule. EFdA exerts minimal 
inhibition to the activity of human DNA polymerases alpha, 
beta, and gamma. Comparative sequential selection study 
to generate drug-resistant HIV variants demonstrated 
that the emergence of HIV-1 resistant to EFdA was 
significantly delayed. The present data demonstrate that 
EFdA persistently exerts the most potent activity against 
even EFdA-selected HIV-1 variants and warrant further 
clinical development as a novel QD-possible NRTI with an 
extremely high genetic barrier and potency against a variety 
of multi-drug-resistant HIV-1 variants.
S2E-19-3  Drug Discovery and 
Development in Academia – How to 
Maximize the Serendipity
Masatoshi Hagiwara
Dept. Anatomy and Develop. Biol., Grad. Sch. Med., Kyoto Univ.
Patients of congenital diseases have abnormalities in 
their chromosomes and/or genes. Therefore, it has been 
considered that drug treatments can serve to do little for 
these patients more than to patch over each symptom 
temporarily when it arises. Although we cannot normalize 
their chromosomes and genes with chemical drugs, we may 
be able to manipulate the amounts and patterns of mRNAs 
transcribed from patients DNAs with small chemicals. 
Based on this simple idea, we have looked for chemical 
compounds which can be applicable for congenital diseases 
and found INDY, TG003, and SRPIN340, and RECTAS. 
These are promising as clinical drugs for Down syndrome 
(DS), Duchenne muscular dystrophy (DMD), Denys Drash 
Syndrome (DDS), and Familial dysautonomia (FD), 
respectively. Through the development of these chemicals, 
we eventually succeeded to find candidate compounds 
available for more common diseases such as viral infections, 
cancers, age-related macular degeneration, chronic pain, 
and Parkinson disease. We propose the strategy to maximize 
the serendipity for academic drug development with open 
innovation.
S2F-20-2  The effect of PDE5 
inhibitors on testicular dysfunction in 
oligoasthenospermic and azoospermic 
men
Motoaki Saito1, Fotios Dimitriadis2, SoÀ kitis Nikolaos3
1Dept. Pharmacol. Kochi Medical Sch. Kochi Univ., 2B’Urologic Dept. 
Papageorgiou General Hospital, Aristotle Univ. Sch. Med., 3Dept. Urology, 
Sch. Med. Univ. Ioannina
As recent evidences suggest that the expression of PDE5 
in the testicular peritubular cells, Leydig cells and possibly 
Sertoli cells suggest that PDE5 plays an important role in 
the pathophysiology of testicular dysfunction. We performed 
two clinical trials whether PDE5 inhibitors, i.e., vardenaÀ l 
or sildenafil improved testicular dysfunction in patients 
with oligoasthenospermia and azoospermia. In these clinical 
trials we suggest that PDE5 inhibitors enhance Leydig 
cell secretory function such as insulin-like-3 peptides and 
androgen-binding protein secretion, and that this treatment 
might contribute to the increase in sperm concentration and 
sperm motility. In this symposium, we will show our data 
and possible effects and their mechanisms in the testicular 
dysfunction.S4S2F-20-1  A novel approach for 
ischemia-induced erectile dysfunction
Yuji Hotta1, Kazunori Kimura1,2,3 
1Dept. Hosp. Pharm., Grad. Schl. Pharm. Sci., Nagoya City Univ., 2Dept. Clin. 
Pharm. & Th er., Grad. Schl. Medical Sciences., Nagoya City Univ., 3Dept. 
Pharm., Nagoya City Univ. Hosp.
Pelvic  blood f low is  important  and necessary for 
penile erection. Pelvic ischemia induced by trauma or 
atherosclerosis sometimes causes erectile dysfunction (ED). 
Ischemia can induce not only ED but also penile À brosis by 
downregulating the NO/cGMP signaling pathway. 
PDE-5 inhibitors are the only oral medicines for ED, and 
they are commonly used on-demand. In cases of impaired 
blood Á ow, on-demand therapy with a PDE-5 inhibitor may 
not improve symptoms. However, it was reported that long-
term treatment with a PDE-5 inhibitor might improve 
erectile function in a nerve injury-induced ED model. In 
addition, long-term treatment with a PDE-5 inhibitor also 
induced angiogenesis and improved hemodynamic status in 
a femoral ischemic model. Thus, long-term enhancement of 
the NO/cGMP system might improve acute arteriogenic ED. 
To enhance this system, we focused on a PDE-5 inhibitor and 
L-citrulline. L-citrulline is known to convert to L-arginine 
and improve NO production. 
We investigated whether long-term treatment with 
vardenaÀ l, a PDE-5 inhibitor, or L-citrulline could improve 
erectile function in a rat model of arteriogenic ED. In this 
symposium, I will discuss the effects of long-term treatment 
with a PDE-5 inhibitor or L-citrulline on arteriogenic ED.
S2F-20-3  Effect of phosphodiesterase 
5 inhibitors on lower urinary tract 
symptoms in patients with benign 
prostatic hyperplasia
Seiji Matsumoto1, Hidehiro Kakizaki 
Dept. Renal and Urologic Surgery, Asahikawa Med. Univ.
The phosphodiesterase 5 (PDE5) inhibitor tadalafil was 
approved in Japan for the treatment of lower urinary 
tract symptoms (LUTS) in patients with benign prostatic 
hyperplasia (BPH) in April 2014. Andersson KE et al 
reviewed that major mechanisms contributing to LUTS 
include: reduced nitric oxide (NO) / cyclic guanosine 
monophosphate (cGMP) signaling; increased RhoA kinase 
pathway activity; autonomic overactivity; increased bladder 
afferent activity; and pelvic ischemia. Tadalafil and other 
PDE5 inhibitors have demonstrated beneficial effects on 
smooth muscle relaxation, smooth muscle and endothelial 
cell proliferation, nerve activity, and tissue perfusion that 
may impact LUTS in men (Neurourol Urodyn. 2007). 
We previously investigated whether the PDE5 inhibitor 
(vardenaÀ l) would protect the bladder from decompensatory 
changes in a 4-week rat bladder outlet obstruction (BOO) 
model (BJU Int. 2009). Chronic treatment with a high dose 
of PDE5 inhibitor protected the rat bladder from BOO-
induced contractile dysfunction to carbachol. The PDE5 
inhibitors have the effect on several pathways that may 
impact LUTS/BPH.9
S2F-20-4  The future of Men’s health 
with PDE5-inhibitors
Shin-ichi Hisasue
Dept. Urol., Juntendo Univ.
Recently daily administration of phosphodiesterase type-
5 inhibitor (PDE5i)= tadalafil was newly approved for 
lower urinary tract symptoms (LUTS) by benign prostatic 
hyperplasia  (BPH) in Japan. Daily dose of tadalafil 
improves LUTS significantly, and it contributes to a 
maximum flow rate in combination with alpha-blockers. 
In the animal model, daily PDE5i leads to the prevention 
from fibrosis of prostate. Therefore it has a potential to 
avoid the worsening of LUTS by BPH. It has been revealed 
that PDE5i has an anti-oxidative effect, which leads to the 
restoration of endothelial function and the testosterone 
increase. Therefore the potential of PDE5i on the anti-aging 
in middle age and elderly males is promising. In the meta-
analysis of daily tadalafil, the prognostic factors for the 
efÀ cacy were severity of symptoms, age, and BMI. (Gacci et 
al. Eur Urol 2012) The patients with low testosterone level 
hardly respond to PDE5i for their ED, and testosterone 
replacement ameliorates it. Daily dose of tadalafil will be 
the essential drug not only for ED and LUTS patients, but 
for any of aged male population. In the future, we need to 
optimize the use of tadalaÀ l to induce the maximum effect.
S2B-21-2  Autism and epigenetics
Toru Takumi
RIKEN BSI
Autism spectrum disorders (ASD) are child psychiatric 
illnesses that are characterized by impairments in social 
interactions and verbal and non-verbal communications, 
and pervasive stereotypic behavior. Most of their causes are 
unknown, whereas there are several known causes of ASD, 
in syndromic cases (fragile X syndrome, tuberous sclerosis, 
Rett syndrome, etc.), chromosomal abnormality (15q11-
13 duplication, other CNVs), and rare mutations. Among 
CNVs and rare mutations, cell adhesion molecules that are 
involved in synapse formation and other related molecules 
to synaptic functions are particularly intriguing. The cause 
of ASD may be considered as abnormality in postnatal 
development of synapses. We have generated a mouse model 
for duplication of human chromosome 15q11-13 using a 
chromosome-engineering technique. The duplicated region is 
also known to be an imprinting region, so the model would 
be interesting in light of epigenetics. I will present our 
analyses on these mice towards understanding of molecular 
pathophysiology of ASD.S50S2B-21-1  Neuroepigenetics in chronic 
pain
Hitoshi Uchida1, Hiroshi Ueda 
Dept. Pharmacol. Th er. Innov., Nagasaki Univ. Grad. Sch. of Biomed. Sci.
Chronic pain is closely associated with memory processes 
that require long-term gene expression in the somatosensory 
nervous system. Accordingly, there is emerging evidence 
that epigenetic mechanisms, such as DNA methylation and 
histone modiÀ cations, are engaged in the development and 
maintenance of chronic pain. Our previous studies have 
clarified the epigenetic regulation of pain-related genes 
in the primary afferent neurons underlying abnormal 
pain sensations and resistance to morphine in a model of 
peripheral nerve injury-induced chronic neuropathic pain 
in mice. Importantly, we have also shown that neuron-
restrictive silencer factor (NRSF, also known as RE-1-
silencing transcription factor; REST) orchestrates histone 
deacetylation-mediated transcriptional repression of pain-
related genes to cause pathological and pharmacological 
dysfunction of C-À bers after nerve injury. In this symposium, 
we will discuss the molecular mechanisms of epigenetic gene 
regulation underlying chronic pain, based on our recent 
findings. Also, we will discuss the therapeutic potential of 
epigenetic modifying compounds in the treatment of chronic 
pain.
S2B-21-3  Infl uences of environmental 
factors on phenotypes of psychiatric 
diseases through epigenetic modulation
Toshitaka Nabeshima1,2 
Dept. Regional. Pharmac. Care Sci., Fac. Pharm., Meijo Univ., 2Jap. Drug Org. 
Approp. Use Res.
Human behavior is inÁ uenced by environmental conditions 
during childhood and adolescence. Psychiatric diseases have 
not 100 % of concordance rate even in monozygotic twins. 
Not only genetic factors but also environmental factors, 
during the critical period of brain development, might 
contribute to the onset and/or progression of psychiatric 
diseases. Conversely, environmental interventions may 
protect against the onset of psychiatric diseases. Little 
is known how environmental factors might modulate 
the pathogenesis of psychiatric diseases and /or disease 
progression. Recent studies have reported that epigenetic 
mechanisms, which exert lasting control over gene 
expression without altering the genetic code, could mediate 
stable changes in brain function induced by environmental 
factors.We have investigated 1) whether interaction of 
gene and environmental stressors during childhood and 
adolescence influences postnatal brain maturation and 
behavioral patterns in adulthood of DISC 1 transgenic 
mice, 2) whether enriched environment during adolescence 
protects phencyclidine-induced abnormal behavior through 
epigenetic mechanisms, 3) whether clozapine ameliorates 
epigenetic and behavioral abnormalities induced by 
phencyclidine.
S2B-21-4  Dnmt3a in Sim1 neurons 
is necessary for normal energy 
homeostasis
Daisuke Kohno
ASRLD Unit, Gunma Univ.
Obesity rates continue to rise throughout the world. 
Recent evidence has suggested that environmental factors 
contribute to altered energy balance regulation. However 
the role of epigenetic modifications to the central control 
of energy homeostasis remains unknown. To investigate 
the role of DNA methylation in the regulation of energy 
balance, we investigated the role of the de novo DNA 
methyltransferase, Dnmt3a, in Sim1 cells. Dnmt3a 
expression levels were decreased in the paraventricular 
nucleus of the hypothalamus (PVH) of high-fat-fed mice. 
Mice lacking Dnmt3a specifically in the Sim1 neurons, 
which are expressed in the forebrain, including PVH, 
became obese. The mice were found to have hyperphagia 
and decreased energy expenditure. Gene expression proÀ ling 
and DNA methylation analysis revealed that the expression 
of tyrosine hydroxylase was highly upregulated in the PVH 
of Sim1-specific Dnmt3a deletion mice. DNA methylation 
levels of the tyrosine hydroxylase promoter were decreased 
in the PVH of the deletion mice. These results suggest that 
Dnmt3a in the PVH is necessary for the normal control 
of body weight and energy homeostasis. These results 
provide evidence for a role for Dnmt3a in the PVH to link 
environmental conditions to altered energy homeostasis.
S2D-22-2  Theoretical prediction of 
ototoxic mechanism in spiral ligament 
by multi-level simulation with ion 
transports in the cochlea
Fumiaki Nin1, Takamasa Yoshida3, Shingo Murakami2, 
Genki Ogata1, Yoshihisa Kurachi2, Hiroshi Hibino1
1Dept. Mol. Physiol., Niigata Univ. Sch. Med., 2Div. Mol. Cell Pharmacol., 
Dept. Pharmacol., Grad. Sch. Med., Osaka Univ., 3Dept. Otolaryngol., Grad. 
Sch. Med., Kyushu Univ.
The sensory hair cells in cochlea flow ions from the 
endolymph for the excitation. The stria vascularis in the 
lateral wall sustains the endolymph’s unique potential, 
called the endocochlear potential (EP) that enhances 
the hair cell’s excitation. It is reported that furosemide, 
a blocker of Na+, K+, 2Cl--cotransporter (NKCC), elicits 
deafness by decreasing the EP. However, how the furosemide 
induces loss of the EP is unclear. We have shown that how 
the NKCC and Na+, K+-ATPase in the strial marginal cells 
control the EP electrophysiologically. In addition, we have 
developed a mathematical model of cochlear K+ transport, 
and reproduced the electrochemical properties under the 
furosemide induced loss of EP. NKCC in the spiral ligament 
of the lateral wall is also considered to be the target of 
furosemide. We recently showed that not the NKCC but 
the Na+, K+-ATPase controls K+ transport and [K+] in the 
spiral ligament. Based on the results, we developed the 
Na+ dependent K+ transport model of spiral ligament. We 
experimentally and theoretically proved that the target of 
furosemide is the NKCC not in the spiral ligament but in 
strial marginal cells as a pathophysiology of the furosemide 
induced deafness.S5S2D-22-1  Live-cell measurements of 
dissociation constants of signaling 
molecule complexes by fl uorescence 
cross-correlation spectroscopy
Kazuhiro Aoki
Grad. Sch. Med., Kyoto Univ.
The Ras-ERK pathway plays an important role in many 
cellular functions including proliferation, differentiation 
and tumorigenesis. Computer-assisted simulation is one of 
promising approaches for dissecting complicated signaling 
networks as a system; however, this approach has been so 
far limited by a deÀ ciency of reliable kinetic parameters. To 
pursue this issue, we applied Á uorescence cross-correlation 
spectrometry (FCCS) to measure dissociation constants 
of signaling molecule complexes within a cell (in vivo Kd). 
Among several pairs of fluorescent molecules tested, that 
of mEGFP and HaloTag-tetramethylrhodamine was most 
suitable for the measurement of in vivo Kd by FCCS. Using 
this pair, we determined more than 20 in vivo Kd values of 
signaling molecule complexes including Ras-ERK pathway. 
Interestingly, most of the in vivo Kd values determined 
in this study were higher than the in vitro Kd values 
reported previously. This data implicated the importance of 
competitive bindings inside cells, but not macromolecular 
crowding, which reduced Kd values. These in vivo Kd 
values will provide an important basis for the quantitative 
understanding of signal transduction.
S2D-22-3  Regulation of Inorganic 
phosphate homeosutasis; analysis of 
crosstalk between kidney and other 
organs
Sawako Tatsumi1, Ken-ichi Miyamoto 
Dept. Molecular Nutrition., Inst. of Health Biosci., Th e Univ. of Tokushima 
Grad. Sch.
Inorganic phosphate (Pi) is a nutrient essential for a large 
number of biological processes including cell metabolism 
(energy production and signaling) and structure (nucleic 
acids, phospholipid membranes). The maintenance of a 
constant circulating level of Pi depends on the coordinated 
activity of three major organs: intestine, kidney, and bone. 
Dysregulation of Pi causes some syndromes characterized by 
hypo or hyperphosphatemia states. Hyperphosphatemia is 
associated with ectopic calciÀ cation, cardiovascular disease, 
and increased mortality in patients with chronic kidney 
disease (CKD). As dietary restriction or hemodialysis is 
not enough in phosphate control, oral Pi binders are used 
in over 90% of patients with renal failure. Furthermore, 
hyperphosphatemia in the hemodialysis population is 
ubiquitous, but Pi kinetics during hemodialysis is poorly 
understood. Recent study showed that a mathematical 
modeling of Pi kinetics during hemodialysis implies 
regulation involving up to four Pi pools. A mathematical 
modeling approach is a useful to control serum Pi levels 
during hemodialysis. In this presentation, we would like to 
review these investigations briefly, and report recent our 
progress on Pi homeostasis.1
S2D-22-4  Systems pharmacological 
prediction of cardiotoxicity based on 
intracellular signaling network
Yoshiaki Kariya1, Masashi Honma2, Hiroshi Suzuki1
1Dept. of Pharm., Univ. of Tokyo Hosp., 2Pharcol. and Pharmacokinet., Univ. 
of Tokyo Hosp.
Adverse  drug  react ions  (ADRs)  occurr ing  out  o f 
extrapolation of main pharmacological mechanisms are often 
difÀ cult to predict. One example is tyrosine kinase inhibitor 
(TKI)-associated cardiotoxicity  whose cause is cardiac cell 
apoptosis. This toxicity occurs upon the integration of at 
least two factors, inhibition of each TKI against various 
kinases (including both primary and off-target kinases) and 
impact of each kinase on cardiac cell apoptosis. The former 
is evaluable from the comprehensive measure of affinities 
reported previously. To address the latter, we adopted 
systems biological analyses. The intracellular signaling 
pathways from various kinases to apoptosis in cardiac cells 
were collected from knowledge bases like REACTOME 
together with original reports and was integrated into a 
large single map (about 900 entities with 600 reactions) 
using CellDesigner. Based on the map structure analysis and 
dynamic simulations, we evaluated risks of various kinases 
on apoptosis. Drug risk scores calculated by considering both 
the affinity and the pathway factors were well correlated 
with clinically observed cardiac event rates for various TKIs, 
suggesting that our systems-pharmacological method could 
be applied for ADR predictions.
S2F-23-1  Epidermal keratinocytes and 
itch-related lipid mediator
Tsugunobu Andoh
Dept. Applied Pharmacol., Sch. Med. Pharm. Sci., Univ. Toyama
Until now, cutaneous mast cells, which are mainly 
distributed in dermis, as major cell for the induction of 
pruritus have been known. However, it is believed that 
itch is received by nerve endings at dermal-epidermal 
junction. In addition, the increase of the density of the 
fibers accompanied with the promotion of the sprouting of 
primary afferent fibers into the epidermis is observed in 
the epidermis of several pruritic skin diseases (e.g., atopic 
dermatitis and xerosis). Taken together, it is suggested that 
keratinocytes distributed widely in epidermis may play an 
important role on itch. We have focused on keratinocytes 
in order to investigating the mechanisms of itch. Most of 
pruritic skin diseases show the disorder of lipid metabolism 
in the skin. Especially, recent studies have been shown 
that metabolites of arachidonic acid and sphingolipids in 
epidermis are involved in itch in pruritic skin diseases. 
This symposium outlines recent À ndings on the itch-related 
metabolites of arachidonic acid and sphingolipids and the 
mechanisms of itch.SS2D-22-5  Multi-layer hierarchical 
physiology-based modeling for the 
prediction of pharmacokinetic drug-
drug interactions
Fumiyoshi Yamashita
Dept. Drug Delivery Res., Kyoto Univ. Grad. Sch. Pharm. Sci.
Pharmacokinetic drug-drug interaction (DDI) is an event 
that pharmacokinetics of a drug is altered by concomitant 
intake of another drug or food, possibly resulting in 
unexpected side effects or changes in pharmacological 
action. It is primarily mediated by inhibition and induction 
of drug metabolizing enzymes and transporters. The success 
of DDI predictions requires understanding of quantitative 
relationship between drug disposition and its influential 
factors. Physiologically based pharmacokinetic (PBPK) 
modeling is a technique in which pharmacokinetics is 
described with physiological and biochemical parameters 
such as blood Á ow rate, protein binding, and metabolic rate. 
The mechanism-based approach allows in vitro-in vivo and 
inter-species extrapolations of pharmacokinetics. We have 
been developing PBPK models to predict the DDI mediated 
by induction of drug metabolizing enzymes. It requires 
PBPK modeling for both inducer and victim drug, together 
with enzyme induction kinetics accompanying transcription 
and translation processes. In this presentation, we present 
modeling of the individual processes based on clinical and 
in vitro data and implementation and simulation in the 
PhysioDesigner/Flint platform.
S2F-23-2  Development of mouse 
model for atopic dermatitis using 
hairless mice and analysis of 
pathogenic mechanisms
Masanori Fujii
Dept. Pharmacol., Kyoto Pharm. Univ.
We have reported a unique, diet-induced mouse model for 
atopic dermatitis (AD). HR-1 hairless mice fed a special diet 
(named HR-AD) develop AD-like pruritic skin inÁ ammation. 
Pharmacological approaches revealed that skin barrier 
dysfunction contributed to itch-related scratching. We 
also found that administration of ethanol, barbiturates or 
allopregnanolone markedly enhanced scratching only in mice 
suffering from AD, suggesting that some neural changes 
in central nervous system are involved in AD itch. HR-AD-
induced AD symptoms were ameliorated by supplementation 
of polyunsaturated fatty acids (PUFAs) or starch, indicating 
that deficiencies of PUFAs and starch are responsible 
for this dermatitis. In HR-AD-fed mice, epidermal cells 
(predominantly keratinocytes) largely produced thymic 
stromal lymphopoietin that was completely blocked by 
topical PUFA treatment. Furthermore, we have elucidated 
that a mutation in the hairless gene (Hr ) predisposes to HR-
AD-induced pruritic dry skin. HR encoded by the Hr  gene 
is known to function as a corepressor of various nuclear 
receptors (NRs). Collectively, these findings from the diet-
induced AD model suggest that certain PUFAs and NRs are 
potential therapeutic targets for treating AD.52
S2F-23-3  Novel therapeutic strategy to 
control atopic dermatitis using a newly 
generated JAK inhibitor JTE-052 via 
promoting skin barrier functions
Kenji Kabashima
Dept. Dermatol., Kyoto Univ. Grad. Sch. Med.
Majority of atopic dermatitis (AD) patients exhibit impaired 
barrier dysfunction due to genetic, environmental, and 
immunological factors. Th2 milieu is known to impair 
keratinocyte terminal differentiation; however, its 
underlying mechanism remains unclear.  In the present 
study, we demonstrated that Th2-STAT3 signaling is crucial 
for keratinocyte terminal differentiation.Therefore, we 
evaluated a therapeutic potential of a JAK inhibitor by 
using a novel JAK inhibitor JTE-052. Using normal human 
keratinocytes and a reconstructed human skin equivalent 
model, we found that JTE-052 promoted the production of 
terminal differentiation proteins such as À laggrin (FLG) and 
loricrin (LOR) in the presence of Th2 cytokines. In addition, 
using NC/Nga mice as an AD model, we revealed that 
topical administration of JTE-052 improved TEWL in accord 
with increased FLG and natural moisturizing factor (NMF) 
productions. Taken together, our findings suggest that 
JAK-STAT signaling is critical for keratinocyte terminal 
differentiation in mice and human, which may open new 
therapeutic avenues in the treatment of AD.
S2D-24-1  Differential roles of NOX1/
NADPH oxidase-derived ROS in 
cardiovascular disease
Kazumi Iwata, Kuniharu Matsuno, 
Chihiro Yabe-Nishimura
Dept. Pharmacol., Kyoto Pref. Univ. Med.
NADPH oxidase is a major source of superoxide generated 
in cardiovascular tissues. In recent years, 7 homologs 
of NOX, a catalytic subunit of the enzyme, have been 
identified. We here demonstrate roles of NOX1, one of the 
inducible NOX isoforms, in cardiovascular disease by using 
Nox1  deficient mice (NOX1-KO). Continuous infusion of 
angiotensin II significantly increased blood pressure (BP) 
along with increased expression of NOX1 mRNA in the 
aorta of wild-type mice. Elevated BP was significantly 
blunted in NOX1-KO by retaining the bioavailability of 
nitric oxide. On the other hand, a high level of NOX1 
mRNA was expressed in pulmonary arteries of naive mice 
compared with other cardiovascular tissues. Nox1  deÀ ciency 
impaired the turnover of pulmonary arterial smooth muscle 
cells by reducing a voltage-dependent K+ channel, Kv1.5 
protein. In the heart, strong induction of NOX1 mRNA by 
lipopolysaccharides caused apoptosis in cardiomyocytes, 
whereas moderate induction of NOX1 by doxorubicin 
increased the expression of pro-inflammatory and fibrotic 
cytokines without cardiomyocyte apoptosis. These results 
suggest that NOX1-derived ROS play differential roles 
depending upon expression levels and localization in the 
development of cardiovascular disease.S5S2F-23-4  A therapeutic strategy 
for atopic dermatitis targeting a 
matricellular protein, periostin
Kenji Izuhara1, Kazuhiko Arima1, Shoichiro Ohta2, 
Masahiro Ogawa1
1Div. Med. Biochemi., Dept. Biomolecular Sci., Saga Med. Sch., 2Dept. Lab. 
Med., Saga Med. Sch.
Periostin is an extracellular matrix protein belonging to the 
fasciclin family. Periostin acts as a matricellular protein 
functioning in cell activation by binding to cell surface 
receptors, thereby exerting its biological activities. A sizable 
accumulation of evidence has shown that periostin plays 
a critical role in tissue remodeling during tissue/organ 
development or repair. After we found that periostin is a 
downstream molecule of interleukin (IL)-4 and IL-13, the 
signature cytokines of type 2 immune responses, we showed 
that periostin is involved in allergic inflammation leading 
to bronchial asthma and atopic dermatitis. In skin tissues, 
periostin is critical for amplification and persistence of 
allergic inflammation by communicating between between 
fibroblasts and keratinocytes. Blocking the interaction 
between periostin and its receptor, ǂ v integrin, or down-
regulating periostin expression both lead to improvement 
in periostin-induced inflammation in mouse models or in 
in vitro  systems. From these findings, it is reasonable to 
expect periostin to be a promising therapeutic target for 
atopic dermatitis. In this presentation, we will describe 
our therapeutic strategy for atopic dermatitis targeting 
periostin.
S2D-24-2  NADPH oxidase 1 (NOX1)-
derived reactive oxygen species 
mediates colonic infl ammation
Shinichi Kato1, Haruka Yokota1, Azusa Imai1, 
Ayaka Tsuzuki1, Yuki Shimada1, Kikuko Amagase1, 
Kazumi Iwata2, Chihiro Yabe-Nishimura2 
1Div. Pathol. Sci., Dept. Pharmacol. Exp. Th er., Kyoto Pharm. Univ., 2Dept. 
Pharmacol., Kyoto Pref. Univ. Med.
NADPH oxidase (NOX) was originally found as a major 
source of reactive oxygen species (ROS) in phagocytes. 
Multiple homologs have been identiÀ ed, such as NOX2 and 
NOX1, which are phagocytic and non-phagocytic isoforms of 
the enzyme, respectively. Although NOX1 has been shown to 
be highly expressed in the gastrointestinal tract, especially 
the colon, the physiological and pathophysiological roles of 
this enzyme are not fully understood. In this symposium, 
we demonstrate the role of NOX1 in the pathogenesis of 
colonic inÁ ammation. Intrarectal injection of TNBS caused 
severe colitis, but the severity of colitis was significantly 
less in NOX1 knockout (KO) than wild-type (WT) mice. 
The expression of various inflammatory cytokines and 
production of ROS were markedly increased by TNBS 
injection, but all these responses were also significantly 
mitigated in NOX1KO mice. We further found that NOX1 
was expressed macrophages in colonic lamina propria. 
These results suggest that NOX1 plays an important role in 
the pathogenesis of TNBS-induced colitis via up-regulating 
inflammatory cytokines. Therefore, NOX1 may be a novel 
target for the treatment and prevention of inflammatory 
bowel diseases.3
S2D-24-3  Physiological roles of 
hydrogen sulfi de and polysulfi des
Hideo Kimura
Dept. Mol. Pharmacol. Natl. Inst. Neurosci. NCNP
Hydrogen sulÀ de (H2S) is a well-known toxic gas that emits 
an unpleasant smell of rotten eggs.  About 20 years ago, the 
discovery of endogenous sulÀ de in mammalian brain urged 
us to study the role of H2S in neuronal transmission. We 
found a neuromodulatory role with cystathionine ǃ-synthase 
(CBS) as H2S-producing enzyme in the brain in 1996. In the 
following year we demonstrated that H2S relaxes vascular 
smooth muscle in synergy with nitric oxide (NO) with 
cystathionine Ǆ-lyase (CSE) as another enzyme. Our À nding 
of a cytoprotective effect of H2S on neurons from oxidative 
stress led to the identiÀ cation of protecting various tissues 
and organs from ischemia-reperfusion injury. In addition 
to the H2S-producing pathway with 3-mercaptopyruvate 
sulfurtransferase (3MST) and cysteine aminotransferase 
(CAT), we recently found a novel pathway with 3MST 
and D-amino acid oxidase (DAO) that produces H2S from 
D-cysteine. This pathway is more efÀ cient than L-cysteine 
pathways in the kidney, and promises the therapeuric 
application of D-cysteine to the renal ischemic diseases. H2S 
is oxidized to polysuÀ des that exist in the brain and activate 
transient receptor potential ankyrin 1 (TRPA1) channels in 
astrocytes more efÀ ciently than parental H2S.
S2F-25-1  Current status of the 
treatment in the patients with peripheral 
arterial disease
Kimihiro Komori
Div. Vascular Surgery, Dept. Surgery, Nagoya Univ. Grad. Sch. Med.
The incidence of arteriosclerotic disease is increasing 
in Japan due to the aging of the population and the 
westernization of the diet. Peripheral arterial disease (PAD) 
presents with various clinical conditions. The choices of 
the treatment are supervised exercise therapy, medical 
treatment, endovascular therapy (EVT) and surgical bypass. 
According to the Fontaine classification, location of the 
pathological lesion and the general condition, the treatment 
was selected. EVT of iliac occlusive disease is an established 
treatment. However, the treatment of the infrainguinal 
lesions remains still controversial. In particular, the 
management of patients with critical limb ischemia (CLI) 
such as pain at rest, ischemic ulcer, or gangrene in the 
lower extremities has been problematic and the treatment 
of these patients varies widely among the patients. A 
surgical approach such as distal bypass using an autogenous 
saphenous vein is still the gold standard for the treatment 
of CLI. In addition, due to recent advances in endovascular 
technologies, EVT has become a viable option. In the 
presentation, we present the current status of the treatment 
in the patients with peripheral arterial disease.S5S2D-24-4  Reactive oxygen species 
signaling in the regulation of microglial 
function
Hisashi Shirakawa1, Takayuki Nakagawa1,2, 
Shuji Kaneko1
1Dept. Mol. Pharmacol., Grad. Sch. Pharm. Sci., Kyoto Univ., 2Dept. Clin. 
Pharmacol. Th er., Kyoto Univ. Hosp.
Microglia are immune cells that maintain brain homeostasis 
at a resting state by surveying the environment and 
engulfing debris whereas excessively activated microglia 
produce a large amount of reactive oxygen species (ROS) 
and nitric oxide (NO), causing progressive neuronal damage 
in the CNS; however there is little knowledge regarding the 
physiological role of ROS at low level in cellular signaling 
in microglia. Using mouse cultured microglia, we examined 
the involvement of ROS signaling in microglial activation, 
focusing on transient receptor potential (TRP) channel 
function. Among those are TRP melastatin 2 (TRPM2) and 
TRP vanilloid 1 (TRPV1), both of which are Ca2+-permeable 
nonselective cation channels and functionally expressed 
in microglia. With respect to TRPM2 channel, we found 
that NADPH oxidase-derived ROS is important for TRPM2 
channel activation and resultant iNOS expression and NO 
release in microglia. As to TRPV1 channel, we found that 
mitochondrial TRPV1 activation induced Ca2+-dependent 
production of ROS followed by MAP kinase activation, 
which correlated with an augmented migration of microglia. 
Therefore, ROS signaling pathway could be associated with 
TRP channels-mediated microglial activation.
S2F-25-2  Vein graft and endothelium 
function
Takeo Itoh1, Junko Kajikuri1, Kimihiro Komori2
1Dept. Pharmacol., Nagoya City Univ. Grad. Sch. Med. Sci., 2Dept. Vasc. Surg., 
Nagoya Univ Grad. Sch. Med.
Surgical revascularization using autologous vein continues 
to be the most commonly used option for treatment of 
peripheral arterial disease, its main advantages being 
ready availability and suppleness. Such venous implants 
are subject to increased shear stress, loss of endothelial 
cells, migration and invasion of inflammatory cells, and 
migration and proliferation of smooth muscle cells. These 
changes lead to intimal hyperplasia and subsequently 
accelerate atherogenesis, being responsible for vein graft 
occlusion. Various treatments have been so far examined to 
reduce neointimal hyperplasia; however, a standard clinical 
treatment has not yet been established. Endothelium, 
through the synthesis and release of nitric oxide (NO), 
prostacyclin and endotheli-dependent hyperpolarization 
(EDH), is critical in the regulation of vascular tone and 
vascular wall structure changes. Several studies have 
demonstrated the importance of preserving the function of 
endothelium NO to inhibit intimal hyperplasia in autologous 
vein grafts. Here, we show how a 5-HT2A receptor blocker, 
a cholesterol-lowering agent and a DPP-4 inhibitor each 
enhances the function of NO derived from endothelium in 
the vein grafts.4
S2F-25-3  Translational research in 
cardiovascular medicine: Vascular 
regeneration therapy
Toyoaki Murohara
Dept. Cardiol., Nagoya Univ. Grad. Sch. Med.
In addition to basic and clinical research, promotion of 
translational research is very important in any fields of 
medical science. We have continuously performed vascular 
regenerative translational research, so called “therapeutic 
angiogenesis”. Recently we are focusing on the role of 
adipose tissue-derived regenerative cells (ADRC) for 
therapeutic angiogenesis and lymphangiogenesis. Also, we 
recently reported about the significance of anti-angiogenic 
splicing isoform VEGF-A165b that was paradoxically 
elevated in the serum of patients with critical limb ischemia. 
I would like to discuss these issues.
S3B-26-1  Imaging and controlling the 
biochemical reactions in synapses
Hideji Murakoshi1,2 
1NIPS, 2JST PREST
Ca2+/Calmodulin-dependent kinase II (CaMKII) is one 
of the most important signaling molecules for long-
term potentiation and associated spine enlargement 
underlying learning and memory. Here, we developed 
genetically encoded light-inducible CaMKII inhibitor and 
photo-activatable CaMKII by using LOV2 derived from 
phototropin1. We applied these newly developed optogenetic 
tools for the study of structural plasticity of single 
dendritic spines by using 2-photon Á uorescence microscope, 
and found that 1) About 60 s of CaMKII activation is 
sufficient for inducing transient and sustained spine 
enlargement, 2) CaMKII activation alone is sufficient for 
triggering structural plasticity. In addition, using 2-photon 
fluorescence lifetime imaging microscopy, we visualized 
the activity of Rho GTPases which are the regulator of 
actin polymerization. And, we found that Cdc42 and RhoA 
were rapidly activated in the stimulated spine, and were 
then followed by a phase of persistent activation lasting 
more than 30 min. Furthermore, the inhibition of the RhoA 
pathway preferentially inhibited the initial spine growth, 
whereas the inhibition of the Cdc42 pathway blocked the 
maintenance of sustained structural plasticity. Thus, RhoA 
and Cdc42 are required for spine structural plasticity.S5S2F-25-4  R&D of DVC1-0101 as a new 
class of RNA gene medicine to treat 
peripheral arterial disease
Yoshikazu Yonemitsu1, Takuya Matsumoto2, 
Yoshihiko Maehara2
1R&D Lab. Innov. Biothera., Grad. Sch. Pharm. Sci., Kyushu Univ., 2Dep. Surg. 
Sci. Grad. Sch., Med. Sci., Kyushu Univ.
The gene-based therapeutic angiogenesis has been clinically 
evaluated as a new treatment option for peripheral arterial 
disease (PAD); however, candidate drugs have not yet 
succeeded in showing efficacy. We therefore returned to 
basic research and have found that the combination of 
recombinant Sendai virus vector (SeV) and À broblast growth 
factor-2 (FGF-2) showed the optimal effect for multiple 
pathological animal models. Importantly, we identiÀ ed that 
FGF-2 activates the multiple signal transduction system 
for inducing multiple endogenous angiogenic factors on 
downstream. The safety and efÀ cacy of this new RNA gene 
medicine DVC1-0101 to treat PAD has been evaluated by 
a phase I/IIa open-label four dose-escalations clinical trial. 
DVC1-0101 was safe and well tolerated, and resulted in 
significant improvement of limb function. Based on these 
À ndings, a pivotal phase IIb study, which is a randomized, 
placebo-controlled, parallel design, single-dose blinded, has 
been initiated from October 2014. The primary endpoints 
are to evaluate the efficacy of DVC1-0101 versus placebo 
on peak walking time and the safety and tolerability of 
repeated dosage of DVC1-0101, and the results will also help 
with the design of a future phase III study.
S3B-26-2  Comprehensive analysis 
of phospho-signaling pathways 
downstream of monoamine 
neurotransmitters
Mutsuki Amano, Tomoki Nishioka, 
Shinichi Nakamuta, Md. Hasanuzzaman Shohag, 
Kozo Kaibuchi 
Dept. Cell Pharmacol., Nagoya Univ. Sch. Med.
Protein phosphorylation is one of the most ubiquitous 
and essential mechanisms mediating intracellular signal 
transduction in various cellular processes. In the cell, 
numerous proteins are continuously and dynamically 
phosphorylated and dephosphorylated under the control of 
complex signaling networks. Dysfunctions of protein kinases 
are associated with a number of severe pathological states 
including cancers, inflammation and neurodegenerative 
diseases, and the protein kinases are regarded as 
therapeutic targets.  Dopamine, one of monoamine 
neurotransmitters, modulates the activities of several 
kinases including PKA and MAPK, but knowledge about 
the downstream cascades is far from the comprehensive 
understanding of molecular network beneath the kinase to 
exert the physiological functions. Despite the importance 
of identifying substrates, efficient methods to search for 
substrates remain poorly explored. We have recently 
developed the efficient screening methods, and found a 
number of known and novel substrates for these kinases 
from rodent brains. These results enable us to understand 
the phospho-signaling networks downstream of monoamine 
neurotransmitters.5
S3B-26-3  Intracellular signal 
transduction in the brain reward system
Taku Nagai
Dept. Neuropsychopharmacol. Hosp. Pharm., Nagoya Univ. Grad. Sch. Med.
Activation of the mesolimbic dopamine system, which 
originates in the midbrain ventral tegmental area and 
projects to the nucleus accumbens, has been implicated 
in the positive reinforcing (rewarding) effects of abused 
drugs. There is a distinct class of spatially intermixed 
medium spiny neurons (MSN) which express D1- or D2-
class dopamine receptors in the NAc. Although the part 
of molecular mechanism of rewarding system is becoming 
clear, it remains unclear the signal substrates that involves 
in the dopamine-dependent rewarding effect. Recently, we 
focus on the protein phosphorylation to elucidate signal 
transduction pathway implicated in reward regulation. To 
this end, we explore phosphorylated substrate for protein 
kinases A and mitogen-activated protein kinase under 
the control of dopamine D1 receptor. We also attempt to 
characterize neurochemical and behavioral significance 
of these phosphorylated substrates that are identified by 
phosphoproteomic approach. In this symposium, I will 
introduce and discuss our recent À ndings how intracellular 
signal pathway regulates the dopamine-dependent reward 
system in D1R-expressing MSN.
S3C-27-1  Comprehensive evaluation of 
cancer specifi c amino acid transporter 
LAT1 reveals multiple physiological 
functions of LAT1 and mechanism of 
anti-tumor activity by LAT1 inhibitors
Shushi Nagamori, Yoshikatsu Kanai
Bio-system Pharmacol., Grad. Sch. of Med., Osaka Univ.
As growing cancers have strong metabolic demands, cancer 
cells increase expression of nutrients transporters to obtain 
nutrients. Among the transporters, L-type amino acid 
transporter 1 (LAT1) transports many essential amino 
acids. While LAT1 is found in limited normal tissues, most 
of cancer cells express LAT1 and higher LAT1 expression 
relates to poor prognosis in various cancers. It has been 
suggested that LAT1 plays an important role in cancer 
cells. By means of comprehensive proteomics combined with 
uptake assays, we have evaluated the role of LAT1 in tumor 
nutrition and found that LAT1 is the main transporter 
particularly responsible for the uptake of leucine which 
stimulates mTOR signaling for tumor growth. Furthermore, 
phosphoproteomics showed the importance of LAT1 not only 
in mTOR signaling but also in other signaling pathways. 
Thus, LAT1 is an attractive target for cancer diagnosis/
prognosis and therapy. Discovery of new drugs targeting 
LAT1 is being required and currently in progress.S56S3B-26-4  Phosphoproteomic analysis 
of PKCȖ substrates in the striatum 
and their involvement in Parkinsonian 
syndrome
Naoaki Saito1, Toshihiko Shirafuji2
1Lab. Mol. Phamacol., Biosignal Res. Ctr., Kobe Univ., 2Dept. Mol., Phamacol. 
Neurosci., Grad. Sch. Biomed. Sci., Hiroshima Univ.
The AS/AGU rat, a Parkinson disease model rat, has been 
shown to be a PKCǄ-knockout animal at the protein level 
and we also demonstrated thatPKCǄ-knockout mice also 
show Parkinsonian symptoms, such as dopamine release 
impairments.  To elucidate the involvement of PKCǄ in 
Parkinson disease, we identified PKCǄ substrates in 
the caudate-putamen using PKCǄ knockout mice and 
a phosphoproteome analysis with the hydroxy acid-
modified metal oxide chromatography method.  We 
found 10 candidates of phosphoproteins including CSPǂ, 
calnexin, MADD, ǃPIX and adducin. We determined the 
PKCǄ phosphorylation sites of these proteins and showed 
their involvement in dopamine release.  In the present 
symposium, we discuss physiological significance of PKCǄ 
in Parkinsonian syndrome. The PKCǄ signaling in nigro-
striatal pathway may be a new therapeutic target for the 
treatment of Parkinsonian syndrome.
S3C-27-2  Development on boron-
doped diamond electrodes and the 
application for in vivo electrochemical 
analysis
Yasuaki Einaga1,2
1Dept. Chemistry, Keio Univ., 2JST-CREST
Boron-doped diamond (BDD) electrodes are very attractive 
material, because of their wide potential window, low 
background current, chemical inertness, and mechanical 
durability.  In these years, we have reported several 
examples for electrochemical sensor applications.  Here, 
we report some recent examples of electrochemical 
sensor application of BDD such pH, in vivo detection of 
neurotransmitter, and in vivo detection of glutathione for 
assessment of cancerous tumors using BDD microelectrodes. 
For example, we have reported in vivo detection of dopamine 
in a mouse brain by using BDD microelectrodes with the 
tip diameter of about 5 um. The BDD microelectrodes were 
successfully prepared, and reward-induced burst firing 
of dopaminergic neurons has mainly been studied in the 
primate midbrain.  Furthermore, in vivo electrochemical 
detection of glutathione (GSH) using BDD microelectrode for 
potential application in the assessment of cancerous tumors 
is also presented. In vivo GSH detection measurements 
have been performed in human cancer cells inoculated in 
immunodeficient mice. These measurements have shown 
that the difference of GSH level between cancerous and 
normal tissues can be detected.
S3C-27-3  Pharmacological and 
physiological analysis of membrane 
transport of the inner ear by advanced 
electrochemical techniques
Genki Ogata1,2, Fumiaki Nin1,2, Yuya Ishii3, 
Kai Asai3, Takamasa Yoshida1,4, Yasuaki Einaga3, 
Hiroshi Hibino1,2
1Dept. Mol. Physiol., Niigata Univ. Sch. Med., 2Ctr. for Transdisciplinary 
Res., Niigata Univ., 3Dept. Chem., Fac. Sci. and Tech., Keio Univ., 4Dept. 
Otolaryngol., Grad. Sch. Med., Kyushu Univ.
The lateral cochlea wall composed of epithelial tissue
transports a variety of ions and small molecules to function
the inner ear. K+-transport through the lateral wall critically
contributes to maintenance of the unique electrochemical
properties of the extracellular fluids in the cochlea, which
are essential for hearing. Na+,K+,2Cl--cotransporter
(NKCC) plays pivotal roles in the K+-transport. Vascular
injection of bumetanide, a loop diuretic that inhibits NKCC,
induces deafness. It is important for pharmacological and
pathophysiological studies to investigate the relevance of
the kinetics of the drug and the electrochemical properties
in local areas of in vivo cochlea. For such purpose, we
developed a multi-sensing system equipped with a boron
doped diamond microelectrode targeted to the drug and
a glass microelectrode sensitive to potential and [K+]. We
succeeded in simultaneous, continuous, and real-time
measurement of change of bumetanide’s concentration as
well as the potential and [K+] in the cochlear Á uid of living
animals. This system may be applied to monitor other ions
and drugs in numerous tissues and organs and thus useful
to promote researches in not only basic sciences but also
clinical À elds.
S3D-28-1  Stabilization of GABAA
R synaptic structure by IP3-induced
calcium release
Hiroko Bannai1,2, Fumihiro Niwa2, Antoine Triller3, 
Katsuhiko Mikoshiba2
1Div. Biol Sci, Grad Sch Sci, Nagoya Univ, 2RIKEN BSI, 3IBENS
GABA synaptic transmission regulates the excitation-
inhibition balance critical for brain function. However, how
GABAergic synapses are shaped by external signals remains
unknown. Here, we describe a regulatory pathway for the
spatial control of GABAAR synaptic structure. Metabotropic
glutamate receptor signaling triggered endoplasmic
reticulum IP3 receptor calcium release and activation of PKC
to enhance GABAAR clustering and GABA transmission.
This pathway opposed calcineurin-induced GABAAR
dispersion triggered by NMDAR-dependent calcium influx
from plasma membrane. Thus, distinct cell compartments
initiate competing calcium signals to control the stability
and efÀ cacy of GABA synapses. This mechanism of GABAA
synaptic integration shows how a unitary transmitter
and calcium signal can be converted into a bidirectional
intracellular control system and will permit new therapeutic
targets to correct excitation-inhibition imbalances in





















S3C-27-4  An application of human 
iPS-derived cardiomyocytes in cardiac 
safety screening assay
Junko Kurokawa1, Takashi Ashihara2, Tet sushi 
Furukawa1, Yasunari Kanda3
1Dept. Bio-info. Pharmacol., Mde. Res. Inst., Med. & Dent. Univ., 2Dept. 
Cardiovasc. Med., Shiga Univ. Med. Sci., 3Div. Pharmacol., Natio. Inst. Health 
Sci.
Human iPS cell-derived cardiomyocyte (hiPS-CM) is 
expected to be a reliable alternative to pre-clinical animal 
models, but the ability to differentiate into mature 
ventricular myocytes has not yet been demonstrated. The 
immature electrical properties may hinder to evaluate 
ventricular arrhythmias. We here generated functionally-
matured hiPS-CMs by overexpressing a ventricular ion 
channel. The protein-X over-expression stopped spontaneous 
beatings of hiPS-CMs, and made them excitable by electrical 
stimulations. The hiPS-CMs overexpressing protein-X 
enabled us to demonstrate quantitatively that E4031, 
a selective hERG blocker, prolongs durations of action 
potential in single myocytes and extracellular À eld potential 
in cardiac sheets, respectively. Furthermore, redundancy 
of cardiac repolarizing currents was demonstrated using 
the X-expressing hiPS-CMs, that is very critical for testing 
pro-arrhythmic risks of drugs. The impact of protein-X on 
cardiac electrophysiology and pharmacology was proved by 
our mathematical simulation using computational cardiac 
models. Our novel strategy provides understandings of 
the underlying mechanisms for drug effects in human 


















S3D-28-2  New calcium imaging method 
for the visualization of subtle and local 
activity of astrocytes in intact brain
Kazunori Kanemaru
Dept. Pharmacol., Sch. Med., Tokyo Univ.
Astrocytes generate Ca2+ signals that are thought to 
regulate their interactions with neurons and other brain 
cells. In vivo  Ca2+ imaging data with high spatiotemporal 
resolution may be instrumental for clarification of 
astrocytic functions. Here we describe a method for in vivo 
astrocytic Ca2+ imaging using transgenic mice expressing 
the ultrasensitive ratiometric Ca2+ indicator YC-Nano50 in 
astrocytes. Using the method, we succeeded in detecting a 
previously unidentiÀ ed pattern of spontaneous Ca2+ signals 
(Ca2+ twinkles), which occur predominantly in the fine 
processes but not the cell body. Upon sensory stimulation, 
astrocytes initially responded with Ca2+ signals at the À ne 
processes, and the Ca2+ signal subsequently propagated to 
the cell body. Ca2+ twinkles and evoked Ca2+ signals were 
partially and fully dependent on the Ca2+ release via the 
type 2 IP3 receptor, respectively. These results suggest 
that astrocytic À ne processes function as a high-sensitivity 
detector of neuronal activities, and indicate the importance 
of intracellular Ca2+ stores in the regulation of astrocytic 
functions. Thus, the current method provides a useful tool to 
uncover the functions of astrocytes in the intact brain.S57
S3D-28-3  Nitric oxide-induced calcium 
release in central neurons
Toshiko Yamazawa
Dept Mol. Physiol., Jikei Univ. Sch. Med.
Ca2++ and nitric oxide (NO) are two principal inorganic 
signaling molecules, regulating myriads of biological 
functions. We found that NO directly activates the 
ryanodine receptors (RyRs) and generates prolonged 
intracellular Ca2+ signals by inducing Ca2+ release (NO-
induced Ca2+ release; NICR) from the Ca2+ stores of HEK293 
cells stably expressing RyR1. Reversible S -nitrosylation of 
RyR1 underlies this Ca2+ release. There are three subtypes 
of RyR. RyR2 has a high Ca2+-induced Ca2+ release activity 
and cells expressing this subtype generate spontaneous 
Ca2+ oscillations. However, there was very little effect of 
NO on RyR2. Cells expressing RyR3, on the other hand, 
responded to NO, although the sensitivity to NO was lower 
than that of RyR1. Thus, NICR is supported by RyR1 and to 
a lesser extent by RyR3, but not by RyR2. We conÀ rmed the 
presence of RyR1 and NICR in cerebral neurons in culture. 
NO production has also been implicated in pathological 
conditions including ischaemic brain injury, and our results 
suggest that NICR is involved in NO-induced neuronal 
cell death. These findings suggest that NICR-mediated 
Ca2+ signaling plays important roles in pathophysiological 
functions in the brain and is a potential therapeutic target 
for the treatment of ischemic brain disease.
S3E-29-1  Interspecies comparative 
gene expression profi ling revealed 
impaired insulin production and insulin 
signaling accompanied by mitochondrial 
dysfunction in Alzheimer’s disease 
brains: The Hisayama study
Yusaku Nakabeppu1, Sugako Oka1, Julio Leon1, 
Nona Abolhassani1, Masaaki Hokama1, Toru Iwaki2, 
Yutaka Kiyohara3, Dongchon Kang4
1Div. Neurofunc. Genomics, Med. Inst. Bioreg. Kyushu Univ., 2Dept. 
Neuropathol., Grad. Sch. Med. Sci., Kyushu Univ., 3Dept. Environ. Med., 
Grad. Sch. Med. Sci., Kyushu Univ., 4Dept. Clin. Chem. & Lab. Med., Grad. 
Sch. Med. Sci., Kyushu Univ.
To identify molecular pathological alterations in Alzheimer’s 
disease (AD) brains, we performed interspecies comparative 
microarray analyses using RNA prepared from postmortem 
human brain tissues donated for the Hisayama study, and 
hippocampal RNAs from the triple-transgenic mouse model 
of AD (3xTg-AD). The hippocampi of AD brains showed 
the most significant alteration in gene expression profile. 
Genes involved in noninsulin-dependent diabetes mellitus 
(DM) and obesity were significantly altered in both AD 
brains and the AD mouse model, as were genes related 
to psychiatric disorders and AD. The altered expression 
profiles in AD brains were independent of peripheral DM-
related abnormalities. Moreover, the altered gene expression 
proÀ les in AD brains indicate mitochondrial dysfunction and 
increased ROS production supporting that mitochondrial 
dysfunction is considered to have a pivotal role for 
developing AD. We thus further examined effects of human 
mitochondrial transcriptional factor A (hTFAM) transgene, 
which plays important roles to maintain mitochondrial 
homeostasis, on the pathology of 3xTg-AD mice.S58S3D-28-4  Sigma-1 receptor stimulation 
improves depressive-like behaviors 
through regulation of mitochondrial 
function
Shigeki Moriguchi, Kohji Fukunaga
Dept. Pharmacol., Tohoku Univ., Grad. Sch. Pharmaceut. Sci.
Sigma-1 receptor (Sig-1R) is molecular chaperone 
regulating calcium transport from endoplasmic reticulum 
to mitochondria in neurons. We previously documented that 
impaired cognitive-related and depressive-like behaviors 
in olfactory bulbectomized mice are improved by chronic 
oral administration of dehydroepiandrosterone (DHEA) 
(Moriguchi et al., J. Neurochem. 2011; PLoS One 2013). In 
the present study, we demonstrated that chronic stimulation 
of Sig-1R by treatment with SA4503 or fluvoxamine for 
14 days improves depressive-like behaviors observed in 
CaMKIV null mice. By contrast paroxetine without afÀ nity 
for Sig-1R failed to improve the depressive-like behaviors. 
Reduction of BrdU-positive cells, expression of BDNF 
mRNA and Akt (Ser-473) phosphorylation in hippocampal 
dentate gyrus in CaMKIV null mice were significantly 
restorted by the chronic stimulation of Sig-1R by SA4503 
or fluvoxamine. Chronic stimulation of Sig-1R by SA4503 
or fluvoxamine increased ATP production. Taken together, 
Sig-1R stimulation ameliorates depressive-like behaviors 
observed in CaMKIV null mice by increasing hippocampal 
neurogenesis through activation of Akt and/or BDNF 
pathways. (Moriguchi et al., Mol Neurobiol 2014 in press)
S3E-29-2  Altered CNS 
microenvironment in response to low 
grade systemic infl ammation: A role for 
microglia?
J. L. Teeling, U. Püntener, S. G. Booth, V. H. Perry
CNS Infl  ammation Group, Centre for Biological Sciences, Univ. of 
Southampton
Bacterial infections and diabetes are a common cause for 
morbidity and mortality in the elderly. Experimental models 
of ageing and neurodegeneration have shown that LPS-
induced systemic inÁ ammation increases neuronal damage, 
a process that believed to be mediated by activation of 
‘primed’ microglia. In this study we investigated the effects 
on microglia and cerebral endothelial cells in response to 
a real low grade systemic bacterial infection. Mice with or 
without a pre-existing neurodegenerative disease were given 
a single systemic injection of live bacteria. Serum cytokine 
levels (i.e. IFNg, IL-1b, IL-6) peaked at day 7 post-infection. 
In contrast, brain cytokine levels (IL-1ǃ, IL-12) in infected 
mice increased over three weeks, following high circulating 
IFN-Ǆ levels. A second immune challenge with LPS resulted 
in an exaggerated inflammatory response when compared 
to non-infected mice, suggesting priming of innate immune 
cells in the CNS. Infection of mice with a pre-existing 
neurodegenerative disorder showed further increased 
expression of various microglial markers and an increase 
of inÀ ltrating leukocytes into the brain parenchyma. These 
studies reveal that the innate immune cells in the brain are 
activated by systemic infection, which may lead to prolonged 
cytokine production and altered microglial phenotype. This 
altered microenvironment of the CNS may contribute to 
the onset and/or progression of neurodegeneration. We are 
currently investigating if hyperglycemia induces microglial 
priming similar to bacterial infections.
S3E-29-3  Periodontitis induced by 
Porphyromonas gingivalis infection 
exacerbates features of Alzheimer’s 
disease in transgenic mice
Kenji Matsushita
Dept. Oral Dis. Res., NCGG
Periodontitis is a localized infectious disease caused by oral 
bacteria, such as  Porphyromonas gingivalis  . Recently, 
associations between periodontitis and Alzheimer’s disease 
(AD) have been suggested. However, evidence is sparse 
regarding the causative relationship. In this study, we used 
a transgenic mouse model of AD to investigate whether 
periodontitis, evoked by  P. gingivalis , modulates the 
pathological features of this neurodegenerative disease. We 
found that cognitive functions were significantly impaired 
in J20 mice inoculated with  P. gingivalis  compared to 
those in control J20 mice. Additionally, brain levels of Aǃ1-
40 and Aǃ1-42 were higher in inoculated J20 mice than in 
control J20 mice. Aǃ deposition in the hippocampus and 
cortex was also significantly greater in inoculated J20 
mice than in control J20 mice. Furthermore, brain levels 
of proinÁ ammatory cytokines, including IL-1ǃ; and TNF-ǂ, 
were higher in inoculated mice than in control mice. These 
results suggest that periodontitis, evoked by  P. gingivalis , 
may exacerbate brain amyloid deposition and trigger brain 
inÁ ammation, leading to enhanced cognitive impairment.
S3F-30-1  The multimodal functions 
of constitutively active Gs-coupled 
receptor GPR3 in neurons
Shigeru Tanaka1, Yoshinaga Saeki2, 
Chiocca E. Antionio3, Norio Sakai1
1Dept. Mol. & Pharmacol. Neurosci., Hiroshima Univ. Inst. Biomed. & Health 
Sci., 2Saeki Hosp., 3Dept. Neurosurg., Dana-Farber Cancer Inst.
G-protein coupled receptor 3 (GPR3), GPR6, and GPR12 
constitute a family of constitutively active Gs-coupled 
receptors that activate adenylate cyclase and are expressed 
predominantly in neurons of central nervous system. 
Among these receptors, GPR3 is highly distributed in 
the hippocampus, the medial habenular nucleus, and the 
cerebellum. We have previously reported that the expression 
of these GPRs in primary cultured neurons enhanced 
neurite outgrowth (Tanaka et al., JBC 2007). In addition, 
GPR3 expression increases in rat granule neurons during 
development, and its expression contributes to neuronal 
development (Tanaka et al., PLoS One 2009). More recently, 
we have clariÀ ed an additional neuroprotective function of 
GPR3 against various apoptosis-inducing stimuli including 
brain ischemia (Tanaka et al., Neurobiol Dis 2014). 
Intrinsic expressions of GPR3 affect multiple neuronal 
functions and might contribute to maintain homeostasis 
in neurons. Although the detailed molecular mechanisms 
of GPR3 function are still elusive, further precise analyses 
of the constitutively active GPCRs may hold potential as a 
therapeutic strategy to treat various neurological disorders.S5S3E-29-4  Systemic porphyromonas
gingivalis LPS induces cathepsin 
B-dependent microglial activation 
and amyloid accumulation in the 
hippocampus
Zhou Wu, Hiroshi Nakanishi
Dept. Aging Sci. & Pharmacol., Kyushu Univ. Faculty. Dent.
Accumulating clinic evidence suggests a possible link 
between periodontitis and Alzheimer disease (AD) and 
LPS from Porphyromonas gingivalis (P. g) are found 
in the brain of AD patients, but the mechanism is 
unknown. Microglia are the primary cells that respond to 
peripheral inflammatory signals. We have recently found 
that microglia isolated from the brains of aged, but not 
young, mice, can release IL-1ǃ in response to amyloidǃ, 
indicate the senescence is an important factor for AD. 
Furthermore, systemic inflammation promotes microglia 
senescence to induce exaggerated neuroinflammation in 
middle-aged rats, resulting in deficits of the hippocampal 
long-term potentiation, a cellular basis of learning and 
memory. Therefore, both senescence and chronic systemic 
inflammation are considered to be potent accelerators of 
Microglia Aging. In this symposium, we will introduce our 
recent works on systemic P.g LPS-induced the cathepsin B- 
dependent microglial activation and amyloid ǃaccumulation 
in hippocampus. We believe that better understanding 
of Microglial Aging will help to develop strategies for 
preventing the cognitive impairments during aging and 
aging-related neurodegenerative diseases such as AD.
S3F-30-2  A novel assay for detecting the 
activation of G protein-coupled receptors 
using cellular dielectric spectroscopy
Kanako Miyano1, Yuka Sudo2, Akinobu Yokoyama1,2, 
Hitomi Nishimura1,2, Megumi Kawaida1,3, 
Shiori Sato1,3, Etsuko Nemoto1,3, Kazue Nakashima4, 
Minoru Takebayashi5,6, Norimitsu Morioka4, 
Seiji Shiraishi1, Yoshikazu Higami2, Hideaki Fujii3, 
Yoshihiro Nakata4, Yasuhito Uezono1
1Div. Cancer Pathophysiol., NCCRI., 2Dept. Mol. Pathol. Metab. Dis., Faculty 
of Pharmaceut. Sci., Tokyo Univ. Sci., 3Dept. Med. Chem., Sch. Pharm., 
Kitasato Univ., 4Dept. Pharmacol., Hiroshima Univ. Grad. Sch. Biomed. 
Health. Sci., 5Inst. Clin. Res., Natl. Hosp. Org. Kure Med. Ctr., 6Dept. 
Psychiatry, Natl. Hosp. Org. Kure Med. Ctr.
The G protein-coupled receptors (GPCRs) form the largest 
and the most versatile superfamily that share a seven-
transmembrane-spanning architecture. GPCR signaling 
is involved in vision, taste, olfaction, and sympathetic/
parasympathetic nervous functions; metabolism; and 
immune regulation, indicating that GPCRs are extremely 
important therapeutic targets for various diseases. In 
fact, several pharmaceutical companies have developed 
medicines that can modulate GPCR signaling pathways, 
which are estimated to be 30% in the market. Cellular 
dielectric spectroscopy (CDS) is a novel technology that 
employs a label-free, kinetic, cell-based assay approach 
for the comprehensive pharmacological evaluation of cells 
that exogenously or endogenously express GPCRs. Among 
the biosensors that use CDS technology, the CellKeyTM 
system not only detects the activation of GPCRs but also 
distinguishes between signals through different subtypes of 
the Gǂ protein (Gs, Gi/o, and Gq) on the same platform. In 
this symposium, we introduce the principles of CellKeyTM 
system, evaluation of the GPCR activation, advantages and 
future prospects of this system.9
S3F-30-3  A visual intracellular 
GPCR localization assay with novel 
fl uorescent-based technology
Yuka Sudo1, Akinobu Yokoyama1,2, Kanako Miyano2, 
Takahiro Nagase3, Hitomi Nishimura1,2, 
Seiji Shiraishi2, Yasuhito Uezono2, Yoshikazu Higami1
1Dept. Mol. Pathol. Metab. Dis., Faculty of Pharmaceut. Sci,, Tokyo Univ. Sci., 
2Div. Cancer Pathophysiol., NCCRI, 3Dept. Biotechnology Res., Kazusa DNA 
Res Inst.
There are almost 800 kinds of G protein-coupled receptors 
(GPCR) in human genome, and not a few numbers of GPCR 
are targets of clinically important drugs that mimic and 
inhibit endogenous ligands for the GPCRs. To visually 
monitor GPCR signaling events in mammalian cells with 
fluorescence microscopy, we are currently using HaloTag® 
technology. The technology is based on the formation of a 
covalent bond between a protein fused to HaloTag® and a 
variety of synthetic ligands designed for HaloTag®. This 
enables investigation and understanding of protein functions 
in cellular and biochemical environments. In the present 
study we used HaloTag®-tagged GPCR and investigated 
GPCR signaling, in particular, detection of the fate of GPCRs 
in cells. To this end we constructed GPCR expression clones 
fused to N-terminal HaloTag® protein. By using the cells 
expressing HaloTag-fused GPCR, we compared localization 
of the GPCRs after agonist activation by labeling with 
both membrane impermeable and permeable fluorescent 
HaloTag® ligands.
We will further present results using a pH-sensitive 
HaloTag® ligands for accurate GPCR internalization 
mechanisms. We show the usefulness of such HaloTag-fused 
GPCR for detecting for GPCR signaling.
S3B-31-1  Developmental disorders and 
prefrontal cortical pathology
Kazuhiro Takuma1,2, Yukio Ago2, Yusuke Onaka2, 
Toshio Matsuda2,3
1Dept. Pharmacol., Grad. Sch. Dent., Osaka Univ., 2Lab. Med. Pharmacol., 
Grad. Sch. Pharm. Sci., Osaka Univ., 3United Grad. Sch. Child Dev., Osaka 
Univ. Kanazawa Univ. Hamamatsu Univ. Sch. Med. Chiba Univ. & Univ. 
Fukui
Recent clinical studies have shown that functional and 
anatomical impairments of prefrontal cortex are involved in 
the pathology of developmental disorders, such as autism 
spectrum disorders (ASD) and attention deÀ cit hyperactivity 
disorder. We have recently demonstrated that dosing valproic 
acid (VPA), a major antiepileptic drug, caused ASD-like 
behavioral abnormalities, such as impaired social interaction 
and anxiety, in mice (Int J Neuropsychopharmacol. 2013). 
We have also found an increase in apoptotic cell death 
in the neocortex and a decrease in cell proliferation in 
the ganglionic eminence within 24 h after VPA exposure, 
and the Nissl-positive cell loss in the prefrontal and 
somatosensory cortices at young-adult age in the prenatal 
VPA-induced ASD mouse model. The present review 
summarizes the roles of prefrontal cortical pathology in the 
pathogenesis of developmental disorders, focused on our 
recent in vivo findings on dopaminergic dysfunction and 
dendrite spine loss in the prefrontal cortex of ASD mouse 
model. Furthermore, we present our recent in vitro À ndings 
suggesting the involvement of disrupted cortical neuronal 
maturation in prenatal VPA-mediated ASD pathology.SS3F-30-4  Signaling specifi city on 
the melanin-concentrating hormone 
receptor 1
Yumiko Saito
Grad. Sch. Int Arts & Sci.
The signaling and trafficking of most GPCRs involves 
receptor interactions with G proteins, GRKs,  arrestins 
and other receptors. In addition to these widespread 
GPCR associations, there are many other types of GPCR-
interacting proteins that can interact with particular 
receptors to f ine-tune receptor activity.  Melanin-
concentrating hormone (MCH) is a cyclic neuropeptide 
exerting its action through two G GPCRs, MCHR1 and 
MCHR2. The extensive progress using genetic and 
pharmacological approaches has confirmed that the MCH-
MCHR1 system is involved in feeding, energy homeostasis 
and possibly emotional processing. In mammalian cells 
transfected with MCHR1, MCH is able to activate multiple 
signaling pathways including calcium mobilization, p-ERK 
activation, and inhibition of cyclic AMP generation through 
Gi/o- and Gq-coupled pathways. In this symposium, I review 
the recent advances regarding the mechanism controlling 
the fine-tuning of MCHR1 signaling by receptor-selective 
partners and their possible physiological signiÀ cance.
S3B-31-2  Prefrontal cortex as targets 
of developmental insults associated 
with developmental psychiatric 
disorders - mouse model analyses
Takeshi Sakurai1, Shuhei Ueda1, Minae Niwa2, Akira 
Sawa2
1Med. Innova. Cr., Kyoto Univ. Grad. Med., 2Dept. Psych., John Hopkins Univ. 
Med.
Schizophrenia is a disorder that is caused by altered 
neurodevelopment induced by a combination of genetic and 
environmental insults.  Main symptom of the disorder is 
impairments in cognitive functions for which prefrontal 
cortex (PFC) is responsible.  We use animal models with 
construct validity to identify the nature of alterations in 
developing PFC that would lead to cognitive impairments 
relevant to the disorder in humans.  To pinpoint the altered 
developmental processes in the animal models, we first 
characterized a sequence of molecular events in developing 
PFC of normal mice.  By qPCR analysis of genes covering a 
wide range of biological events, we are now able to examine 
time window for each biological process vulnerable for 
developmental insults targeting PFC.  In parallel, we are 
using a touch panel screen system that identified some 
cognitive alterations in some model mice for developmental 
psychiatric disorders.  By combining these, we aim to 
link between altered biological processes and behavioral 
phenotypes in mice that can be translated into humans.60
S3B-31-3  The insular neural system 
controls decision-making in healthy and 
drug-dependent rats
Hiroyuki Mizoguchi1, Kiyofumi Yamada2
1Fut. Environmental Sim. Center, Res. Inst. Environmental Med., Nagoya 
Univ., 2Dep. Neuropsychopharmacol. Hosp. Pharm., Nagoya Univ. Grad. Sch. 
Med.
Patients suffering from neuropsychiatric disorders 
such as substance-related and addictive disorders have 
impairments in decision-making, which may be associated 
with their behavioral abnormalities.  However, the neuronal 
mechanisms underlying such impairments are largely 
unknown.  Using a gambling test, we demonstrated that 
methamphetamine (METH)-dependent rats chose a high-
risk/high-reward option more frequently, and assigned 
higher value to high returns, than control rats, suggesting 
that decision-making was impaired in the drug-dependent 
animals.  Immunohistochemical analysis following the 
gambling test revealed aberrant activation of the insular 
cortex (INS) and nucleus accumbens in METH-dependent 
animals.  Pharmacological studies together with in vivo 
microdialysis showed that GABAergic neurotransmission 
in INS played a crucial role in decision-making.  Moreover, 
manipulation of INS activation using DREADD technology 
resulted in alterations to decision-making.  Our findings 
suggest that INS is a critical region involved in decision-
making, and that insular GABAergic dysfunction results in 
risk-taking behaviors associated with poor decision-making.
S3C-32-2  Targeting PTEN/Akt/mTOR 
signaling pathway in pulmonary arterial 
hypertension
Haiyang Tang1, Jiwang Chen3, Dustin R. Fraidenburg3, Joe G. N. Garcia1, 
Roberto F. Machado3, Ayako Makino2, Jason X. -J. Yuan1,3
1Dept. Medicine, Univ. of Arizona, 2Dept. Physiol., Univ. of Arizona, 3Dept. 
Med., Univ. of Illinois at Chicago
Rationale: Pulmonary vascular remodeling, mainly due to enhanced pulmonary 
arterial smooth muscle cell (PASMC) proliferation and migration, is a major 
cause for elevated pulmonary vascular resistance (PVR) and pulmonary 
arterial pressure (PAP) in patients with pulmonary arterial hypertension 
(PAH). Akt/mTOR signaling regulates a wide array of physiological cell 
functions including cell survival, proliferation and migration. In this study, we 
investigated whether the Akt/mTOR pathway contributes to the development 
and progression of pulmonary vascular remodeling in pulmonary hypertension.
Methods: Chronic hypoxia-induced pulmonary hypertension (HPH) model 
in wild-type (WT), Akt1-/- , Akt2-/- , PTEN transgenic (TG) mice, and mTOR 
conditional knockout (KO) mice was used in this study. Right ventricular 
systolic pressures (RVSP) and right ventricular hypertrophy (Fulton Index: 
RV/ (LV+S) ratio) were measured. PASMCs were isolated from WT or KO/
TG mice for cell proliferation assay and for molecular and cellular biological 
experiments. 
Results: In comparison to the WT littermates, Akt1-/-  mice were protected 
against the development and progression of HPH as indicated by signiÀ cant 
decreased RVSP and RV hypertrophy, while Akt2-/-  mice did not demonstrate 
any significant protection against the development of HPH. Furthermore, 
pulmonary vascular remodeling was significantly attenuated in the PTEN 
transgenic mice after chronic exposure to hypoxia. Conditional and inducible 
knockout of mTOR in smooth muscle cell was also found to attenuate the rise 
in RVSP and the development of RV hypertrophy in HPH. 
Conclusion: PTEN/Akt1/mTOR signaling plays critical roles in pulmonary 
vascular remodeling associated with HPH and targeting the PTEN/Akt1/
mTOR signaling pathway continues to be an important strategy to develop 
novel drugs for treatment of PAH.SS3C-32-1  Pulmonary arterial 
hypertension
Aya Yamamura
Kinjo Gakuin Univ. Col. Pharm.
Pulmonary arterial hypertension (PAH) is defined as an 
intractable disease characterized by a progressive elevation 
of pulmonary vascular resistance and pulmonary arterial 
pressure, leading to right heart failure and premature 
death. The five-year survival rate after diagnosis is 
approximately 57%. Although extensive research has 
identified some factors associated with the cause of PAH, 
the etiology and pathogenesis remain unclear. In addition 
to Ca2+ channel blockers (nifedipine, diltiazem), three 
categories of drug have been developed for the treatment of 
PAH based on the pathological mechanisms: prostacyclin 
and its analogues (epoprostenol, treprostinil, iloprost), 
endothelin receptor antagonists (bosentan, ambrisentan), 
and phosphodiesterase type 5 inhibitors (sildenafil, 
tadalafil). We recently found that the extracellular Ca2+-
sensing receptor (CaSR) is upregulated in pulmonary 
arterial smooth muscle cells (PASMCs) from patients with 
idiopathic PAH. Pharmacological blockage of CaSR with 
the calcilytic prevents the development of pulmonary 
hypertension and right ventricular hypertrophy in animal 
models of pulmonary hypertension. Targeting CaSR in 
PASMCs may help develop a novel therapeutic approach for 
PAH.
S3C-32-3  “Pulmonary hypertension” in 
diabetes?
Ayako Makino
Dept. Physiol., Univ. of Arizona
Type 2 diabetes is a global pandemic and 8.3 % of the 
population in the world is suffering from diabetes. Diabetes 
is the 7 th leading cause of death and 50% of people with 
diabetes die because of cardiovascular diseases. Heart 
disease and stroke are the primary causes of death; 
less attention was paid to the lung functions in diabetic 
patients. Recently, several reports highlight the incidence 
of pulmonary hypertension (PH) in diabetic patients and 
demonstrate that the survival rate in PH patients with 
diabetes or insulin resistance is significantly lower than 
in PH patients without any of these diseases. The first 
question is whether diabetes leads to PH. Next question is 
whether diabetic “preconditioning” or “priming” affects the 
development and progression of pulmonary hypertension. 
In this talk, I will address these questions using recent 
clinical reports as well as our recent data obtained from 
type 2 diabetic mice with hypoxia-induced pulmonary 
hypertension.61
S3C-32-4  Current progress in 
therapeutic agents for pulmonary 
arterial hypertension: new insights 
into their mechanisms of action from 
endothelin system
Takahiro Horinouchi, Koji Terada, Tsunehito Higashi, 
Akimasa Hoshi, Karki Sarita, Soichi Miwa
Dept. Cell. Pharmacol., Hokkaido Univ. Grad. Sch. Med.
Endothelin (ET) system plays a pathophysiological role in 
the pathogenesis of pulmonary arterial hypertension (PAH). 
The ET system consists of two distinct ET receptors (ETRs), 
ETAR and ETBR, and three endogenous ligands, ET-1, ET-2 
and ET-3.  ETAR expressed in vascular smooth muscle cells 
is considered as a bad receptor involved in pathogenesis and 
development of PAH.  On the other hand, ETBR expressed 
in vascular endothelial cells is classiÀ ed as a good receptor 
involved in both the clearance of circulating ET-1 and the 
production of endothelium-derived relaxing factors, nitric 
oxide and prostacyclin.  Since ET-1 level in the plasma is 
elevated in patients with PAH, ETR antagonists such as 
bosentan are clinically used for PAH.  In addition to ETR 
antagonists, prostacyclin analogues, phosphodiesterase type 
5 inhibitors and a soluble guanylate cyclase activator have 
been approved for PAH, and these drugs can inhibit ETR-
mediated activation of signaling molecules such as TRPC6 
channel, which are involved in the development of PAH. 
In this presentation, we will overview current progress in 
therapeutic agents for PAH, and discuss their mechanisms 
of action focusing on the ETR signaling.
S3D-33-1 Į7 nicotinic acetylcholine 
receptor (nAChR)-mediated 
neuroprotection against the progress of 
neurodegenerative disorders
Shun Shimohama
Dept. Neurol.,Sapporo Med. Univ. Sch. Med.
Alzheimer’s disease (AD) and Parkinson’s disease (PD) have 
multiple lines of evidence from molecular and cellular to 
epidemiological, that nicotinic transmission is implicated 
in their pathogenesis. We have shown evidence of nicotinic 
acetylcholine receptor (nAChR)-mediated protection against 
neurotoxicity induced by amyloid-ǃ, glutamate, rotenone, 
and 6-hydroxydopamine and the signal transduction 
involved in this mechanism. Our studies clarified that 
survival signal transduction,ǂ7; nAChR-Src family-PI3K-
AKT pathway, and subsequent upregulation of Bcl-2 and 
Bcl-x, would lead to neuroprotection.  Recently analyzing 
the properties of galantamine, we clarify the independent 
neuroprotective pathway, which is mediated by enhancement 
of microglial ǂ7; nAChR resulting in upregulation of Aǃ 
phagocytosis. Galantamine sensitizes microglial ǂ7; nAChRs 
to choline and induce Ca2+ inÁ ux into microglia. The Ca2+-
induced intracellular signaling cascades may then stimulate 
Aǃphagocytosis through actin reorganization. The discovery 
would facilitate further investigation of possible nAChRs 
enhancing drugs targeting not only neuronal but also 
microglial nAChRs.SS3C-32-5  New insight in the 
pathobiology of pulmonary 
hypertension
Keiko Yamauchi-Takihara1,2
Health Care Center, Osaka University, 2Dept. Cardiovasc. Med., Osaka Univ. 
Graduate Sch. Med.
Pulmonary hypertension (PH) is a serious condition 
characterized by the vascular remodeling of pulmonary 
arteries resulting in elevated pulmonary arterial pressure. 
Although the knowledge of the pathobiology of PH continues 
to accelerate, the factors responsible for the aggravation 
of PH are not fully defined yet. These contributing factors 
likely involve accumulation of multiple events on a 
background of genetic predisposition. 
Inflammation and autoimmunity are currently recognized 
as potential key contributors to the pathogenesis of PH. 
Cytokines and growth factors associated with inÁ ammatory 
cells promote the hyperproliferation of pulmonary artery 
endothelial cells and smooth muscle cells. Interleukin (IL)-
6 is a multifunctional proinflammatory cytokine that is 
linked to numerous disorders, and also implicated in the 
pathogenesis of PH. However, the molecular mechanisms by 
which IL-6 promotes pulmonary vascular remodeling have 
been elusive. In our experimental study, using mice model 
of hypoxia-induced PH, we demonstrated for the À rst time 
that the IL-6/Th17/IL-21-signaling axis plays a central role 
by skewing alveolar macrophages toward the M2 phenotype. 
Cytokines and immune cells appear to play signiÀ cant but 
complex roles in the initiation and progression of PH.
S3D-33-2  Roles of Į7 nicotinic 
acetylcholine receptor in development 
and function of T cells
Takeshi Fujii1, Koichiro Kawashima2 
1Dept. Pharmacol., Fac. Pharm. Sci., Doshisha Women’s Coll., 2Dept. Mol. 
Pharmacol., Kitasato Univ. Sch. Pharm. Sci.
Lymphocytes possess most of the cholinergic components 
including acetylcholine (ACh), choline acetyltransferase, and 
muscarinic and nicotinic ACh receptors (nAChRs).  Acute 
or intermittent stimulation by nicotine activates T cells 
via ǂ7 nAChR-mediated pathways, at least in part, while 
continuous and long-term stimulation suppresses their 
activity by reducing nAChR expression. Levels of ǂ7 subunit 
mRNA expression in smokers were significantly decreased 
compared with those in non-smokers. ǂ7 nAChR suppresses 
synthesis and release of proinflammatory cytokines, 
leading to modulation of antibody production. ǂ7 nAChR 
allosteric ligand, secreted Ly-6/urokinase-type plasminogen 
activator receptor-related protein (SLURP)-1, is detected in 
human tonsilar dendritic cells (DCs).  SLURP-1 activates 
lymphocytic cholinergic transmission by potentiating 
ACh synthesis acting at ǂ7 nAChRs, thereby facilitating 
functional development of T cells.  These findings support 
the notion that ǂ7 nAChRs on T cells along with ACh and 
SLURP-1 released from T cells and DCs, respectively, play 








































 S3D-33-3  Antiinfl ammatory signaling 
via activation of Į7nACh receptors in 
small intestine
Masatoshi Hori1, Yuuki Imura1, Hitomi Kimura1, 
Takahisa Murata2, Hiroshi Ozaki1
1Dept. of Vet. Pharmacol., Grad. Sch. of Agri. & Life Sci., Th e Univ. of Tokyo, 
2Dept. of Animal Radiology, Grad. Sch. of Agri. & Life Sci., Th e Univ. of Tokyo
Vagal nerve stimulation induced anti-inflammatory reflex 
via activation of ǂ7 nicotinic acetylcholine receptors 
(ǂ7nAChR) on macrophages in spleen (Nature Rev Immunol 
9:418, 2009). We previously reported that myenteric plexus 
nervous stimulation via serotonin-4 receptors induces anti-
inflammatory action in postoperative ileus (POI) and the 
inhibitory action may be mediated through activation of 
ǂ7nAChR (Gut 60:638, 2011). However, it is still unclear 
that stimulation of myenteric nerve plexus can stimulate 
the cholinergic anti-inÁ ammatory reÁ ex pathway, and/or can 
directly activate ǂ7nAChR of macrophages in the inÁ amed 
legion. Selective ǂ7nAChR agonists, PNU-282987 and 
AR-R17779 inhibited infiltration of macrophages but not 
neutrophils in animal model of POI. The anti-inÁ ammatory 
action by ǂ7nAChR agonists was disappeared in POI 
model of ǂ7nAChR null mice. Whereas serotonin-4 receptor 
agonist, mosapride citrate, inhibited infiltration of both 
macrophages and neutrophils in POI. Anti-inflammatory 
action against macrophages inÀ ltration was disappeared in 
POI model of ǂ7nAChR null mice. In isolated cells from the 
intestinal muscle layer, ǂ7nAChR mRNA expression was 
increased in CD11b-positive macrophages in animal model 
of POI.
S3F-34-2  New therapeutic strategies 
for age-related macular degeneration 
-Identifi cation of the pathological 
mechanisms and discovery of new 
therapeutic targets-
Masamitsu Shimazawa, Hideaki Hara
1Mol. Pharmacol., Dept. Biofunct. Eval., Gifu Pharmaceut. Univ.
Age-related macular degeneration (AMD) is the leading 
cause of blindness among the elderly in leading countries 
in the West. Exudative AMD, an advanced form of AMD, is 
characterized by choroidal neovascularization (CNV) that 
invades the sub-retinal space. CNV pathology has been 
extensively studied using rodents and non-human primates. 
Vascular endothelial growth factor (VEGF) is a key 
angiogenic and vasopermeability factor that is upregulated 
in AMD. Therefore, anti-VEGF therapies using anti-VEGF 
antibodies (ranibizumab and bevacizumab), an anti-VEGF 
aptamer (pegaptanib), and a fusion protein (aflibercept) 
that blocks all isoforms of VEGF-A and placental growth 
factor (PlGF)-1 and -2 are successfully used for the 
treatment of exudative AMD, and their potent efficacies 
have been demonstrated in many clinical studies. However, 
relapse following anti-VEGF therapies is a major problem. 
Accordingly, new therapeutic strategies for AMD need to 
be developed; these will likely emerge from the discovery of 
new causative factors. Here, we introduce recent À ndings on 
new therapeutic strategies for AMD.S6S3F-34-1  Systems pharmacology for 
retinal diseases
Yuhei Nishimura1,2,3,4,5, Reiko Kawase1, 
Toshio Tanaka1,2,3,4,5 
1Dept. Pharmacogenomics, Mie Univ. Grad. Sch. Med., 2Dept. Systems 
Pharmacol., Mie Univ. Grad. Sch. Med., 3Mie Univ. Medical Zebrafi sh 
Research C., 4Dept. Bioinfo., Mie Univ. Life Science Research C., 5Dept. Omics
Med., Mie Univ. Ind. Tech. Innov. Inst.
Systems pharmacology has attracted a lot of attention in
the field of drug discovery. In the systems pharmacology
approach,  zebraf ish  have many advantages .  The
development and function of zebrafish organs are very
similar to those of humans. Zebrafish possess orthologs
for more than 80% of human drug targets. Zebrafish are
prolific and small, making the species suitable for high
throughput screening application with relatively smal
quantities of compounds. These compounds can be easily
administered to zebrafish by introducing them into thei
swim water. Quantitative imaging of various tissues using
fluorescent proteins/dyes and quantitative analysis o
various neurobehavior can be performed in a relatively high
throughput manner, which can be used for phenotypic drug
discovery. In this presentation, we would like to introduce
our strategy using zebrafish-based systems pharmacology
focusing on various retinal diseases.
S3F-34-3  Research of prostaglandin 
receptors and glaucoma drug discovery
Shinsaku Yamane
Dept. Biol. & Pharmacol., ONO Pharm. Co.
Prostaglandin (PG), including PGE2 and PGF2ǂ,is a
bioactive lipid. By binding to various PG receptors
PG exhibits diverse physiological effects. In the field
of glaucoma, PGF2ǂ,has long since been recognized as
exhibiting intraocular pressure (IOP)-lowering effects and
PGF2ǂ derivatives have been used to treat glaucoma. On
the other hand, although PGE2 also exhibits potent IOP
lowering effects, it has not yet been used clinically due to
side effects such as hyperemia and inflammation. PGE2
binds to four receptors, EP1, EP2, EP3 and EP4, and its
IOP-lowering effects have been reported in several anima
studies using a number of PG receptor agonists.Based
on these reports, we conducted experiments to clarify
the effects of these EP receptors on IOP regulation using
selective agonists. The results showed that EP2 and EP3
receptor agonists lower IOP, suggesting a potential fo
EP2 and EP3 receptor agonists to become a new class o
anti-glaucoma medication. After screening approximately
100,000 compounds for compounds that activate the EP2
or EP3 receptor, we discovered ONO-0476, a selective
EP2 agonist, and ONO-9054, an EP3/FP agonist. At this
symposium, I will discuss our research on PG receptors and
glaucoma, with a focus on preclinical data for ONO-9054
and ONO-0476.3
S3F-34-4  Ripasudil hydrochloride 
hydrate, a novel Rho-kinase inhibitor, 
development for glaucoma therapeutic 
ophthalmic solution
Yoshio Kaneko
Tokyo New Drug Research Laboratories, Kowa Company, LTD.
Ripasudil hydrochloride hydrate (GLANATEC® ophthalmic 
solution: K-115) was approved as the first glaucoma 
therapeutic drug by the Rho-kinase (ROCK: Rho-associated, 
coiled-coil containing protein kinase) inhibition in Japan. 
ROCK is a serine-threonine protein kinase, and the ROCK 
signal is involved in various physiological functions. In 
the eyes, the ROCK inhibitor indicates to promote the 
aqueous outflow from the conventional pathway through 
the trabecular meshwork to Schlemm’s canal, thereby 
lowering the intraocular pressure (IOP).Ripasudil was 
developed to have a selective inhibitory effect on the ROCK, 
and it showed the strong IOP-lowering effect to increase 
the outÁ ow facility through the conventional pathway. This 
mechanism of ripasudil is different from other glaucoma 
drugs, such as ǃ-receptor blockers and carbonic anhydrase 
inhibitors to reduce the aqueous humor, and prostaglandin 
analogs to increase the uveoscleral outÁ ow (non-conventional 
pathway). Therefore, ripasudil provides a new therapeutic 
option in the clinical practice of glaucoma treatments.
S3C-35-2  Biological molecular target 
of reactive sulfur species
Yasuo Watanabe
Dept. Pharmacol., Showa Pharmaceut. Univ.
Cystine (Cys-SS-Cys) can be converted to cysteine 
hydropersulÀ de (Cys-SSH) via the actions of cystathionine 
Ǆ-lyase (CSE) or cystathionine ǃ-synthase (CBS). The 
biological reactivity of Cys-SSH including other Cys-SSH 
derivatives of peptides/proteins is thought to be involved 
in the catalytic activity of particular molecules. Calcium 
ion acts as a ubiquitous second messenger, especially in 
neural tissues where many of its physiological responses 
are mediated by the Ca2+-binding protein calmodulin 
(CaM). The actions of CaM are mediated by its association 
with specific target proteins, some of which are known 
as CaM-binding proteins, which include kinases such as 
CaM kinases (CaMKs) and Á avoproteins such as the nitric-
oxide synthases (NOSs). Here, we identified CaMKs and 
NOSs as candidates for Cys-SSH derivatives of proteins. In 
vitro incubation of CaMK or NOS with Cys-SSH generated 
from Cys-SS-Cys by CSE resulted in inactivation of each 
enzyme activities. Dithiothreitol but not excess CaM 
restored the each enzyme activity. Mutagenesis studies of 
CaMK conÀ rmed that Cys residue in its catalytic region is 
both necessary and sufficient for this inhibition of CaMK. 
Thus, we propose the novel mechanism of CaMK and 
nNOS regulation via Cys-SSH-induced modification of the 
enzymes.SS3C-35-1  Discovery of re-emerging 
reactive sulfur-containing compounds 
and their unique biological functions
Tomoaki Ida1, Takaaki Akaike
Dept. Environ. Health Sci. Mol. Toxicol., Tohoku Univ. Grad. Sch. Med.
Reactive sulfur-containing compounds such as L-cysteine 
(Cys) hydropersulÀ des are known to form endogenously in 
mammals.  We determined here that these reactive sulfur 
species are synthesized from cystine via  cystathionine 
ǃ-synthase (CBS) and cystathionine Ǆ-lyase (CSE).  Most 
notably, various hydropersulfide and hydropolysulfide 
derivatives of Cys, homocysteine, and Cys-containing 
peptides and proteins formed endogenously in a manner 
depending on CSE and CBS.  We identified high levels 
(>100 ǍM) of glutathione hydropersulfide and other Cys 
persulfide/polysulfide derivatives of peptides/proteins in 
cells, tissues, and plasma from mice and humans.  These 
sulfur derivatives had superior scavenging abilities for 
reactive oxygen species and electrophiles compared with 
their thiol counterparts (e.g., reduced glutathione).  We 
propose, therefore, that these Cys persulÀ de-derived species 
have a unique regulatory function in redox cell signaling. 
Our study demonstrates, on the basis of our new polysulfur 
metabolomic and proteomic analysis developed herein, the 
biological relevance of reactive Cys persulÀ des in mammals.
(Ref. Ida et al. PNAS, 2014; Ono et al. FRBM, 2014)
S3C-35-3  Novel mechanism of 
methylmercury-induced neurotoxicity: 
Disruption of reactive sulfur species-
regulated NO/ROS redox signaling
Hideshi Ihara
Dept. Biol. Sci., Sch. Sci., Osaka Pref. Univ.
Methylmercury (MeHg) is a broad environmental pollutant 
and well-known neurotoxicant.  MeHg disrupts redox 
homeostasis in cells due to its strong electrophilicity, and 
causes neurotoxicity.  However, the mechanistic details 
remain to be elucidated.  A novel nitrated cyclic nucleotide, 
8-nitroguanosine 3’,5’-cyclic monophosphate (8-nitro-cGMP), 
is a second messenger of redox signaling, which regulates 
cell senescence.  Recently, we reported that 8-nitro-cGMP 
redox-signaling was controlled by reactive sulfur species 
(persulÀ des and polysulÀ des).  This À nding suggested that 
reactive sulfur species was involved in MeHg neurotoxicity. 
Here we investigated the participation of 8-nitro-cGMP and 
reactive sulfur species in MeHg neurotoxicity.  We found 
that MeHg disrupted reactive sulfur species-regulated NO/
ROS redox signaling, resulting in neurotoxicity.64
S3C-35-4  Functional chemical donors 
for investigation of reactive polysulfi des
Hidehiko Nakagawa
Dept. Org. & Med. Chem., Grad. Sch. Pharmaceutical Sci. Nagoya City Univ.
Reactive polysulfide is recently getting attractive to the 
researchers of redox biology as a key modification and 
mediator, and may plays many important roles in signal 
transduction processes. To investigate the potential 
physiological and pharmacological roles of these sulfide 
species, it is indispensable to use chemical donors that 
release sulfide species you intended specifically. In 
addition, it is advantageous if the releasing activity can 
be controlled in the spatiotemporal manner. Based on this 
consideration, as the first step, we developed caged H2S 
(that is, photoconotrollable H2S chemical donors), in which 
H2S is directly caged with ketoprofenate-type photolabile 
protecting groups. Upon photoirradiation, all the protecting 
groups were almost simultaneously cleaved to release 
H2S in vitro, and the release activity was dependent on 
the irradiation time and intensity. We also confirmed the 
donor is photocontrollable in cultured cells. Although 
further improvement is necessary in optical properties, the 
donor would be useful for physiological/pharmacological 
experiments of sulÀ de species.




We designed and synthesized delta agonist, TAN-67 by 
removal of accessary sites of the delta antagonist, NTI. The 
TAN-67 showed high delta selectivity and potent agonist 
activity in in vitro assays. However, The agonist showed no 
potent analgesic activity in in vivo. So, we re-examined the 
accessary site of the NTI and designed and synthesized SN-
28. The improvement of the penetration of B.B.B. in the SN-
28 afforded KNT-127. KNT-127 showed high delta selectivity, 
potent agonist activity and strong analgesic activity(3mg/kg, 
sc). Furthermore, KNT-127 showed no catalepsy different 
from SNC-80. The details of Pharmacological activities of 
KNT-127 will be reported by Drs. Nakata and Saitoh in the 
following presentaions.S65S3D-36-1  Possibility for the 
development of delta opioid receptor-
based therapeutic agents
Junzo Kamei
Dept. Pathophysiol. Th er., Hoshi Univ. Sch. Pharm. Pharmaceut. Sci.
Evidence that the delta opioid receptor (DOP) is an 
attractive target for the treatments of nerve and/or brain 
disorders such as cough, painful diabetic neuropathy and 
depression, has strengthened in recent years. DOP is broadly 
expressed in the central nervous systems including limbic 
forebrain area, binds endogenous opioid peptides and shows 
as functional proÀ le highly distinct from those of mu (MOP) 
and kappa (KOP) opioid receptors. The characterization of 
DOP has lagged behind that of MOP and KOP, mainly due 
to the lack of DOP agonist with high stability and selectivity. 
DOP is now receiving increasing attention, along with 
progress in the synthesis of novel compounds (e.g. TAN-
67, KNT-127, SNC80) with high stability and selectivity 
in vivo. In this symposium, we will discuss and introduce 
latest knowledge regarding the development of DOP-based 
therapeutic agents.
S3D-36-3  The antidepressant-like 
and anxiolytic-like effects of į opioid 
receptor agonists
Akiyoshi Saitoh, Mitsuhiko Yamada
Dept. Neuropsychopharm. NIMH, NCNP.
It has been proposed that ǅopioid receptor (DOP) agonists 
might be attractive agents as novel antidepressants and/or 
anxiolytics. Unfortunately, DOP agonists, such as SNC80, 
produce convulsive effects, which limit their therapeutic 
potential and clinical development. Recently, a DOP agonist, 
KNT-127, has been introduced. Interestingly, KNT-127 
produced no convulsive effect in rodent. More recently, we 
have demonstrated that KNT-127 has potent antidepressant-
like and anxiolytic-like effects in several types of animal 
models. In addition, in contrast to benzodiazepines, KNT-
127 did not produce adverse effects associated with the 
GABAA/benzodiazepine receptor chloride channel complex, 
such as amnesia, ethanol interaction and motor coordination 
deficits. Therefore, it is proposed that KNT-127 would be 
considered as a candidate compound for the development 
of DOP-based antidepressants and/or anxiolytics. In this 
symposium, we will share our current data and knowledge 
regarding the antidepressant-like and anxiolytic-like effects 
of DOP agonists.
S3D-36-4  Discovery of novel delta 
opioid receptor agonists without 
convulsive effects
Eriko Nakata1, Junichi Sakai1, Yoshikazu Watanabe1,2, 
Daisuke Saito1, Toshihiro Takahashi1, Takashi Iwai2, 
Shigeto Hirayama2, Hideaki Fujii2, Tomio Yamakawa1, 
Hiroshi Nagase2,3 
1Disc. Res. Labs., Nippon Chemiphar, 2Sch. Pharm., Kitasato Univ., 3WPI-IIIS, 
Univ. Tsukuba
We have  ident i f ied  a  novel  s tructural  c lass  o f  ǅ 
opioid receptor agonists with a novel fundamental 
oxazatr icyc lodecane structure ,  which is  ent ire ly 
different from SNC80 and the analogues that possess a 
diarylmethylpiperazine or a similar scaffold. Although 
optimization of these structures gave the improvement of 
brain penetration and analgesic activity, some compounds 
produced convulsion and catalepsy behavior but others did 
not. With regard to four ǅ receptor agonists which had a 
slightly different structure and showed similar G protein-
mediated agonistic activities in the ǅ receptor-expressing 
cells, we analyzed their ǅ receptor-mediated ǃ-arrestin2 
signaling activities in vitro and convulsive effects in 
mice. Interestingly, two ǅ agonists without the convulsion 
appeared to be a consequence reduced ǃ-arrestin2 
recruitment and followed internalization activities, 
suggested that ǅ receptor-induced convulsive effects could be 
mediated by ǃ-arrestin2 signaling.
This study was supported by the Japan Science and 
Technology Agency (JST) grants.
S3E-37-2  Autonomic nervous system-
mediated effects of GALP on energy 
metabolism in liver
Seiji Shioda1, Satoshi Hirako1, Nobuhiro Wada1, 
Fumiko Takenoya2
1Dept. Anat., Showa Univ. Sci. Med., 2Hoshi Uni. Sch. Pharmacy Pharmaceut. 
Sci.
Galanin-like peptide (GALP) is a neuropeptide which 
regulates feeding behavior and energy metabolism. 
We studied the effect of GALP on food intake and lipid 
metabolism and its precise mechanism. The effect of 
GALP on lipid metabolism was studied by blocking the 
sympathetic nervous system with guanethidine. Moreover, 
to study the anti-obese effect of chronic administration of 
GALP, the animals were fed a high fat diet to induce obesity 
and they were treated with intranasal infusion of GALP for 
1-2 weeks. The respiratory exchange ratio (RER) of GALP-
treated group was lower than that of the control group. 
In the GALP-treated group, fatty acid synthesis-related 
gene mRNA levels were decreased but fatty acid oxidation-
related gene mRNA levels were increased in liver. The RER 
was reduced by GALP infusion but was not significantly 
changed in the guanethidine treatment. In the adipose 
tissue, the mRNA levels of HSL and ATGL, which were 
involved in lipolysis, were increased with GALP treatment. 
The body weight gain and WAT was decreased after GALP 
administration for 1 week. These results indicate that anti-
obese effect of GALP is evident and this effect is caused by 
the sympathetic nervous system.S66S3E-37-1  Inter-organ neural network 
mediate the regulation of systemic 
energy metabolism
Tetsuya Yamada, Hideki Katagiri
Dept. Metabolism and Diabetes, Tohoku Univ. Grad. Sch. Med.
The importance of inter-organ neural network in energy 
metabolism has been acknowledged. For example, we 
found that neural signals from the visceral adipose tissues 
suppress food intake (Cell Metab 2006) and furthermore 
that afferent neural signals from the hepatic PPARǄ during 
overnutrition activate energy consumption thus contributing 
to body weight homeostasis (Science 2006). Failure in 
homeostatic mechanism, but not an intrinsic machinery, 
has previously been considered to be the cause of weight 
gain. On the other hand, we recently discovered a novel 
inter-organ neural network contributing to energy storage 
at the whole-body level. The activation of hepatic glucose 
metabolism due to overnutrition led to energy storage by 
suppressing metabolic heat production in the brown adipose 
tissue, revealing an inter-organ neural signaling from the 
liver to brown adipose tissue. Furthermore, detailed analysis 
of the brain let us identify a speciÀ c nucleus to participate 
in this inter-organ neural network (Cell Metab 2012). This 
system may have worked in favor of survival during periods 
when sufÀ cient food was not always available. However, in 
the current age of plenty, it is assumed that this mechanism 
would Á ip the metabolic switch toward obesity.
S3E-37-3  Involvement of 
communication system between 
brain and peripheral tissues on the 
development of post-ischemic glucose 
intolerance induced by cerebral 
neuronal damage
Shinichi Harada, Shogo Tokuyama
Dept. Clinic. Pharm., Sch. Pharmaceu. Sci., Kobe Gakuin Univ.
We have previously found that the development of post-
ischemic glucose intolerance is one of the triggers of ischemic 
neuronal damage. However, the mechanisms underlying 
post-ischemic glucose intolerance remain unclear. The 
communication system between brain and peripheral tissues 
through the autonomic nervous system is important for 
maintaining glucose and energy metabolism. Here, we would 
like to discuss about on the mechanisms through which 
ischemic neuronal damage develops and on the role of post-
ischemic glucose intolerance focusing on communication 
system between brain and peripheral tissues. Specially, we 
focused the effect of orexin-A, one of neuropeptides and well 
known as regulatory factor of the communication between 
brain and peripheral tissues, on the development of the 
post-ischemic glucose intolerance and neuronal damage. 
In conclusion, our evidences support valuable insight for 
the advanced treatment of cerebral stroke and add to the 
existing literature about the role of post-ischemic glucose 
intolerance and the communication between the brain and 
peripheral tissues as a new therapeutic target for use in 
ischemic stroke patients.
S3E-37-4  Roles of the bed nucleus 
of the stria terminalis in brain-gut 
interactions
Soichiro Ide, Masabumi Minami
Dept. Pharmacol., Grad. Sch. Pharm. Sci., Hokkaido Univ.
There is a complex bidirectional communication system 
between the central nervous system and the enteric nervous 
system (brain-gut interactions). Gastrointestinal problems 
could have serious effects on mental health conditions. On 
the other hand, various mental stressors have been shown 
to regulate visceral pain responses and be associated with 
severity in functional gastrointestinal disorders. However, 
the precise mechanisms underlying brain-gut interactions 
remain to be understood. The bed nucleus of the stria 
terminalis (BNST) is a limbic structure involved in stress 
responses and negative affective states such as anxiety and 
fear. Thus, we investigated the roles of the BNST in brain-
gut interactions using unanesthetized male rats. In vivo 
microdialysis showed that extracellular noradrenaline levels 
within the BNST were increased by gastric and colorectal 
distention stimuli. Furthermore, intra-BNST injection of 
isoproterenol, a ǃ-adrenoceptor agonist, caused significant 
hypersensitization to the colorectal distention stimulus, and 
suppressed gastric emptying and small intestinal transit. 
The present findings suggest the important roles of the 
noradrenergic transmission via ǃ-adrenoceptors within the 
BNST in brain-gut interactions.
S3F-38-2  Role of type I diacylglyserol 
kinases in the regulation of insulin 
secretion from pancreqatic ȕ-cells
Tomohisa Ishikawa, Yukiko Kaneko 
1Dept. Pharmacol., Sch. Pharmaceut. Sci., Univ. Shizuoka
The disruption of diacylglycerol (DAG) metabolism in 
pancreatic ǃ-cells is suggested to be related to ǃ-cells 
dysfunction in type 2 diabetes. Diacylglycerol kinase (DGK) 
is one of key enzymes in the DAG metabolism. Among 10 
mammalian DGK isoforms, type I DGKs, i.e., DGKǂ, ǃ, 
and Ǆ, have Ca2+-binding EF-hand motifs. Therefore, type I 
DGKs are highly possible to be involved in the regulation of 
insulin secretion from ǃ-cells which is closely related to Ca2+; 
however, so far no data is available concerning type I DGKs 
in ǃ-cells. We have investigated the expression and function 
of type I DGKs in ǃ-cells, and showed the expression of 
DGKǂ and Ǆ in mouse pancreatic islets and the ǃ-cell line 
MIN6, inhibition by the type I DGK inhibitor R59949 of 
glucose- and high K+-induced insulin secretions from MIN6 
cells, decreases in the insulin secretions in MIN6 cells with 
knockdown of DGKǂ and Ǆ by siRNA, and inhibition by 
R59949 of the insulin secretions from mouse and rat islets. 
We propose from these findings that DGKǂ and Ǆ present 
in ǃ-cells act as a positive regulator of insulin secretion 
and that hypoactivity of the DGKs results in a pronounced 
suppression of [Ca2+] i elevation, thereby leading to impaired 
insulin secretion.S6S3F-38-1  Diacylglycerol kinase ȕ as a 
possible therapeutic target for memory 
loss and mania
Yasuhito Shirai
Dept. Applied Chem. in Biosci., Grad. Sch. Agricul. Sci., Kobe Univ.
Diacylglycerol kinase (DGK) is a lipid kinase converting 
diacylglycerol to phosphatidic acid, and regulates many 
enzymes including protein kinase C and mTOR, etc. 
Among ten mammalian DGK subtypes, DGKǃ is enriched 
in brain, specifically in the caudate putamen, cortex and 
hippocampus. The enzyme is not present at the birth but 
its expression is rapidly increased from day 14 to day 28, 
and its splice variant has been reported to be related to 
bipolar disorder. These facts suggest importance of DGKǃ 
in the neuronal network. Indeed, DGKǃ KO mice that we 
had produced showed impairment of cognitive functions 
and mania-like behavior. In this talk, we introduce newly-
found mechanisms of the DGKǃ-mediated neurite and 
spine formation, and discuss about possibility of DGKǃ as a 
therapeutic target for neuronal disease including memory 
loss and mania.
S3F-38-3  Regulation of cholesterol 
metabolism by diacylglycerol kinase ș
Marion B. Sewer, Kai Cai
Skaggs Sch. Pharm. and Pharmacol. Sci, Univ. of California San Diego
Diacylglycerol kinases (DGKs) catalyze the conversion of 
diacylglycerol (DAG) into phosphatidic acid (PA). Although 
it was once believed that the primary function of DGKs 
was to inactivate DAG and reduce cellular signaling, 
PA regulates a number of signaling proteins, including 
protein kinase C, mammalian target of rapamycin (mTOR), 
and sphingosine kinase 1. Further, mounting evidence 
supports a role for individual DGK isoforms exerting 
speciÀ c regulatory control through unique interactions with 
proteins partners. Differential subcellular localization of 
DGK isoforms is thought to enable local regulation of DAG 
and PA concentrations for spatial and temporally separated 
cellular processes. We have investigated the role of DGKǉ 
in regulating the conversion of cholesterol to cortisol in 
adrenocortical cells and have identiÀ ed that DGKǉ acts in 
the nucleus to modulate gene transcription by regulating the 
production of PA. These studies also revealed that DGKǉǉ 
regulates the expression of genes required for cholesterol 
biosynthesis and sphingolipid metabolism. Further, based 
on the expression of DGKǉ in liver and the key role of PA in 
modulating the activity of mTOR, we also established that 
bile acids increase the expression of DGKǉ in hepatocytes 
via a pathway that required the farnesoid X receptor. DGKǉ-
catalyzed PA production promoted the phosphorylation of 
mTOR and FoxO1, and was required for bile acid-dependent 
decreased glucose production. In summary, our findings 
establish DGKǉ as a key regulator of cholesterol metabolism 
in multiple tissues.7
S3F-38-4  Diacylglycerol kinase Į as 
an ideal therapeutic target for refractory 
cancer
Fumio Sakane
Dept. Chem., Chiba Univ. Grad. Sch. Sci.
Diacylglycerol (DG) kinases (DGK) ǂ is highly expressed in 
hepatocellular carcinoma, melanoma and breast cancer cells. 
Suppression of DGKǂ activity inhibits progression of these 
cancers. In melanoma cells, DGKǂ positively regulates the 
tumor necrosis factor-ǂ-dependent NF-ǋB (p65) activation 
via the protein kinase C-Ǉ-mediated Ser311 phosphorylation 
of p65. On the other hand, DGKǂ is abundantly expressed 
in T lymphocytes where it facilitates the non-responsive 
state known as anergy. Anergy induction of cytotoxic T cells 
represents the main mechanism for advanced tumors to 
avoid immune action. Therefore, DGKǂ enhances malignant 
traits and suppresses immune surveillance. One of the main 
problems of almost every existing anti-cancer drugs is a 
suppressive side effect to immune system. However, DGKǂ 
inhibitors will be ideal anti-tumor drugs without undesired 
immunosuppressive side effects. Recently, we have obtained 
several promising compounds, which selectively inhibit 
DGKǂ with IC50 values of 0.6 - 8 ǍM using a newly developed 
high-throughput assay. In addition, we revealed that the 
Ca2+-induced dissociation of the intra-molecular interaction 
between the EF-hand motifs and the C1 domains of DGKǂ is 
the key event of its activation.
S3C-39-2  Intracellular Ca2+ regulation 
by SR/ER counter-ion channels
Daiju Yamazaki1,2, Hiroshi Takeshima2,3
1Div. Pharmacol., NIHS, 2Res. Unit for Physiol. Chem., the Center for the 
Prom. of Interdiscipl. Edu. and Res., Kyoto Univ., 3Dept. of Biol. Chem., Grad. 
Sch. of Pharmaceut. Sci., Kyoto Univ., Kyoto, Japan
The TRIC (trimeric intracellular cation) channel subtypes 
assemble into bullet-shaped homo-trimers to form 
monovalent cation-selective channels in SR/ER. Double-
knockout mice lacking both the Tric-a  and Tric-bgenes show 
embryonic cardiac failure, and the mutant cardiomyocytes 
display weak RyR-mediated Ca2+ release. Moreover, skeletal 
muscle from Tric-a-/-  mice exhibits alternan contraction 
responses, likely due to destabilized RyR-mediated Ca2+ 
release. These defects observed in the mutant mice support 
our hypothesis that TRIC channel subtypes partly mediate 
counter-ion movements to facilitate SR/ER Ca2+ release.
Vascular smooth muscle cells (VSMCs) contain both TRIC 
subtypes and two Ca2+ release mechanisms; incidental 
opening of RyRs generates local Ca2+ sparks to induce 
hyperpolarization and relaxation, whereas agonist-induced 
activation of IP3R produces global Ca2+ transients causing 
contraction. Tric-a -/-  mice develop hypertension due to 
insufÀ cient Ca2+ sparks in VSMCs. However, the SM-sepciÀ c 
Tric-a  transgenic mice developed congenital hypotension 
due to frequent Ca2+ sparks. Moreover, in clinical study, the 
TRIC-A gene polymorphisms in the Japanese population 
were associated with both hypertension susceptibility and 
sensitivity to antihypertensive medications.S6S3C-39-1  Intestinal myofi broblast 
TRPC6 channel may contribute to 
stenotic fi brosis in Crohn’s disease
Lin Kurahara1, Miho Sumiyoshi1, Kunihiko Aoyagi2, 
Keizo Hiraishi1, Ryuji Inoue1 
1Dept. Physiol., Fukuoka Univ. Sch. Med., 2Dept. Gastroenterol., Fukuoka 
Univ. Sch. Med.
Intestinal fibrosis is a frequent complication of Crohn’s 
disease (CD) and often leads to detrimental stricture 
formation. Myofibroblasts play active roles in mediating 
fibrotic changes in various tissues. We investigated 
whether transient receptor potential (TRP) channels in 
intestinal myofibroblasts are involved in CD-associated 
intestinal À brosis. TGF-ǃ1 treatment trans formed spindle-
shaped intestinal myofibroblast cell line (InMyoFibs)  into 
filament-shaped cells with enhanced TRPC4 and TRPC6 
mRNA and protein expressi on, and agonist-induced Ca2+ 
influxes. TGF-ǃ1 also enhanced the formation of TRPC6/
ǂ-SMA/N-cadhern/TRPC4 complexes. Inhibition of TRPC6 
in InMyoFibs by RNA interference or dominant-negative 
mutations increased COL1A1, IL10, and IL11 expression, 
as well as Smad-2, ERK, and p38-MAPK phosphorylation. 
In stenotic areas of CD patients, expression of TRPC6 
was significantly increased. These results suggest that 
augmented Ca2+ influxes due to TRPC6 upregulation 
facilitate stress fiber formation and strengthen cell-cell 
interactions by negatively regulating the synthesis of anti-
À brotic factors in TGF-ǃ1-treated myoÀ broblasts.
S3C-39-3  IP3 receptor-mediated 
calcium oscillation-dependent and 
-independent osteoclastogenesis
Yukiko Kuroda1, Chihiro Hisatsune2, 
Akihiro Mizutani3, Katsuhiko Mikoshiba2, 
Koichi Matsuo1
1Lab. Cell and Tissue Biology, Keio Univ. School of Med., 2Lab. Dev. 
Neurobiol., RIKEN BSI, 3Dept. Pharmacotherapeutics, Showa Pharmaceutical 
Univ.
Maintenance of bone homeostasis is achieved by continuous 
bone remodeling consists of two opposing processes, 
bone resorption by osteoclasts and bone formation by 
osteoblasts. Osteoclasts are multinuclear cells formed by 
fusion of monocyte-macrophage lineage precursor cells. 
Activation of nuclear factor of activated T cells c1 (NFATc1), 
a transcription factor downstream the receptor activator of 
NF-ǋB ligand (RANKL) signaling, is a critical step for their 
differentiation. We demonstrated that osteoblasts induced 
two parallel pathways, Ca2+ oscillation-dependent and 
-independent NFATc1 activation pathways for osteoclast 
differentiation. In the Ca2+ oscillation-dependent pathway, 
type2 IP3R was essential for RANKL-induced Ca2+ oscillation 
and induced the transcriptional activation of NFATc1. 
On the other hand, in the Ca2+ oscillation-independent 
pathway, the activity of Cot (cancer osaka thyroid), a serine/
threonine kinase, in osteoclasts was enhanced via cell-
cell interaction with osteoblasts and increased NFATc1 
stability through phosphorylation. Collectively, our À ndings 
provide a mechanistic insight into how osteoblasts promote 
osteoclastogenesis through both Ca2+ oscillation-dependent 
and -independent NFATc1 activation.8
S3C-39-4  Using human iPS cell models 
of cardiac arrhythmia to study cardiac 
calcium handling and to identify new 
drugs
Masayuki Yazawa
Dept. Rehab. & Regenerative Med. Columbia Univ.
Timothy syndrome is a disorder characterized by multi-
organ dysfunctions including long QT syndrome, cardiac 
arrhythmia and autism.  Although the de novo missense 
mutation in L-type calcium channel (CaV1.2) causes 
Timothy syndrome, how the mutation alters calcium 
signaling and electrical activity in human hearts remains 
unknown.  Mouse models of human cardiac arrhythmia 
have proved to be problematic because the mouse resting 
heart rate is approximately ten-fold faster than that of 
humans and therefore mouse cardiomyocytes have different 
electrical properties from their human counterparts.  Taking 
advantage of human induced pluripotent stem (iPS) cells, 
we generated human patient-specific cardiomyocytes to 
investigate cellular phenotypes in Timothy syndrome using 
a variety of cellular assays including live cell imaging, 
electrophysiological recordings, gene expression profiling 
and immunocytochemistry.  Here I report the phenotypes 
in calcium handling that were observed in cardiomyocytes 
derived from two Timothy syndrome patients.  In addition, I 
talk about future directions of researches using human iPS 
cells as well as a directed test of chemical compounds and 
blockers to rescue the cellular defects in Timothy syndrome.
S3D-40-2  A novel therapeutic strategy 
for neuropathic pain through regulating 
peripheral immune cells
Yuka Kobayashi1, Norikazu Kiguchi1, 
Yohji Fukazawa1, Fumihiro Saika1, Takehiko Maeda2, 
Shiroh Kishioka1
1Dept. Pharmacol., Wakayama Med. Univ., 2Dept. Pharmacol., Niigata Univ. 
Pharm. Applied. Life Sci.
Growing evidence indicates that several types of immune 
cells play a crucial role in peripheral neuroinflammation 
associated with neuropathic pain. We have demonstrated 
the role of macrophages, T cells and their interaction in 
neuropathic pain.
After partial sciatic nerve ligation (PSL), macrophages 
and T cel ls  migrated in the injured sciatic  nerve 
(SCN). The depletion of macrophages by liposomed-
clodronate attenuated PSL-induced thermal hyperalgesia 
and tacti le allodynia,  indicating that infi ltrating 
macrophages participate in neuropathic pain. FTY720, an 
immunosuppressive agent, also alleviated PSL-induced 
neuropathic pain. Furthermore, we explored the involvement 
of co-stimulating molecules expressed on immune cells in 
neuropathic pain. The glucocorticoid induced TNF receptor 
ligand (GITRL) and its receptor were up-regulated in the 
injured SCN after PSL, which were localized on inÀ ltrating 
macrophages and T cells, respectively. Perineural injection 
of GITRL neutralizing antibody attenuated PSL-induced 
neuropathic pain. Therefore, the regulating peripheral 
immune cells may be a useful approach for treatment of 
neuropathic pain, and the co-stimulating molecules may 
offer new insight into underlying mechanisms of neuropathic 
pain.SS3D-40-1  The involvement of 
glycolipids in nociception
Shun Watanabe, Mitsuo Tanabe
Lab. Pharmacol., Sch. Pharm., Kitasato Univ.
Gangliosides belong to the group of glycosphingolipids that 
are components of cell membranes. They have many diverse 
variations of sialic acids containing carbohydrate-chain, and 
are divided into several groups (asialo-, a-, b-, and c-series 
gangliosides) based on their biosynthetic pathway. These 
gangliosides are abundant in neural tissues and previous 
studies revealed important roles played in neuronal 
functions. However, the mechanisms of gangliosides in pain 
sensing remain unclear. To address this issue, we examined 
whether intraplantar injection of gangliosides produced 
nociceptive behavior in mice. b-Series ganglioside GT1b 
produced nociceptive behavior, mechanical allodynia, and 
enhanced 0.05% formalin-induced nociception (GT1b-induced 
hyperalgesia). Furthermore, GT1b-induced hyperalgesia 
was blocked by glutamate receptor antagonists, and GT1b 
induced glutamate accumulation in subcutaneous tissues, 
indicating that glutamate signaling is involved in GT1b-
induced hyperalgesia. In addition, sialidase which cleaves 
sialyl residues of glycoconjugates including gangliosides 
reduced inflammatory pain, suggesting that endogenous 
gangliosides are involved in hyperalgesia or allodynia.This 
work was supported by JSPS KAKENHI Grant Number 
26860385.
S3D-40-3  HMG-CoA reductase 
inhibitors as a new candidate for the 
treatment of neuropathic pain.
Masahiro Ohsawa, Kazuhiko Kume
Dept. Neurophaｒ macol., Grad. Sch. Pharmaceut. Sci. Nagoya City Univ.
Nerve injury leads to the persistent activation of sensory 
afferents, which triggers neuropathic pain. Several 
intracellular signaling molecules have been considered 
to participate in neuropathic pain. Rho-associated kinase 
(ROCK) has been reported to play an important role in the 
development and maintenance of chronic pain in nerve-
injured and diabetic mice. Despite the promising findings 
regarding the involvement of RhoA/ROCK signaling in 
neuropathic pain, the detailed mechanisms of RhoA/ROCK-
induced nociceptive sensitization remain to be elucidated. 
The activity of ROCK systems is modulated by protein 
isoprenylation. Treatment with mevalonate, which is a 
precursor of isoprenoids, activates RhoA/ROCK signaling 
through RhoA isoprenylation, and induces thermal and 
mechanical hyperalgesia. Statins, a HMG-CoA reductase 
inhibitors suppress mevalonate production. Therefore, it 
is possible that statins might elicit an antihyperalgesic 
effect through the inhibition of the RhoA/ROCK singaling 
pathway.In the present symposium, the preliminary analysis 
of HMG-CoA reductase inhibitor, simvastatin, as a possible 
drug on the hyperalgesia in the neuropathic pain in mice, 
and the role of RhoA/ROCK signaling will be discussed.69
S3D-40-4  Alternative splicing of TRPA1 
under neuropathic pain condition in 
mice
Yoshiro Suzuki1,2, Yiming Zhou1, Kunitoshi Uchida1,2, 
Makoto Tominaga1,2
1Div. Cell Signal., Okazaki Inst. Integ. Biosci. (NIPS), 2Dept. Physiol. Sci., 
Grad. Univ. Adv. Studies
Transient receptor potential ankyrin 1 (TRPA1) is a 
nonselective Ca2+-permeable cation channel which has been 
suggested to be involved in mechanical hyperalgesia under 
some pathological pain conditions such as inflammatory 
and neuropathic pain. However, the molecular mechanism 
of the TRPA1 involvement in these pain conditions has 
remained unclear. We identified an alternative splicing 
variant of mouse TRPA1 (TRPA1b) whose regulation of 
expression was different from that of original one (TRPA1a) 
under 2 different pathological pain conditions. TRPA1b 
physically interacted with TRPA1a and increased TRPA1a 
protein expression in the plasma membrane. Co-experssion 
of TRPA1a and TRPA1b significantly increased current 
density in response to different agonists without affecting 
their single channel conductance. Moreover, exogenous 
overexpression of TRPA1b in wild-type and Trpa1 knockout 
DRG neurons also increased TRPA1a-mediated AITC 
responses. These results suggest that TRPA1 might be 
regulated through alternative splicing under pathological 
pain conditions including neuropathic pain.
S3E-41-2  Rabies virus tools for 
understanding structure and function of 
neural circuits
Fumitaka Osakada1,2,3
1Dept. Cell. Pharmacol., Nagoya Univ., 2Systems Neurobiol. Lab., Salk Inst., 
3PRESTO, JST
Understanding how neural circuits process information 
requires resolving connectivity with high resolution, 
correlating connectivity with function, and manipulating 
activity of defined circuit components. Rabies viruses 
infect neurons through axon terminals and spread 
transsynaptically in a retrograde direction in the 
nervous system. Rabies whose glycoprotein (G) gene is 
deleted from the genome cannot spread across synapses. 
Transcomplementation of G, however, allows for labeling 
directly-connected, presynaptic neurons. Cre-dependent 
or bridge protein-mediated transduction via EnvA/TVA or 
EnvB/TVB systems allows cell-type-specific or single-cell-
speciÀ c targeting of rabies viruses. ModiÀ ed rabies viruses 
make it possible to identify inputs to specific cell types or 
single neurons and combine high-resolution circuit tracing 
with studies monitoring or manipulating neural activity and 
gene expression. Combining these tools with in vivo imaging 
and optogenetic methods, and/or inducible gene expression 
in transgenic mice, will allow previously unimaginable 
experiments investigating neural circuit development, 
plasticity, and function.SS3E-41-1  The organization of auditory 
neural circuits in the fruit-fl y brain
Azusa Kamikouchi
Grad. Sch. Sci., Nagoya Univ.
How does the brain process acoustic information? The fruit 
Á y is ideally suited for exploring the neural-circuit basis of 
information processing in the brain, with its small brain size 
and a rich repertoire of genetic tools. Toward comprehensive 
identification of auditory neural circuits in the fly brain, 
we systematically analyzed the anatomy and function of 
primary auditory neurons and their brain target. Such 
analysis revealed three zones in the primary auditory center, 
each of which is tuned to sound of a distinct frequency 
range. The frequency information of acoustic stimuli is thus 
À rst represented in three zones in the Á y brain. To elucidate 
the neural substrates for further information processing in 
the brain, we performed a large-scale analysis to identify 
neurons downstream of each frequency-selective zone. Our 
analysis established a projection map comprised of 40 types 
of secondary auditory neurons in the Á y brain, with which 
we found several anatomical similarities between auditory 
neural circuits in flies and mammals, such as parallel 
ascending pathways, binaural interaction, and multimodal 
pathways. Such similarities predict that the basic principle 
of acoustic information processing could be shared between 
mammals and Á ies.
S3E-41-3  Plasticity in the brainstem 
neural circuit associated with drug 
addiction
Katsuyuki Kaneda
Dept. Pharmacol., Grad. Sch. Pharm. Sci., Hokkaido Univ.
Drug addiction is neural circuit dysfunction resulting from 
cellular and synaptic plasticity that is induced by single or 
repeated drug exposure. A large body of evidence suggests 
the significance of neuroplasticity in the reward circuit 
consisting of the ventral tegmental area (VTA), the nucleus 
accumbens and the medial prefrontal cortex. However, 
little is known whether other brain regions and plastic 
changes in those regions are also associated with drug 
addiction. Here, we present our recent data showing that 
the brainstem laterodorsal tegmental nucleus (LDT), one of 
the major sources of cholinergic inputs to the VTA, exhibits 
neuroplasticity and plays a critical role in cocaine-induced 
additive behavior. Ex vivo  electrophysiological recordings 
revealed that repeated cocaine exposure induces enhanced 
excitatory synaptic transmission and intrinsic membrane 
excitation in LDT cholinergic neurons. In addition, 
inhibition of cholinergic transmission from the LDT to 
the VTA and restoration of membrane plasticity in LDT 
cholinergic neurons attenuated the expression of cocaine-
induced conditioned place preference. These À ndings suggest 
that plasticity and resultant activity changes in neural 
circuit including the LDT are crucial for cocaine-induced 
addiction.70
S3E-41-4  Involvement of integrin in 
dopaminergic innervation of striatal 
neruons: potential for regeneration of 
the nigrostriatal projection
Yasuhiko Izumi1, Chisato Kanbara1, Seiko Wakita1, 
Toshie Nakai1, Akinori Akaike1,2, Toshiaki Kume1
1Dept. Pharmacol., Grad. Sch. Pharm. Sci., Kyoto Univ., 2Dept. Cell Phamacol., 
Grad. Sch. Pharm. Sci., Nagoya Univ.
The nigrostriatal dopaminergic pathway is noted in 
Parkinson disease, and the regeneration of the projection 
is expected as a promising therapeutic approach. However, 
the precise mechanisms by which dopaminergic axons 
innervate striatal neurons are still unclear. The present 
study demonstrates that integrin ǂ5ǃ1, one of cell adhesion 
molecules, contributes to the innervation. We have 
established a method to evaluate dopaminergic innervation 
of striatal neurons by using primary dissociated cells. When 
mecencephalic cells were adjacently paired-cultured with 
striatal cells, dopaminergic axons extended along striatal 
neurons. In the presence of pharmacological inhibitors of 
integrin ǂ5ǃ1, the dopaminergic innervation was attenuated. 
To clarify the role of integrin ǂ5ǃ1 which is expressed in 
dopaminergic neurons, we prepared a lentivirus expressing 
shRNA targeted to integrin ǂ5. Selective knockdown 
of integrin ǂ5 in mecencepahalic cells suppressed the 
dopaminergic innervation, but selective knockdown in 
striatal cells did not. These results suggest that integrin 
ǂ5ǃ1 in mesencephalic dopaminergic neurons is important 
for their innervations of striatal neurons.
S3F-42-2  Lipid-mediated immune 
network in the development of intestinal 
allergy
Jun Kunisawa1,2
1Lab. Vaccine Materials, NIBIO, 2Inst. of Med. Sci., Univ. Tokyo
Intestinal tissues are equipped with unique immune 
system for maintaining immunological homeostasis, and 
its disruption would lead to the development of immune 
diseases such as food allergy and intestinal inflammation. 
Accumulating evidence has demonstrated that lipids 
play an important role in the regulation of gut immune 
responses and also in the development of intestinal 
immune diseases. Using murine intestinal allergy model, 
we previously reported that pathogenic T and mast cells 
utilized sphingosine 1-phosphate (S1P) in their trafficking 
into the colon during the development of intestinal allergy. 
Thus, treatment with FTY720, an immunosuppressant to 
induce the down-regulation of S1P receptors, resulted in 
the reduced numbers of pathogenic T and mast cells in the 
colon and consequent inhibition of allergic diarrhea. Our 
subsequent study demonstrated that allergic diarrhea was 
similarly diminished when S1P lyase, a key enzyme in the 
S1P degradation, was inhibited, which was associated with 
the decreased numbers of mast cells in the colon. These 
À ndings implicate the pathogenic roles of S1P metabolism in 
the development of intestinal allergy. We also show recent 
findings on the effects of dietary lipids in the control of 
intestinal allergy.SS3F-42-1  Growth regulation of cancer 
stem cells by sphingosine-1-phosphate
Yasunari Kanda
Div. Pharmacol., NIHS
Cancer stem cells (CSCs) have been identified as a minor 
population of cells that display stem cell properties in many 
types of cancer and are considered to be responsible for 
cancer progression and recurrence. Development of CSC-
targeted agents holds new hope for cancer therapy. However, 
growth regulation of CSCs remain poorly understood. 
Using microarray screening in aldehyde dehydrogenase 
(ALDH)-positive breast CSC model, we have identified a 
lipid mediator sphingosine-1-phosphate (S1P) as a novel 
regulator of CSCs. Stimulation with S1P enhances ALDH-
positive CSC phenotype via S1P receptor 3 (S1PR3) via 
crosstalk with Notch signaling in breast cancer cells. CSCs 
overexpressing sphingosine kinase 1 (SphK1), an S1P-
producing enzyme, showed increased ability to develop 
tumors in nude mice, compared with parent cells or CSCs. 
Chronic administration of S1PR3 antagonist inhibited 
tumorigenicity of CSCs overexpressing SphK1. Furthermore, 
patient-derived mammospheres contain SphK1/ALDH1 cells 
or S1PR3/ALDH1 cells. These data suggest that S1P induces 
proliferation of breast CSCs. Our data provide new insights 
into the lipid-mediated regulation of CSCs and pave way for 
targeting CSCs.
S3F-42-3  The role of S1P for 
controlling migration and function of 
bone and immune cells
Masaru Ishii1,2, Junichi Kikuta1,2
1Dept. Immunol. Cell. Biol., Osaka Univ. Grad. Sch. Med., 2JST, CREST
Bone is a dynamic organ that is continuously turned over 
during growth. During bone remodeling, homeostasis 
is regulated by the balance between bone formation by 
osteoblasts and bone resorption by osteoclasts. Since 
osteoclasts are excessively activated in osteolytic diseases, 
the inhibition of osteoclast function has been a major 
therapeutic strategy. We have recently demonstrated 
that sphingosine-1-phosphate (S1P), a biologically active 
lysophospholipid that is enriched in blood, controls the 
trafÀ cking of osteoclast precursors between the circulation 
and bone marrow cavities via G protein-coupled receptors, 
S1PRs. While S1PR1 mediates chemoattraction toward 
S1P in bone marrow, where S1P concentration is low, 
S1PR2 mediates chemorepulsion in blood, where the S1P 
concentration is high. By means of intravital multiphoton 
imaging of bone tissues, we showed that the reciprocal 
action of S1P controls the migration of osteoclast 
precursors between bone tissues and blood stream. Imaging 
technologies have enabled us to visualize the in situ 
behaviors of different cell types in intact tissues. In this 
review we also discuss future perspectives on this new 
method in the À eld of bone biology and immunology.71
S3F-42-4  A novel path-physiological 
role of bioactive lysophospholipid, 
lysophosphatidic acid
Junken Aoki1,2
1Grad. Sch. Pharm. Sci., Tohoku Univ., 2CREST, JST
Lysophosphatidic acid (LPA) elicits various biological 
responses through sinth GPCRs (LPA1-6). LPA is composed 
of an acyl chain of various types at sn-1 or sn-2 position. 
However, the biological role of LPA species remains 
elusive. Recently, we developed an LC-MS/MS system for 
quantitative determination of LPA species. Analysis of 
LPA using the LC-MS/MS system revealed that multiple 
LPA species are present in blood circulation with linoleic, 
arachidonic and Docosahexanoyl acids were the major 
LPA species. We also found that LPA3 is preferentially 
activated by unsaturated 2-acyl LPA species. Interestingly, 
i.v. injection of a potent LPA3-selective agonist (T13) 
produced marked hypotension, bradycardia and apnea, 
which were completely absent in LPA3 KO mice. Bilateral 
cervical vagotomy abolished T13-induced cardio-respiratory 
responses. T13 responses were also attenuated by direct 
topical application of capsaicin to vagal nerves, indicating 
that the activation of LPA3 receptor exerts cardioinhibitory 
responses through vagal afferent nerves. Our current results 
suggest that circulating 2-acyl LPA modulate vagal cardiac 
responses via LPA3 activation and raise the possibility that 
LPA contributes maintaining blood pressure by vagal nerve.S72
